<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="hbm26235" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Hum Brain Mapp</journal-id><journal-id journal-id-type="iso-abbrev">Hum Brain Mapp</journal-id><journal-id journal-id-type="pmc-domain-id">3754</journal-id><journal-id journal-id-type="pmc-domain">humanbrain</journal-id><journal-id journal-id-type="publisher-id">HBM</journal-id><journal-title-group><journal-title>Human Brain Mapping</journal-title></journal-title-group><issn pub-type="ppub">1065-9471</issn><issn pub-type="epub">1097-0193</issn><publisher><publisher-name>Wiley</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10028678</article-id><article-id pub-id-type="pmcid-ver">PMC10028678.1</article-id><article-id pub-id-type="pmcaid">10028678</article-id><article-id pub-id-type="pmcaiid">10028678</article-id><article-id pub-id-type="pmid">36799565</article-id><article-id pub-id-type="doi">10.1002/hbm.26235</article-id><article-id pub-id-type="publisher-id">HBM26235</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Articles</subject></subj-group></article-categories><title-group><article-title>Brain deficit patterns of metabolic illnesses overlap with those for major depressive disorder: A new metric of brain metabolic disease</article-title><alt-title alt-title-type="left-running-head">Hatch et al.</alt-title></title-group><contrib-group><contrib id="hbm26235-cr-0001" contrib-type="author"><name name-style="western"><surname>Hatch</surname><given-names initials="KS">Kathryn S.</given-names></name><xref rid="hbm26235-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="hbm26235-cr-0002" contrib-type="author"><name name-style="western"><surname>Gao</surname><given-names initials="S">Si</given-names></name><xref rid="hbm26235-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="hbm26235-cr-0003" contrib-type="author"><name name-style="western"><surname>Ma</surname><given-names initials="Y">Yizhou</given-names></name><xref rid="hbm26235-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="hbm26235-cr-0004" contrib-type="author"><name name-style="western"><surname>Russo</surname><given-names initials="A">Alessandro</given-names></name><xref rid="hbm26235-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="hbm26235-cr-0005" contrib-type="author"><name name-style="western"><surname>Jahanshad</surname><given-names initials="N">Neda</given-names></name><xref rid="hbm26235-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="hbm26235-cr-0006" contrib-type="author"><name name-style="western"><surname>Thompson</surname><given-names initials="PM">Paul M.</given-names></name><xref rid="hbm26235-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="hbm26235-cr-0007" contrib-type="author"><name name-style="western"><surname>Adhikari</surname><given-names initials="BM">Bhim M.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1164-0989</contrib-id><xref rid="hbm26235-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="hbm26235-cr-0008" contrib-type="author"><name name-style="western"><surname>Bruce</surname><given-names initials="H">Heather</given-names></name><xref rid="hbm26235-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="hbm26235-cr-0009" contrib-type="author"><name name-style="western"><surname>Van der Vaart</surname><given-names initials="A">Andrew</given-names></name><xref rid="hbm26235-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="hbm26235-cr-0010" contrib-type="author"><name name-style="western"><surname>Sotiras</surname><given-names initials="A">Aristeidis</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0795-8820</contrib-id><xref rid="hbm26235-aff-0003" ref-type="aff">
<sup>3</sup>
</xref><xref rid="hbm26235-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="hbm26235-cr-0011" contrib-type="author"><name name-style="western"><surname>Kvarta</surname><given-names initials="MD">Mark D.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1093-1648</contrib-id><xref rid="hbm26235-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="hbm26235-cr-0012" contrib-type="author"><name name-style="western"><surname>Nichols</surname><given-names initials="TE">Thomas E.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4516-5103</contrib-id><xref rid="hbm26235-aff-0005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib id="hbm26235-cr-0013" contrib-type="author"><name name-style="western"><surname>Schmaal</surname><given-names initials="L">Lianne</given-names></name><xref rid="hbm26235-aff-0006" ref-type="aff">
<sup>6</sup>
</xref><xref rid="hbm26235-aff-0007" ref-type="aff">
<sup>7</sup>
</xref></contrib><contrib id="hbm26235-cr-0014" contrib-type="author"><name name-style="western"><surname>Hong</surname><given-names initials="LE">L. Elliot</given-names></name><xref rid="hbm26235-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="hbm26235-cr-0015" contrib-type="author" corresp="yes"><name name-style="western"><surname>Kochunov</surname><given-names initials="P">Peter</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3656-4281</contrib-id><xref rid="hbm26235-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>pkochunov@som.umaryland.edu</email></address></contrib></contrib-group><aff id="hbm26235-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Maryland Psychiatric Research Center, Department of Psychiatry</named-content>
<institution>University of Maryland School of Medicine</institution>
<city>Baltimore</city>
<named-content content-type="country-part">Maryland</named-content>
<country country="US">USA</country>
</aff><aff id="hbm26235-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Imaging Genetics Center, Stevens Neuroimaging and Informatics Institute</named-content>
<institution>Keck School of Medicine of USC</institution>
<city>Marina del Rey</city>
<named-content content-type="country-part">California</named-content>
<country country="US">USA</country>
</aff><aff id="hbm26235-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Institute of Informatics</named-content>
<institution>University of Washington, School of Medicine</institution>
<city>St. Louis</city>
<named-content content-type="country-part">Missouri</named-content>
<country country="US">USA</country>
</aff><aff id="hbm26235-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Department of Radiology</named-content>
<institution>University of Washington, School of Medicine</institution>
<city>St. Louis</city>
<named-content content-type="country-part">Missouri</named-content>
<country country="US">USA</country>
</aff><aff id="hbm26235-aff-0005">
<label>
<sup>5</sup>
</label>
<institution>Nuffield Department of Population Health of the University of Oxford</institution>
<city>Oxford</city>
<country country="GB">UK</country>
</aff><aff id="hbm26235-aff-0006">
<label>
<sup>6</sup>
</label>
<named-content content-type="organisation-division">Centre for Youth Mental Health</named-content>
<institution>The University of Melbourne</institution>
<city>Melbourne</city>
<named-content content-type="country-part">Victoria</named-content>
<country country="AU">Australia</country>
</aff><aff id="hbm26235-aff-0007">
<label>
<sup>7</sup>
</label>
<institution>Orygen</institution>
<city>Parkville</city>
<country country="AU">Australia</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Peter Kochunov, Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, USA.<break/>
Email: <email>pkochunov@som.umaryland.edu</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>17</day><month>2</month><year>2023</year></pub-date><pub-date pub-type="collection"><day>15</day><month>4</month><year>2023</year></pub-date><volume>44</volume><issue seq="380">6</issue><issue-id pub-id-type="pmc-issue-id">431731</issue-id><issue-id pub-id-type="doi">10.1002/hbm.v44.6</issue-id><fpage>2636</fpage><lpage>2653</lpage><history><date date-type="rev-recd"><day>30</day><month>1</month><year>2023</year></date><date date-type="received"><day>10</day><month>11</month><year>2022</year></date><date date-type="accepted"><day>01</day><month>2</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>17</day><month>02</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>22</day><month>03</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-03-22 04:10:11.457"><day>22</day><month>03</month><year>2023</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2023 The Authors. <italic toggle="yes">Human Brain Mapping</italic> published by Wiley Periodicals LLC.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non&#8208;commercial and no modifications or adaptations are made.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="HBM-44-2636.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:HBM-44-2636.pdf"/><abstract><title>Abstract</title><p>Metabolic illnesses (MET) are detrimental to brain integrity and are common comorbidities in patients with mental illnesses, including major depressive disorder (MDD). We quantified effects of MET on standard regional brain morphometric measures from 3D brain MRI as well as diffusion MRI in a large sample of UK BioBank participants. The pattern of regional effect sizes of MET in non&#8208;psychiatric UKBB subjects was significantly correlated with the spatial profile of regional effects reported by the largest meta&#8208;analyses in MDD but not in bipolar disorder, schizophrenia or Alzheimer's disease. We used a regional vulnerability index (RVI) for MET (RVI&#8208;MET) to measure individual's brain similarity to the expected patterns in MET in the UK Biobank sample. Subjects with MET showed a higher effect size for RVI&#8208;MET than for any of the individual brain measures. We replicated elevation of RVI&#8208;MET in a sample of MDD participants with MET versus non&#8208;MET. RVI&#8208;MET scores were significantly correlated with the volume of white matter hyperintensities, a neurological consequence of MET and age, in both groups. Higher RVI&#8208;MET in both samples was associated with obesity, tobacco smoking and frequent alcohol use but was unrelated to antidepressant use. In summary, MET effects on the brain were regionally specific and individual similarity to the pattern was more strongly associated with MET than any regional brain structural metric. Effects of MET overlapped with the reported brain differences in MDD, likely due to higher incidence of MET, smoking and alcohol use in subjects with MDD.</p></abstract><abstract abstract-type="graphical"><p>Metabolic illnesses (MET) are detrimental to brain integrity and are common comorbidities in patients with mental illnesses, including major depressive disorder. We propose a regional vulnerability index for MET (RVI&#8208;MET) to measure each an individual's brain similarity to the expected patterns in MET found by analysis of large scale meta&#8208;data<boxed-text position="anchor" content-type="graphic" id="hbm26235-blkfxd-0001" orientation="portrait"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="HBM-44-2636-g001.jpg"/></boxed-text>
</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="hbm26235-kwd-0001">brain imaging</kwd><kwd id="hbm26235-kwd-0002">major depressive disorder</kwd><kwd id="hbm26235-kwd-0003">metabolic disorders</kwd><kwd id="hbm26235-kwd-0004">regional vulnerability index</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>Dame Kate Campbell Fellowship</funding-source></award-group><award-group id="funding-0002"><funding-source><institution-wrap><institution>National Institutes of Health
</institution><institution-id institution-id-type="doi">10.13039/100000002</institution-id></institution-wrap></funding-source><award-id>R01AG095874</award-id><award-id>R01EB015611</award-id><award-id>R01MH112180</award-id><award-id>R01MH116147</award-id><award-id>R01MH116948</award-id><award-id>R01MH117601</award-id><award-id>S10OD023696</award-id><award-id>U01MH108148</award-id></award-group><award-group id="funding-0003"><funding-source>NHMRC Career Development Fellowship</funding-source><award-id>1140764</award-id></award-group></funding-group><counts><fig-count count="7"/><table-count count="5"/><page-count count="18"/><word-count count="14904"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>April 15, 2023</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.2.6 mode:remove_FC converted:21.03.2023</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="hbm26235-cit-9001"><string-name name-style="western"><surname>Hatch</surname>, <given-names>K. S.</given-names></string-name>, <string-name name-style="western"><surname>Gao</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Ma</surname>, <given-names>Y.</given-names></string-name>, <string-name name-style="western"><surname>Russo</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Jahanshad</surname>, <given-names>N.</given-names></string-name>, <string-name name-style="western"><surname>Thompson</surname>, <given-names>P. M.</given-names></string-name>, <string-name name-style="western"><surname>Adhikari</surname>, <given-names>B. M.</given-names></string-name>, <string-name name-style="western"><surname>Bruce</surname>, <given-names>H.</given-names></string-name>, <string-name name-style="western"><surname>Van der Vaart</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Sotiras</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Kvarta</surname>, <given-names>M. D.</given-names></string-name>, <string-name name-style="western"><surname>Nichols</surname>, <given-names>T. E.</given-names></string-name>, <string-name name-style="western"><surname>Schmaal</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western"><surname>Hong</surname>, <given-names>L. E.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Kochunov</surname>, <given-names>P.</given-names></string-name> (<year>2023</year>). <article-title>Brain deficit patterns of metabolic illnesses overlap with those for major depressive disorder: A new metric of brain metabolic disease</article-title>. <source>Human Brain Mapping</source>, <volume>44</volume>(<issue>6</issue>), <fpage>2636</fpage>&#8211;<lpage>2653</lpage>. <pub-id pub-id-type="doi">10.1002/hbm.26235</pub-id><pub-id pub-id-type="pmid">36799565</pub-id><pub-id pub-id-type="pmcid">PMC10028678</pub-id></mixed-citation>
</p><fn-group><fn id="hbm26235-note-1002"><p>
<bold>Funding information</bold> Dame Kate Campbell Fellowship; National Institutes of Health, Grant/Award Numbers: R01AG095874, R01EB015611, R01MH112180, R01MH116147, R01MH116948, R01MH117601, S10OD023696, U01MH108148; NHMRC Career Development Fellowship, Grant/Award Number: 1140764</p></fn></fn-group></notes></front><body id="hbm26235-body-0001"><sec id="hbm26235-sec-0001"><label>1</label><title>INTRODUCTION</title><p>Chronic metabolic illnesses (MET), including hypertension, diabetes, and hyperlipidemia, are common but often overlooked comorbidities in individuals with mental illness, especially those with major depressive disorder (MDD) (Clarke et al.,&#160;<xref rid="hbm26235-bib-0009" ref-type="bibr">2017</xref>; Papakostas et al.,&#160;<xref rid="hbm26235-bib-0066" ref-type="bibr">2005</xref>; Wu et al.,&#160;<xref rid="hbm26235-bib-0090" ref-type="bibr">2012</xref>). Patients with MDD have a two&#8208; to six&#8208;fold higher risk of having MET than non&#8208;psychiatric controls and individuals with other mental illnesses (Maaroganye et al.,&#160;<xref rid="hbm26235-bib-0050" ref-type="bibr">2013</xref>; Mitchell et al.,&#160;<xref rid="hbm26235-bib-0059" ref-type="bibr">2013</xref>; Toalson et al.,&#160;<xref rid="hbm26235-bib-0081" ref-type="bibr">2004</xref>). The high co&#8208;occurrence of MET in subjects with mental illness was hypothesized to be due to sharing of genetic vulnerabilities and environmental risks, higher smoking and alcohol consumption, and side&#8208;effects of psychiatric medications (Andersohn et al.,&#160;<xref rid="hbm26235-bib-0004" ref-type="bibr">2009</xref>; Hennekens et al.,&#160;<xref rid="hbm26235-bib-0024" ref-type="bibr">2005</xref>; Kirkpatrick et al.,&#160;<xref rid="hbm26235-bib-0031" ref-type="bibr">2008</xref>; Kochunov et al.,&#160;<xref rid="hbm26235-bib-0037" ref-type="bibr">2009</xref>, <xref rid="hbm26235-bib-0035" ref-type="bibr">2010</xref>; Kochunov, Glahn, Lancaster, et al.,&#160;<xref rid="hbm26235-bib-0034" ref-type="bibr">2011</xref>). MET have strongly deleterious effects on brain integrity including accelerated brain aging, lower cognitive scores, formation of hyperintensive white matter necrotic regions and higher rates of dementia (Angoff et al.,&#160;<xref rid="hbm26235-bib-0005" ref-type="bibr">2022</xref>; Du et al.,&#160;<xref rid="hbm26235-bib-0014" ref-type="bibr">2022</xref>; Marseglia et al.,&#160;<xref rid="hbm26235-bib-0056" ref-type="bibr">2021</xref>). Neuroimaging studies in psychiatric illnesses may not fully account for higher rates of MET in patients versus controls, and some of the brain effects reported in mental disorders may be due to higher rates of MET comorbidity in people with mental illnesses (Ferri et al.,&#160;<xref rid="hbm26235-bib-0018" ref-type="bibr">2021</xref>; Ryan et al.,&#160;<xref rid="hbm26235-bib-0072" ref-type="bibr">2022</xref>; Zheng et al.,&#160;<xref rid="hbm26235-bib-0092" ref-type="bibr">2022</xref>).</p><p>MET are common and chronic disorders that typically emerge in the third to fourth decades of life, although some reports suggest adolescence as the age of onset of pathological processes leading to MET (Buterbaugh,&#160;<xref rid="hbm26235-bib-0008" ref-type="bibr">2021</xref>; Suvila et al.,&#160;<xref rid="hbm26235-bib-0080" ref-type="bibr">2021</xref>). MET&#8208;related deficits are observed throughout the brain, including lower cortical thickness and subcortical volumes and lower integrity of cerebral white matter and gliotic changes with detrimental effects on cognition (Hannesdottir et al.,&#160;<xref rid="hbm26235-bib-0023" ref-type="bibr">2009</xref>; Liang et al.,&#160;<xref rid="hbm26235-bib-0045" ref-type="bibr">2019</xref>; Osama et al.,&#160;<xref rid="hbm26235-bib-0063" ref-type="bibr">2020</xref>). Neuroimaging and genetic studies report many similarities between MET and neuropsychiatric illnesses including lower cerebral integrity and shared genetic risk loci and environmental risk factors (Kochunov et al.,&#160;<xref rid="hbm26235-bib-0037" ref-type="bibr">2009</xref>, <xref rid="hbm26235-bib-0035" ref-type="bibr">2010</xref>; Kochunov, Glahn, Lancaster, et al.,&#160;<xref rid="hbm26235-bib-0034" ref-type="bibr">2011</xref>; Ryan et al.,&#160;<xref rid="hbm26235-bib-0072" ref-type="bibr">2022</xref>). For instance, individuals with diabetes tend to have impaired white matter connections between the hippocampus and frontal lobes, as well as reduced volumes of gray matter and subcortical structures and impaired cognitive performance in tests of attention and executive function, information&#8208;processing speed, and memory (Jongen et al.,&#160;<xref rid="hbm26235-bib-0028" ref-type="bibr">2007</xref>; Manschot et al.,&#160;<xref rid="hbm26235-bib-0054" ref-type="bibr">2006</xref>; van Bussel et al.,&#160;<xref rid="hbm26235-bib-0083" ref-type="bibr">2016</xref>; van Harten et al.,&#160;<xref rid="hbm26235-bib-0086" ref-type="bibr">2007</xref>). Diabetes is also associated with altered rates of cerebral glucose metabolism leading to premature aging of the brain (Cohen et al.,&#160;<xref rid="hbm26235-bib-0010" ref-type="bibr">2011</xref>; Reiman et al.,&#160;<xref rid="hbm26235-bib-0068" ref-type="bibr">2010</xref>) and cognitive deficits (Pannacciulli et al.,&#160;<xref rid="hbm26235-bib-0065" ref-type="bibr">2006</xref>; Patriarca et al.,&#160;<xref rid="hbm26235-bib-0067" ref-type="bibr">2017</xref>; Smucny et al.,&#160;<xref rid="hbm26235-bib-0078" ref-type="bibr">2012</xref>; Xu et al.,&#160;<xref rid="hbm26235-bib-0091" ref-type="bibr">2011</xref>). Hypertension is also associated with reduced integrity of white matter microstructure, increased volumes of white matter hyperintensities (WMH) and reduced performance on cognitive tests, in otherwise cognitively healthy participants (Haight et al.,&#160;<xref rid="hbm26235-bib-0022" ref-type="bibr">2018</xref>; Liang et al.,&#160;<xref rid="hbm26235-bib-0046" ref-type="bibr">2022</xref>; Scott et al.,&#160;<xref rid="hbm26235-bib-0076" ref-type="bibr">2015</xref>).</p><p>The higher rates of MET in patients with mental illnesses raise the concern of potential side effects of long&#8208;term use for psychiatric medications. Antipsychotics in particular, may increase the risk of developing metabolic syndrome, obesity, hypertension, and diabetes (Khandker et al.,&#160;<xref rid="hbm26235-bib-0030" ref-type="bibr">2022</xref>; Ouyang et al.,&#160;<xref rid="hbm26235-bib-0064" ref-type="bibr">2022</xref>). Specifically, people taking second generation antipsychotics are at increased risk for developing diabetes compared to patients taking first generation antipsychotics (Nishtala &amp; Chyou,&#160;<xref rid="hbm26235-bib-0060" ref-type="bibr">2017</xref>). Antipsychotic use in adolescent and young adult patients with schizophrenia has been associated with higher overall MET rates (Man et al.,&#160;<xref rid="hbm26235-bib-0053" ref-type="bibr">2022</xref>). Similarly, a study by Andersohn et al. reported that long term antidepressant use was associated with higher rates of diabetes (Andersohn et al.,&#160;<xref rid="hbm26235-bib-0004" ref-type="bibr">2009</xref>). The dose and duration of antidepressant use was significantly correlated with total cholesterol in adults (Noordam et al.,&#160;<xref rid="hbm26235-bib-0061" ref-type="bibr">2015</xref>), including both LDL and HDL levels (Olguner Eker et al.,&#160;<xref rid="hbm26235-bib-0062" ref-type="bibr">2017</xref>). Another study found a positive correlations between the cumulative dose of antidepressants and hypertension (Crookes et al.,&#160;<xref rid="hbm26235-bib-0011" ref-type="bibr">2018</xref>). Conversely, the combined use of antidepressants and antihypertensive drugs resulted in better control over blood pressure in a 24&#8208;week trials versus taking only antihypertensive drugs, especially in older populations (Diminic&#8208;Lisica et al.,&#160;<xref rid="hbm26235-bib-0013" ref-type="bibr">2014</xref>; Fu et al.,&#160;<xref rid="hbm26235-bib-0020" ref-type="bibr">2015</xref>). Overall, there is strong evidence that long&#8208;term use of antipsychotics is associated with risks for MET, but the links between the use of antidepressants and MET are more tenuous.</p><p>Neuroimaging and genetic studies of psychiatric illness may not fully exclude or account for higher MET rates in cases versus controls. Studies by the Enhancing Neuro Imaging Genetics through Meta&#8208;Analysis (ENIGMA) consortium and other collaborations use large, multi&#8208;site, standardized data to report regional effect size patterns of brain deficits in patients with neuropsychiatric illnesses (Kelly et al.,&#160;<xref rid="hbm26235-bib-0029" ref-type="bibr">2018</xref>; Renteria et al.,&#160;<xref rid="hbm26235-bib-0069" ref-type="bibr">2017</xref>; Schmaal et al.,&#160;<xref rid="hbm26235-bib-0074" ref-type="bibr">2017</xref>; van Erp et al.,&#160;<xref rid="hbm26235-bib-0084" ref-type="bibr">2016</xref>, <xref rid="hbm26235-bib-0085" ref-type="bibr">2018</xref>; van Velzen et al.,&#160;<xref rid="hbm26235-bib-0088" ref-type="bibr">2020</xref>). These large&#8208;scale studies have reported robust findings of abnormal white matter microstrucuture, along with lower cortical thickness and subcortical volumes in MDD, bipolar disorder (BD) or schizophrenia spectrum disorder (SSD) (Kochunov, Hong, et al.,&#160;<xref rid="hbm26235-bib-0038" ref-type="bibr">2020</xref>), and other illnesses. The effects of mental illness on brain integrity, as mapped using neuroimaging, are not regionally uniform; instead, some structures such as the hippocampus and the white matter association tracts show deleterious effects of the illness, while many others do not (Schmaal et al.,&#160;<xref rid="hbm26235-bib-0075" ref-type="bibr">2016</xref>; Schmaal et al.,&#160;<xref rid="hbm26235-bib-0074" ref-type="bibr">2017</xref>; van Velzen et al.,&#160;<xref rid="hbm26235-bib-0088" ref-type="bibr">2020</xref>). Regional brain deficit patterns show both similarities and unique features when compared across mental illnesses (Kochunov, Hong, et al.,&#160;<xref rid="hbm26235-bib-0038" ref-type="bibr">2020</xref>). Recently, we showed that an individual brain's similarity to the overall representative pattern of a specific brain illness may serve as a phenotype more sensitive and specific in predicting disease severity than the disease effect on any individual brain structures (Kochunov et al.,&#160;<xref rid="hbm26235-bib-0040" ref-type="bibr">2022</xref>). Here we develop an individual similarity index for MET and use it to study whether effects of MET have contributed to imaging results in mental illnesses.</p><p>We developed a regional vulnerability index (RVI) as a tool to quantify the similarity between brain features of an individual and the pattern of a specific mental illness reported by ENIGMA. Prior studies found that higher RVI for SSD was correlated with poorer treatment response and greater negative symptoms in patients, as well as decreased processing speed in controls (Kochunov, Huang, et al.,&#160;<xref rid="hbm26235-bib-0039" ref-type="bibr">2019</xref>). Alzheimer's disease (AD) RVI measures also revealed similarities between brain abnormalities in SSD and AD (Kochunov, Zavaliangos&#8208;Petropulu, et al.,&#160;<xref rid="hbm26235-bib-0043" ref-type="bibr">2021</xref>), but this index was not significantly elevated in patients with MDD or BD and vice versa (Kochunov et al.,&#160;<xref rid="hbm26235-bib-0040" ref-type="bibr">2022</xref>; Kochunov, Ryan, et al.,&#160;<xref rid="hbm26235-bib-0041" ref-type="bibr">2021</xref>) suggesting RVI also offers some disease specificity. The direct testing of RVI versus a similar index derived from genetic effect sizes&#8212;the polygenic risk score (PRS)&#8212;showed that RVI had greater specificity and stronger effect sizes for case&#8211;control differences than the PRS, further supporting the validity of the RVI construct (Kochunov et al.,&#160;<xref rid="hbm26235-bib-0040" ref-type="bibr">2022</xref>).</p><p>We developed an RVI for MET (RVI&#8208;MET) to further research similar and distinct brain deficits between MET and MDD. We hypothesized that the effects of MET may contribute to the regional neuroimaging patterns of patient&#8208;control differences in mental disorders; we also tested the confounding effects of psychiatric medications and substance use that are higher in people with mental illness. We used a large and representative sample of participants collected from the UKBB to first measure the effects of MET on average and regional brain measures. We then used the anatomical profile of MET deficit patterns to derive an RVI&#8208;MET score for each individual, and to compare the group difference effect sizes for the RVI versus effects of MET on individual brain structures. We then used an independent group of UKBB subjects who were diagnosed with MDD as a replication sample. We replicated the effects of MET on RVI and examined the effects of MDD diagnosis, medication, substance use and depression scores on RVI&#8208;MET.</p></sec><sec sec-type="methods" id="hbm26235-sec-0002"><label>2</label><title>METHODS</title><sec id="hbm26235-sec-0003"><label>2.1</label><title>Participants</title><p>We analyzed data for <italic toggle="yes">N</italic>&#160;=&#160;37,047 (53% Female; age&#160;=&#160;63.7&#8201;&#177;&#8201;7.5&#8201;years) participants in the UK BioBank (UKBB) study from before 2022 (Figure&#160;<xref rid="hbm26235-fig-0001" ref-type="fig">1</xref>) for whom neuroimaging phenotypes were available. We excluded the <italic toggle="yes">N</italic>&#160;=&#160;9510 (48% female, age&#160;=&#160;65.1&#8201;&#177;&#8201;7.5&#8201;years) participants, considered the neuropsychiatric group, who had an ICD10 diagnosis of BD, SSD, AD, Parkinson's disease, stroke, head injury, anxiety, substance abuse/addiction, or demyelinating disease.</p><fig position="float" fig-type="FIGURE" id="hbm26235-fig-0001" orientation="portrait"><label>FIGURE 1</label><caption><p>Flowchart of data sets used for the analyses.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-3" orientation="portrait" xlink:href="HBM-44-2636-g002.jpg"/></fig><p>The remaining <italic toggle="yes">N</italic>&#160;=&#160;27,537 participants who made up the target cohort (55% female, age&#160;=&#160;63.1&#8201;&#177;&#8201;7.5&#8201;years; other summary data in Table&#160;<xref rid="hbm26235-supitem-0001" ref-type="supplementary-material">S1</xref>) were categorized based on ICD10 diagnosis of hyperlipidemia, hypercholesterolemia, diabetes (Type 1 and Type 2), hypertension, and MDD. Of the remaining participants, we identified the clinical cohort <italic toggle="yes">N</italic>&#160;=&#160;5354 (53% female, age&#160;=&#160;62.1&#8201;&#177;&#8201;7.7&#8201;years) who had an ICD10 diagnosis of MET or MDD or who were MET and MDD complete controls (criteria found in Tables&#160;<xref rid="hbm26235-tbl-0001" ref-type="table">1</xref> and <xref rid="hbm26235-tbl-0002" ref-type="table">2</xref>) (flowchart on Figure&#160;<xref rid="hbm26235-fig-0001" ref-type="fig">1</xref>). These participants were divided into four sub&#8208;groups: participants with both MET and MDD, MET+MDD+ (<italic toggle="yes">N</italic>&#160;=&#160;772, 56% female, age&#160;=&#160;65.1&#8201;&#177;&#8201;7.0&#8201;years); participants with MET but no MDD, MET+MDD&#8722; (<italic toggle="yes">N</italic>&#160;=&#160;926, 34% <italic toggle="yes">F</italic>emale, age&#160;=&#160;67.5&#8201;&#177;&#8201;6.8&#8201;years); participants with no MET but with an MDD diagnosis, MET&#8722;MDD+ (<italic toggle="yes">N</italic>&#160;=&#160;990, 74% female, age&#160;=&#160;59.0&#8201;&#177;&#8201;7.1&#8201;years); and participants with neither MET nor MDD, MET&#8722;MDD&#8722; (<italic toggle="yes">N</italic>&#160;=&#160;2666, 52% female, age&#160;=&#160;60.5&#8201;&#177;&#8201;7.2&#8201;years) (Figure&#160;<xref rid="hbm26235-fig-0001" ref-type="fig">1</xref>). The MET&#8722;MDD&#8722; and MET+MDD&#8722; groups were further subdivided and selected for age to create a representative group, which was used to derive the MET related brain changes, and a validation group which was used for the later analyses (Table&#160;<xref rid="hbm26235-tbl-0003" ref-type="table">3</xref>) (UKBB field IDs for MET and MDD Diagnosis found in Table&#160;<xref rid="hbm26235-supitem-0002" ref-type="supplementary-material">S2</xref>).</p><table-wrap position="float" id="hbm26235-tbl-0001" content-type="TABLE" orientation="portrait"><label>TABLE 1</label><caption><p>Criteria for MET based on UKBB blood work, physical data, and diagnoses.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">MET measure</th><th align="left" valign="bottom" rowspan="1" colspan="1">Criteria</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Body mass index</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;30&#8201;BMI</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cholesterol</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;6.2&#8201;mmol/L</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">LDL</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;4.9&#8201;mmol/L</td></tr><tr><td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">HDL</td><td align="left" valign="top" rowspan="1" colspan="1">&gt;1.0&#8201;mmol/L</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Blood pressure</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;140/90&#8201;mmHg</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MET medication<xref rid="hbm26235-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">No</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MET diagnosis</td><td align="left" valign="top" rowspan="1" colspan="1">No</td></tr></tbody></table><table-wrap-foot id="hbm26235-ntgp-0001"><fn id="hbm26235-note-0001"><p>Abbreviations: HDL, high density lipoprotein; LDL, low density lipoprotein; MET, metabolic illnesses; UKBB, UK BioBank.</p></fn><fn id="hbm26235-note-0002"><label>
<sup>a</sup>
</label><p>See Table <xref rid="hbm26235-supitem-0001" ref-type="supplementary-material">SS1</xref>.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="hbm26235-tbl-0002" content-type="TABLE" orientation="portrait"><label>TABLE 2</label><caption><p>Criteria for MDD&#8208;controls based on the UKBB online mental health follow up and diagnoses.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">1.</td><td align="left" valign="top" rowspan="1" colspan="1">Probable recurrent major depression (moderate)</td><td align="left" valign="top" rowspan="1" colspan="1">No</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2.</td><td align="left" valign="top" rowspan="1" colspan="1">Probable recurrent major depression (severe)</td><td align="left" valign="top" rowspan="1" colspan="1">No</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">3.</td><td align="left" valign="top" rowspan="1" colspan="1">Single episode of probable major depression</td><td align="left" valign="top" rowspan="1" colspan="1">No</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">4.</td><td align="left" valign="top" rowspan="1" colspan="1">Seen doctor (GP) for nerves, anxiety, tension or depression</td><td align="left" valign="top" rowspan="1" colspan="1">No</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">5.</td><td align="left" valign="top" rowspan="1" colspan="1">Seen a psychiatrist for nerves, anxiety, tension or depression</td><td align="left" valign="top" rowspan="1" colspan="1">No</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">6.</td><td align="left" valign="top" rowspan="1" colspan="1">Depression possibly related to childbirth</td><td align="left" valign="top" rowspan="1" colspan="1">No</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">7.</td><td align="left" valign="top" rowspan="1" colspan="1">Depression possibly related to stressful or traumatic event</td><td align="left" valign="top" rowspan="1" colspan="1">No</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">8.</td><td align="left" valign="top" rowspan="1" colspan="1">Activities undertaken to treat depression</td><td align="left" valign="top" rowspan="1" colspan="1">No</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">9.</td><td align="left" valign="top" rowspan="1" colspan="1">Substances taken for depression</td><td align="left" valign="top" rowspan="1" colspan="1">No</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">10.</td><td align="left" valign="top" rowspan="1" colspan="1">Number of depression episodes</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">11.</td><td align="left" valign="top" rowspan="1" colspan="1">Days depressed for a whole week</td><td align="left" valign="top" rowspan="1" colspan="1">No</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">12.</td><td align="left" valign="top" rowspan="1" colspan="1">Duration (days) of worst depression</td><td align="left" valign="top" rowspan="1" colspan="1">&lt;1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">13.</td><td align="left" valign="top" rowspan="1" colspan="1">Psychiatric medication<xref rid="hbm26235-note-0004" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">No</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">14.</td><td align="left" valign="top" rowspan="1" colspan="1">Major depressive disorder diagnosis</td><td align="left" valign="top" rowspan="1" colspan="1">No</td></tr></tbody></table><table-wrap-foot id="hbm26235-ntgp-0002"><fn id="hbm26235-note-0003"><p>Abbreviations: MDD, major depressive disorder; UKBB, UK BioBank.</p></fn><fn id="hbm26235-note-0004"><label>
<sup>a</sup>
</label><p>See Table&#160;<xref rid="hbm26235-supitem-0001" ref-type="supplementary-material">SS1</xref>.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="hbm26235-tbl-0003" content-type="TABLE" orientation="portrait"><label>TABLE 3</label><caption><p>Demographics of representative and validation datasets.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="char" char="&#xB1;" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Dataset</th><th align="left" valign="bottom" rowspan="1" colspan="1">MET diagnosis</th><th align="left" valign="bottom" rowspan="1" colspan="1">MDD diagnosis</th><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">N</italic>
</th><th align="left" valign="bottom" rowspan="1" colspan="1">Percent female</th><th align="left" valign="bottom" rowspan="1" colspan="1">Age&#8201;&#177;&#8201;SD</th></tr></thead><tbody valign="top"><tr><td rowspan="2" align="left" valign="top" colspan="1">Representative</td><td align="left" valign="top" rowspan="1" colspan="1">MET&#8722;</td><td align="left" valign="top" rowspan="1" colspan="1">MDD&#8722;</td><td align="left" valign="top" rowspan="1" colspan="1">1110</td><td align="left" valign="top" rowspan="1" colspan="1">51%</td><td align="char" valign="top" rowspan="1" colspan="1">64.6&#160;&#177;&#8201;3.0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MET+</td><td align="left" valign="top" rowspan="1" colspan="1">MDD&#8722;</td><td align="left" valign="top" rowspan="1" colspan="1">470</td><td align="left" valign="top" rowspan="1" colspan="1">33%</td><td align="char" valign="top" rowspan="1" colspan="1">65.9&#160;&#177;&#8201;3.1</td></tr><tr><td rowspan="4" align="left" valign="top" colspan="1">Validation</td><td align="left" valign="top" rowspan="1" colspan="1">MET&#8722;</td><td align="left" valign="top" rowspan="1" colspan="1">MDD&#8722;</td><td align="left" valign="top" rowspan="1" colspan="1">1556</td><td align="left" valign="top" rowspan="1" colspan="1">53%</td><td align="char" valign="top" rowspan="1" colspan="1">57.7&#160;&#177;&#8201;7.9</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MET+</td><td align="left" valign="top" rowspan="1" colspan="1">MDD&#8722;</td><td align="left" valign="top" rowspan="1" colspan="1">456</td><td align="left" valign="top" rowspan="1" colspan="1">35%</td><td align="char" valign="top" rowspan="1" colspan="1">69.1&#160;&#177;&#8201;8.8</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MET&#8722;</td><td align="left" valign="top" rowspan="1" colspan="1">MDD+</td><td align="left" valign="top" rowspan="1" colspan="1">990</td><td align="left" valign="top" rowspan="1" colspan="1">74%</td><td align="char" valign="top" rowspan="1" colspan="1">59.0&#160;&#177;&#8201;7.1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MET+</td><td align="left" valign="top" rowspan="1" colspan="1">MDD+</td><td align="left" valign="top" rowspan="1" colspan="1">772</td><td align="left" valign="top" rowspan="1" colspan="1">56%</td><td align="char" valign="top" rowspan="1" colspan="1">65.1&#160;&#177;&#8201;7.0</td></tr></tbody></table><table-wrap-foot id="hbm26235-ntgp-0003"><fn id="hbm26235-note-0005"><p>Abbreviations: MDD, major depressive disorder; MET, metabolic illnesses.</p></fn></table-wrap-foot></table-wrap><p>Of the target cohort, the remaining <italic toggle="yes">N</italic>&#160;=&#160;22,183 participants (57% female, age&#160;=&#160;63.4&#8201;&#177;&#8201;7.4&#8201;years) did not meet the criteria for complete MET or MDD controls (Tables&#160;<xref rid="hbm26235-tbl-0001" ref-type="table">1</xref> and <xref rid="hbm26235-tbl-0002" ref-type="table">2</xref>) nor were they diagnosed. Because of this, they were considered the subclinical cohort and were used as an independent sample to study associations between individual brain similarity with MET and measures associated with MDD, such as the volume of hyperintensive white matter and a subclinical depression score. This group consisted of <italic toggle="yes">N</italic>&#160;=&#160;7406 (48% female, age&#160;=&#160;64.0&#8201;&#177;&#8201;7.4&#8201;years) participants who did not have a diagnosis of hyperlipidemia, hypertension or high cholesterol, but had elevated blood pressure (&#8805;140/90), body mass index (&#8805;30), and/or cholesterol (total&#160;&#8805;&#8201;6.2, LDL&#160;&#8805;&#8201;4.9, HDL&#160;&#8804;&#8201;1.0) based on the physicals performed for the UKBB, and were thus considered &#8220;at risk&#8221; for MET (UKBB field IDs for subclinical MET and MDD found in Table&#160;<xref rid="hbm26235-supitem-0003" ref-type="supplementary-material">S3</xref>).</p><p>Similarly, <italic toggle="yes">N</italic>&#160;=&#160;6351 individuals (63% female, age&#160;=&#160;61.7&#8201;&#177;&#8201;7.5&#8201;years) were not diagnosed with MDD but also had scored highly for subclinical depression and therefore did not meet the conditions for controls (Table&#160;<xref rid="hbm26235-tbl-0003" ref-type="table">3</xref>) only. The remaining <italic toggle="yes">N</italic>&#160;=&#160;8426 individuals (57% female, age&#160;=&#160;64.0&#8201;&#177;&#8201;7.1&#8201;years) were considered &#8220;at risk&#8221; for both MDD and MET as they had elevated blood pressure, cholesterol, or lipids and/or scored highly on the subclinical depression measures (Figure&#160;<xref rid="hbm26235-fig-0001" ref-type="fig">1</xref>).</p></sec><sec id="hbm26235-sec-0004"><label>2.2</label><title>Neuroimaging data acquisition and processing</title><p>Neuroimaging data were extracted from the UKBB website using the &#8220;<monospace>ukbfetch</monospace>&#8221; bulk data command. The UK UKBB imaging data were collected using a Siemens Skyra 3&#160;T scanner 32&#8208;channgel RF head coil with high resolution T1&#8208;weighted (resolution&#160;=&#160;1&#8201;&#215;&#8201;1&#8201;&#215;&#8201;1&#8201;mm<sup>3</sup>, FOV&#160;=&#160;208&#8201;&#215;&#8201;256&#8201;&#215;&#8201;256, duration&#160;=&#160;5&#160;min, 3D MPRAGE, sagittal, in&#8208;plane acceleration iPAT&#160;=&#160;2, prescan&#8208;normalize) and T2 FLAIR (resolution&#160;=&#160;1.05&#8201;&#215;&#8201;1&#8201;&#215;&#8201;1&#8201;mm<sup>3</sup>, FOV&#160;=&#160;192&#8201;&#215;&#8201;256&#8201;&#215;&#8201;256, duration&#160;=&#160;6&#160;min, 3D SPACE, sagittal, in&#8208;plane acceleration iPAT&#160;=&#160;2, partial 7/8 Fourier sampling) images. Diffusion data were collected with a resolution&#160;=&#160;2&#8201;&#215;&#8201;2&#8201;&#215;&#8201;2&#8201;mm<sup>3</sup> and two diffusion shells of <italic toggle="yes">b</italic>&#160;=&#160;1000 and 2000&#8201;s/mm<sup>2</sup> with 50 diffusions direction per shell, 5<italic toggle="yes">b</italic>&#160;=&#160;0 images, FOV&#160;=&#160;104&#8201;&#215;&#8201;104&#8201;&#215;&#8201;72, and a 7&#8208;min duration.</p><p>We used regional data including cortical gray matter thickness, gray matter volume (subcortical structures), and white matter fractional anisotropy (FA) tract imaging data provided by the UKB. Data were extracted using the UKBB workflow, based on the ENIGMA structural and DTI pipelines. Imaging preprocessing and analysis are all recorded in the UKBB Brain Imaging Document (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://biobank.ctsu.ox.ac.uk/crystal/crystal/docs/brain_mri.pdf" ext-link-type="uri">biobank.ctsu.ox.ac.uk/crystal/crystal/docs/brain_mri.pdf</ext-link>), which provides left and right hemisphere measurements of regional cortical gray matter thickness (35), subcortical gray matter volume (7) and white matter FA (24). Hemispheric data were averaged.</p><p>Fluid attenuated inversion recovery (FLAIR) T2&#8208;hyperintensive volumes for white matter were extracted directly from the UKBB category and normalized using the natural log.</p></sec><sec id="hbm26235-sec-0005"><label>2.3</label><title>Non&#8208;imaging data acquisition</title><p>Non&#8208;imaging data were extracted using the UKBB's Data Access Guide (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://biobank.ctsu.ox.ac.uk/%7Ebbdatan/Data_Access_Guide_v3.0.pdf" ext-link-type="uri">https://biobank.ctsu.ox.ac.uk/~bbdatan/Data_Access_Guide_v3.0.pdf</ext-link>) command &#8220;<monospace>ukbconv</monospace>&#8221; to a csv file. Field IDs that were used to extract data can be found in Tables&#160;<xref rid="hbm26235-supitem-0002" ref-type="supplementary-material">[Link]</xref>, <xref rid="hbm26235-supitem-0008" ref-type="supplementary-material">[Link]</xref>. Non&#8208;imaging data were extracted from timepoints that corresponded with imaging data collection. Some data were only collected by the UKBB at one timepoint. Data were then binarized based on the criteria in the following sections.</p></sec><sec id="hbm26235-sec-0006"><label>2.4</label><title>Depression symptoms, medication usage, and alcohol and smoking habits</title><p>Subclinical depression symptom scores were created from participant ratings of subclinical symptoms from the online survey including: &#8220;felt down, depressed, or hopeless&#8221;, &#8220;had little interest or pleasure in doing things&#8221;, &#8220;felt tense, fidgety, or restless&#8221;, and &#8220;felt tired or had little energy&#8221;, over a two&#8208;week period. Symptoms were scored as feeling &#8220;not at all&#8221; to &#8220;nearly every day&#8221; (0&#8211;3). Scores were then summed for each participant and transformed to a four&#8208;point scale of subclinical depression severity: 0&#8212;no symptoms, 1&#8212;few symptoms, 2&#8212;mild symptoms, and 3&#8212;increased symptoms (UKBB field IDs found in Table&#160;<xref rid="hbm26235-supitem-0005" ref-type="supplementary-material">S5</xref>).</p><p>Medication usage was recorded from the UKBB medication and treatment codes (Tables&#160;<xref rid="hbm26235-supitem-0006" ref-type="supplementary-material">S6</xref> and <xref rid="hbm26235-supitem-0007" ref-type="supplementary-material">S7</xref>), as well as the online survey. The survey collected information on medication usage for depression (prescribed and unprescribed), diabetes, high blood pressure, and high cholesterol.</p><p>Fifty&#8208;one percent of the participants in the validation set had records of weekly alcohol consumption information, and all participants had daily smoking habit information recorded. Daily smokers were defined as participants who smoked every day. Social drinkers were considered those drinking an average of 7 or fewer alcoholic beverages per week, while heavy drinkers were defined by drinking an average of more than 7 alcoholic beverages weekly (UKBB field IDs found in Table&#160;<xref rid="hbm26235-supitem-0008" ref-type="supplementary-material">S8</xref>).</p></sec><sec id="hbm26235-sec-0007"><label>2.5</label><title>Metabolic effect size comparison with neuropsychiatric effects</title><p>All statistical analyses were performed in RStudio v4.1.1 (RStudioTeam,&#160;<xref rid="hbm26235-bib-0071" ref-type="bibr">2020</xref>). Metabolic effect sizes were created from the representative set, comparing regional imaging data in the MET+ and MET&#8208;free testing group (Table&#160;<xref rid="hbm26235-tbl-0001" ref-type="table">1</xref>) with the R packages &#8220;effsize&#8221; (Torchiano,&#160;<xref rid="hbm26235-bib-0082" ref-type="bibr">2020</xref>) and &#8220;psych&#8221; (Revelle,&#160;<xref rid="hbm26235-bib-0070" ref-type="bibr">2021</xref>). Effect sizes were calculated for ENIGMA&#8208;based regional cortical thickness, subcortical volume, and white matter FA values, as well as whole&#8208;brain average cortical thickness, subcortical gray matter volume and white matter FA. The neuropsychiatric effect sizes, including those for SSD, BD, MDD (Schmaal et al.,&#160;<xref rid="hbm26235-bib-0075" ref-type="bibr">2016</xref>, <xref rid="hbm26235-bib-0074" ref-type="bibr">2017</xref>; van Velzen et al.,&#160;<xref rid="hbm26235-bib-0088" ref-type="bibr">2020</xref>), and AD (Kochunov et al.,&#160;<xref rid="hbm26235-bib-0040" ref-type="bibr">2022</xref>), were calculated in the largest meta&#8208;analytical samples for corresponding illnesses.</p></sec><sec id="hbm26235-sec-0008"><label>2.6</label><title>Metabolic regional vulnerability index</title><p>The metabolic effects were used to create the cortical, subcortical, and white matter Metabolic Regional Vulnerability Index (RVI&#8208;MET) scores based on the protocol documented in Kochunov, Fan, et al. (<xref rid="hbm26235-bib-0032" ref-type="bibr">2020</xref>), using the &#8220;RVIpkg&#8221; (Gao et al.,&#160;<xref rid="hbm26235-bib-0021" ref-type="bibr">2021</xref>). Briefly, RVI&#8208;MET scores were calculated by first regressing the effects of age, sex, and intracranial volume from the imaging phenotypes for each individual, transforming the residuals of the imaging phenotypes by inverse normalization, and then standardizing the normalized residuals to <italic toggle="yes">z</italic>&#8208;scores using the average and standard deviation of the MET controls. The Pearson correlation coefficient was then calculated between the individual participants' <italic toggle="yes">z</italic> scores and corresponding effect sizes for metabolic versus control group differences previously created. The whole&#8208;brain RVI&#8208;MET was calculated by averaging the three regional RVIs.</p></sec><sec id="hbm26235-sec-0009"><label>2.7</label><title>Statistical analysis of <styled-content style="fixed-case" toggle="no">RVI&#8208;MET</styled-content>
</title><p>The significance of statistical analyses was evaluated after adjusting for multiple effect size comparisons using Benjamini&#8211;Hochberg correction. Cohen's <italic toggle="yes">d</italic> effect sizes were used to present the differences between MET+ and MET&#8722; groups in the RVI validation dataset (Table&#160;<xref rid="hbm26235-tbl-0003" ref-type="table">3</xref>), with no overlap with participants used to derive RVI. First, the MDD&#8208; groups were compared to investigate how well the RVI&#8208;MET captured the effects of MET in the non&#8208;psychiatric group (MET+MDD&#8722; vs. MET&#8722;MDD&#8722;). Then the effects of MET on RVI&#8208;MET were assessed within the psychiatric group (MET+MDD+ vs. MET&#8722;MDD+). Analysis of variance (ANOVA) in the validation set, using Tukey's test of honest significance difference, was used to test the significant differences between the mean RVI&#8208;MET in each group for all regional and whole&#8208;brain RVIs.</p><p>Increased FLAIR volume is a common neurological consequence of MET. We used it as a proxy measure to evaluate the sensitivity of the whole&#8208;brain and tissue specific RVI to a well&#8208;known effect of MET on the brain. We hypothesized that RVI will capture the whole&#8208;brain nature of MET and therefore, cortical and subcortical RVI will be associated with higher white matter hyperintensity volumes. We tested this hypothesis using a correlation analysis between whole&#8208;brain and tissue specific RVI&#8208;MET and the age and sex corrected residuals for the total FLAIR hyperintensity volume.</p><p>The separate smoking and alcohol habits as well as MET and MDD medication and subclinical depression score <italic toggle="yes">t</italic>&#8208;test analyses were performed in the validation set and subclinical set combined. Correlation analyses with the whole&#8208;brain and regional RVIs were performed using the average weekly number of drinks and daily number of cigarettes, with a Holm's adjusted <italic toggle="yes">p</italic>&#8208;value.</p><p>A full linear regression model was run on the whole&#8208;brain and regional RVI&#8208;MET (Equation 1):<disp-formula id="hbm26235-disp-0001"><label>(1)</label><mml:math id="jats-math-1" display="block" overflow="scroll"><mml:mtable columnalign="left" displaystyle="true"><mml:mtr><mml:mtd><mml:mi mathvariant="normal">RVI</mml:mi><mml:mo>~</mml:mo><mml:msub><mml:mi>&#946;</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:msup><mml:msub><mml:mi>&#946;</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>*</mml:mo></mml:msup><mml:msub><mml:mi mathvariant="normal">DX</mml:mi><mml:mi mathvariant="normal">MET</mml:mi></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:msup><mml:msub><mml:mi>&#946;</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>*</mml:mo></mml:msup><mml:msub><mml:mi mathvariant="normal">DX</mml:mi><mml:mi mathvariant="normal">MDD</mml:mi></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:msup><mml:msub><mml:mi>&#946;</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mo>*</mml:mo></mml:msup><mml:mtext>Smoke</mml:mtext><mml:mo linebreak="goodbreak">+</mml:mo><mml:msup><mml:msub><mml:mi>&#946;</mml:mi><mml:mn>4</mml:mn></mml:msub><mml:mo>*</mml:mo></mml:msup><mml:mtext>Alcohol</mml:mtext></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mspace width="1em"/><mml:mo linebreak="goodbreak">+</mml:mo><mml:mspace width="2px"/><mml:msup><mml:msub><mml:mi>&#946;</mml:mi><mml:mn>5</mml:mn></mml:msub><mml:mo>*</mml:mo></mml:msup><mml:msup><mml:msub><mml:mi mathvariant="normal">DX</mml:mi><mml:mi mathvariant="normal">MET</mml:mi></mml:msub><mml:mo>*</mml:mo></mml:msup><mml:msub><mml:mi mathvariant="normal">DX</mml:mi><mml:mi mathvariant="normal">MDD</mml:mi></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:msup><mml:msub><mml:mi>&#946;</mml:mi><mml:mn>6</mml:mn></mml:msub><mml:mo>*</mml:mo></mml:msup><mml:mi mathvariant="normal">BMI</mml:mi><mml:mo linebreak="goodbreak">+</mml:mo><mml:msup><mml:msub><mml:mi>&#946;</mml:mi><mml:mn>7</mml:mn></mml:msub><mml:mo>*</mml:mo></mml:msup><mml:mi mathvariant="normal">Age</mml:mi><mml:mo linebreak="goodbreak">+</mml:mo><mml:msup><mml:msub><mml:mi>&#946;</mml:mi><mml:mn>8</mml:mn></mml:msub><mml:mo>*</mml:mo></mml:msup><mml:mi mathvariant="normal">Sex</mml:mi><mml:mo linebreak="goodbreak">+</mml:mo><mml:msup><mml:msub><mml:mi>&#946;</mml:mi><mml:mn>9</mml:mn></mml:msub><mml:mo>*</mml:mo></mml:msup><mml:msup><mml:mi mathvariant="normal">Age</mml:mi><mml:mo>*</mml:mo></mml:msup><mml:mi mathvariant="normal">Sex</mml:mi><mml:mo linebreak="goodbreak">+</mml:mo><mml:mi>&#949;</mml:mi><mml:mo>,</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:math></disp-formula>where elevation in the whole&#8208;brain and tissue&#8208;specific RVI&#8208;MET scores were predicted using the following variables: DX is the MET and MDD diagnosis, Smoke is whether a participant smokes regularly or not, Alcohol is whether a participant is a social, heavy or non&#8208;drinker, and BMI is the body mass index. <italic toggle="yes">&#946;</italic>
<sub>0</sub> is the intercept, <italic toggle="yes">&#946;</italic>
<sub>1,2,3,4,5,6,7,8,9</sub> are the regression coefficients, and <italic toggle="yes">&#949;</italic> is the random error.</p></sec></sec><sec sec-type="results" id="hbm26235-sec-0010"><label>3</label><title>RESULTS</title><sec id="hbm26235-sec-0011"><label>3.1</label><title>Effects of <styled-content style="fixed-case" toggle="no">MET</styled-content> on average and regional brain integrity</title><p>In the representative dataset, the average FA of cerebral white matter (WM) was significantly lower in MET participants than in controls (<italic toggle="yes">d</italic>&#160;=&#160;&#8722;0.22, <italic toggle="yes">p</italic>&#160;=&#160;.0004). The effects of MET were not significant for the average subcortical gray matter (SUB) (<italic toggle="yes">d</italic>&#160;=&#160;&#8722;0.13, <italic toggle="yes">p</italic>&#160;=&#160;.06) nor for the average gray matter (GM) thickness (<italic toggle="yes">d</italic>&#160;=&#160;0.02, <italic toggle="yes">p</italic>&#160;=&#160;.84) (Figure&#160;<xref rid="hbm26235-fig-0002" ref-type="fig">2</xref>).</p><fig position="float" fig-type="FIGURE" id="hbm26235-fig-0002" orientation="portrait"><label>FIGURE 2</label><caption><p>Metabolic illness effect sizes are ranked here, for the average white matter, subcortical volume and grey matter thickness, and regional effect sizes (largest significant effects: PTR, posterior thalamic radiation; FXST, fornix/stria terminalis; GCC, genu of the corpus collosum; ALIC, anterior limb of the internal capsule). Significance set at Benjamini&#8211;Hochberg adjusted <italic toggle="yes">p</italic>&#8201;&lt;&#8201;.05.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-5" orientation="portrait" xlink:href="HBM-44-2636-g003.jpg"/></fig><p>MET effects were significant for 23 out of 68 regional measurements, following the Benjamini&#8211;Hochberg procedure for multiple comparisons (Table&#160;<xref rid="hbm26235-tbl-0004" ref-type="table">4</xref>). The strongest effects were observed for the FA of the posterior thalamic radiation (<italic toggle="yes">d</italic>&#160;=&#160;&#8722;0.28, <italic toggle="yes">p</italic>&#160;=&#160;2.54&#8201;&#215;&#8201;10<sup>&#8722;5</sup>), the fornix (<italic toggle="yes">d</italic>&#160;=&#160;&#8722;0.28, <italic toggle="yes">p</italic>&#160;=&#160;1.48&#8201;&#215;&#8201;10<sup>&#8722;5</sup>), the genu of the corpus collosum (<italic toggle="yes">d</italic>&#160;=&#160;&#8722;0.28, <italic toggle="yes">p</italic>&#160;=&#160;1.26&#8201;&#215;&#8201;10<sup>&#8722;5</sup>), and the anterior limb of the internal capsule (<italic toggle="yes">d</italic>&#160;=&#160;&#8722;0.26, <italic toggle="yes">p</italic>&#160;=&#160;3.23&#8201;&#215;&#8201;10<sup>&#8722;5</sup>). For subcortical GM, the volume of thalamus (<italic toggle="yes">d</italic>&#160;=&#160;&#8722;0.23, <italic toggle="yes">p</italic>&#160;=&#160;2.74&#8201;&#215;&#8201;10<sup>&#8722;4</sup>) was the only structure that showed significant MET effects. The cortical thickness of the insula showed the strongest negative effects (<italic toggle="yes">d</italic>&#160;=&#160;&#8722;0.19, <italic toggle="yes">p</italic>&#160;=&#160;.004), followed by the superior temporal gyrus (<italic toggle="yes">d</italic>&#160;=&#160;&#8722;0.16, <italic toggle="yes">p</italic>&#160;=&#160;.01).</p><table-wrap position="float" id="hbm26235-tbl-0004" content-type="TABLE" orientation="portrait"><label>TABLE 4</label><caption><p>Regional effects of MET on brain integrity with <italic toggle="no">p</italic>&#8208;values adjusted for <italic toggle="no">N</italic>&#160;=&#160;68 calculations using the Benjamini&#8211;Hochberg adjusted <italic toggle="no">p</italic>&#8208;values.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="char" char="." span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="left" valign="bottom" rowspan="1" colspan="1">Region</th><th align="left" valign="bottom" rowspan="1" colspan="1">Cohen's <italic toggle="yes">d</italic>
</th><th align="left" valign="bottom" rowspan="1" colspan="1">Adjusted <italic toggle="yes">p</italic>&#8208;values</th></tr></thead><tbody valign="top"><tr><td rowspan="25" align="left" valign="top" colspan="1">White matter</td><td align="left" valign="top" rowspan="1" colspan="1">Posterior thalamic radiation</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.28</td><td align="left" valign="top" rowspan="1" colspan="1">
<bold>2.54&#160;&#215;&#8201;10</bold>
<sup>
<bold>&#8722;5</bold>
</sup>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fornix (crus)/stria terminalis</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.28</td><td align="left" valign="top" rowspan="1" colspan="1">
<bold>1.48&#160;&#215;&#8201;10</bold>
<sup>
<bold>&#8722;5</bold>
</sup>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Genu of the CC</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.28</td><td align="left" valign="top" rowspan="1" colspan="1">
<bold>1.26&#160;&#215;&#8201;10</bold>
<sup>
<bold>&#8722;5</bold>
</sup>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Anterior limb of the IC</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.26</td><td align="left" valign="top" rowspan="1" colspan="1">
<bold>3.23&#160;&#215;&#8201;10</bold>
<sup>
<bold>&#8722;5</bold>
</sup>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sagittal stratum</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.24</td><td align="left" valign="top" rowspan="1" colspan="1">
<bold>2.01&#160;&#215;&#8201;10</bold>
<sup>
<bold>&#8722;4</bold>
</sup>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Superior longitudinal fasciculus</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.24</td><td align="left" valign="top" rowspan="1" colspan="1">
<bold>1.82&#160;&#215;&#8201;10</bold>
<sup>
<bold>&#8722;4</bold>
</sup>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Superior frontooccipital fasciculus</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.22</td><td align="left" valign="top" rowspan="1" colspan="1">
<bold>5.18&#160;&#215;&#8201;10</bold>
<sup>
<bold>&#8722;4</bold>
</sup>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Anterior CR</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.21</td><td align="left" valign="top" rowspan="1" colspan="1">
<bold>1.24&#160;&#215;&#8201;10</bold>
<sup>
<bold>&#8722;3</bold>
</sup>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">External capsule</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.19</td><td align="left" valign="top" rowspan="1" colspan="1">
<bold>2.59&#160;&#215;&#8201;10</bold>
<sup>
<bold>&#8722;3</bold>
</sup>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Corona radiata</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.17</td><td align="left" valign="top" rowspan="1" colspan="1">
<bold>.01</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Uncinate fasciculus</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.16</td><td align="left" valign="top" rowspan="1" colspan="1">
<bold>.01</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Corpus collosum</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.16</td><td align="left" valign="top" rowspan="1" colspan="1">
<bold>.02</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Internal capsule</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.16</td><td align="left" valign="top" rowspan="1" colspan="1">
<bold>.02</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fornix</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.16</td><td align="left" valign="top" rowspan="1" colspan="1">
<bold>.02</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Body of the CC</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.15</td><td align="left" valign="top" rowspan="1" colspan="1">
<bold>.03</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cingulum cingulate gyrus</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.13</td><td align="left" valign="top" rowspan="1" colspan="1">
<bold>.04</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Superior CR</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.12</td><td align="left" valign="top" rowspan="1" colspan="1">.08</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Posterior CR</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.10</td><td align="left" valign="top" rowspan="1" colspan="1">.15</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Retrolenticular limb of the IC</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.10</td><td align="left" valign="top" rowspan="1" colspan="1">.18</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Tapetum</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.04</td><td align="left" valign="top" rowspan="1" colspan="1">.65</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cingulum hippocampus</td><td align="char" valign="top" rowspan="1" colspan="1">0.04</td><td align="left" valign="top" rowspan="1" colspan="1">.65</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Posterior limb of the IC</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.03</td><td align="left" valign="top" rowspan="1" colspan="1">.72</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cortico spinal tract</td><td align="char" valign="top" rowspan="1" colspan="1">0.02</td><td align="left" valign="top" rowspan="1" colspan="1">.83</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Splenium of the CC</td><td align="char" valign="top" rowspan="1" colspan="1">0.01</td><td align="left" valign="top" rowspan="1" colspan="1">.92</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Average effect</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.22</td><td align="left" valign="top" rowspan="1" colspan="1">
<bold>4.36&#160;&#215;&#8201;10</bold>
<sup>
<bold>&#8722;4</bold>
</sup>
</td></tr><tr><td rowspan="34" align="left" valign="top" colspan="1">Grey matter thickness</td><td align="left" valign="top" rowspan="1" colspan="1">Insula</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.19</td><td align="left" valign="top" rowspan="1" colspan="1">
<bold>4.27&#160;&#215;&#8201;10</bold>
<sup>
<bold>&#8722;3</bold>
</sup>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Superior temporal</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.16</td><td align="left" valign="top" rowspan="1" colspan="1">
<bold>.01</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Lateral occipital</td><td align="char" valign="top" rowspan="1" colspan="1">0.16</td><td align="left" valign="top" rowspan="1" colspan="1">
<bold>.02</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Pericalcarine</td><td align="char" valign="top" rowspan="1" colspan="1">0.15</td><td align="left" valign="top" rowspan="1" colspan="1">
<bold>.02</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Superior parietal</td><td align="char" valign="top" rowspan="1" colspan="1">0.14</td><td align="left" valign="top" rowspan="1" colspan="1">
<bold>.04</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Medial orbitofrontal</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.13</td><td align="left" valign="top" rowspan="1" colspan="1">
<bold>.04</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cuneus</td><td align="char" valign="top" rowspan="1" colspan="1">0.11</td><td align="left" valign="top" rowspan="1" colspan="1">.10</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Lingual</td><td align="char" valign="top" rowspan="1" colspan="1">0.11</td><td align="left" valign="top" rowspan="1" colspan="1">.10</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rostral middle frontal</td><td align="char" valign="top" rowspan="1" colspan="1">0.10</td><td align="left" valign="top" rowspan="1" colspan="1">.14</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Frontal pole</td><td align="char" valign="top" rowspan="1" colspan="1">0.09</td><td align="left" valign="top" rowspan="1" colspan="1">.20</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Middle temporal</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.08</td><td align="left" valign="top" rowspan="1" colspan="1">.28</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Pars orbitalis</td><td align="char" valign="top" rowspan="1" colspan="1">0.08</td><td align="left" valign="top" rowspan="1" colspan="1">.29</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Precuneus</td><td align="char" valign="top" rowspan="1" colspan="1">0.07</td><td align="left" valign="top" rowspan="1" colspan="1">.34</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Inferior temporal</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.07</td><td align="left" valign="top" rowspan="1" colspan="1">.39</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Paracentral</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.07</td><td align="left" valign="top" rowspan="1" colspan="1">.39</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Pars opercularis</td><td align="char" valign="top" rowspan="1" colspan="1">0.06</td><td align="left" valign="top" rowspan="1" colspan="1">.43</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Postcentral</td><td align="char" valign="top" rowspan="1" colspan="1">0.06</td><td align="left" valign="top" rowspan="1" colspan="1">.50</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Parahippocampal</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.05</td><td align="left" valign="top" rowspan="1" colspan="1">.55</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Pars triangularis</td><td align="char" valign="top" rowspan="1" colspan="1">0.05</td><td align="left" valign="top" rowspan="1" colspan="1">.58</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Lateral orbitofrontal</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.04</td><td align="left" valign="top" rowspan="1" colspan="1">.63</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rostral anterior cingulate</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.04</td><td align="left" valign="top" rowspan="1" colspan="1">.64</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Caudal middle frontal</td><td align="char" valign="top" rowspan="1" colspan="1">0.03</td><td align="left" valign="top" rowspan="1" colspan="1">.74</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Transverse temporal</td><td align="char" valign="top" rowspan="1" colspan="1">0.03</td><td align="left" valign="top" rowspan="1" colspan="1">.75</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Supramarginal</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.02</td><td align="left" valign="top" rowspan="1" colspan="1">.82</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Inferior parietal</td><td align="char" valign="top" rowspan="1" colspan="1">0.02</td><td align="left" valign="top" rowspan="1" colspan="1">.84</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Isthmus cingulate</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.02</td><td align="left" valign="top" rowspan="1" colspan="1">.83</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Posterior cingulate</td><td align="char" valign="top" rowspan="1" colspan="1">0.02</td><td align="left" valign="top" rowspan="1" colspan="1">.83</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fusiform</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.02</td><td align="left" valign="top" rowspan="1" colspan="1">.84</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Precentral</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">.85</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Banks of superior temporal sulcus</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">.88</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Entorhinal</td><td align="char" valign="top" rowspan="1" colspan="1">0.01</td><td align="left" valign="top" rowspan="1" colspan="1">.87</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Caudal anterior cingulate</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.01</td><td align="left" valign="top" rowspan="1" colspan="1">.89</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Superior frontal</td><td align="char" valign="top" rowspan="1" colspan="1">0.00</td><td align="left" valign="top" rowspan="1" colspan="1">.93</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Average effect</td><td align="char" valign="top" rowspan="1" colspan="1">0.01</td><td align="left" valign="top" rowspan="1" colspan="1">.84</td></tr><tr><td rowspan="8" align="left" valign="top" colspan="1">Subcortical volumes</td><td align="left" valign="top" rowspan="1" colspan="1">Thalamus</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.23</td><td align="left" valign="top" rowspan="1" colspan="1">
<bold>2.74&#160;&#215;&#8201;10</bold>
<sup>
<bold>&#8722;4</bold>
</sup>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Palladium</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.11</td><td align="left" valign="top" rowspan="1" colspan="1">.12</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Accumbens</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.09</td><td align="left" valign="top" rowspan="1" colspan="1">.20</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hippocampus</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.06</td><td align="left" valign="top" rowspan="1" colspan="1">.50</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Caudate</td><td align="char" valign="top" rowspan="1" colspan="1">0.05</td><td align="left" valign="top" rowspan="1" colspan="1">.62</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Amygdala</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.03</td><td align="left" valign="top" rowspan="1" colspan="1">.73</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Putamen</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.03</td><td align="left" valign="top" rowspan="1" colspan="1">.73</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Average effect</td><td align="char" valign="top" rowspan="1" colspan="1">&#8722;0.13</td><td align="left" valign="top" rowspan="1" colspan="1">.06</td></tr></tbody></table></table-wrap><p>The regional effects of MET in non&#8208;psychiatric MET individuals and regional effect sizes for MDD as estimated in ENIGMA showed significant correlation (<italic toggle="yes">r</italic>&#160;=&#160;0.70, adj. <italic toggle="yes">p</italic>&#8201;&lt;&#8201;.0001) (Figure&#160;<xref rid="hbm26235-fig-0003" ref-type="fig">3</xref>), although the effect was mainly driven by white matter and subcortical effects. There was no significant correlation between SSD (<italic toggle="yes">r</italic>&#160;=&#160;0.18, adj. <italic toggle="yes">p</italic>&#160;=&#160;.9), BD (<italic toggle="yes">r</italic>&#160;=&#160;0.28, adj. <italic toggle="yes">p</italic>&#160;=&#160;.2), and AD (<italic toggle="yes">r</italic>&#160;=&#160;&#8722;0.03, adj. <italic toggle="yes">p</italic>&#160;=&#160;.9), and MET regional effect sizes.</p><fig position="float" fig-type="FIGURE" id="hbm26235-fig-0003" orientation="portrait"><label>FIGURE 3</label><caption><p>Correlation between the UK Biobank based metabolic regional effect sizes and the ENIGMA based major depressive disorder effect sizes.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-7" orientation="portrait" xlink:href="HBM-44-2636-g006.jpg"/></fig></sec><sec id="hbm26235-sec-0012"><label>3.2</label><title>Effect size of <styled-content style="fixed-case" toggle="no">MET</styled-content> on <styled-content style="fixed-case" toggle="no">RVI</styled-content> versus regional measures</title><p>We used the regional effect sizes (Table&#160;<xref rid="hbm26235-tbl-0004" ref-type="table">4</xref>) to calculate RVI&#8208;MET in the target cohort and used the validation dataset to compare RVI&#8208;MET between participants with MET and those without in both the MDD patients and controls. Compared to MET&#8208;free participants, the effect size for the elevation of the whole&#8208;brain RVI in nonpsychiatric individuals with MET (Cohen's <italic toggle="yes">d</italic>&#160;=&#160;0.37, <italic toggle="yes">p</italic>&#160;=&#160;1&#8201;&#215;&#8201;10<sup>&#8722;12</sup>) was significantly higher than those for average and regional brain measurements (Table&#160;<xref rid="hbm26235-tbl-0004" ref-type="table">4</xref>). The tissue specific RVIs also showed significant elevation in MET subjects with the highest effect sizes observed for cerebral WM (<italic toggle="yes">d</italic>&#160;=&#160;0.39, <italic toggle="yes">p</italic>&#160;=&#160;5&#8201;&#215;&#8201;10<sup>&#8722;13</sup>), followed by cortical thickness (<italic toggle="yes">d</italic>&#160;=&#160;0.30, <italic toggle="yes">p</italic>&#160;=&#160;1.7&#8201;&#215;&#8201;10<sup>&#8722;8</sup>), and subcortical RVI values (<italic toggle="yes">d</italic>&#160;=&#160;0.13, <italic toggle="yes">p</italic>&#160;=&#160;.01) (Figure&#160;<xref rid="hbm26235-fig-0004" ref-type="fig">4a</xref>).</p><fig position="float" fig-type="FIGURE" id="hbm26235-fig-0004" orientation="portrait"><label>FIGURE 4</label><caption><p>Effect sizes of the whole&#8208;brain, white matter fractional anisotropy (FA), cortical thickness, and subcortical volume regional vulnerability indices (RVIs) in (a) metabolic illnesses (MET) diagnosis and (b) major depressive disorder (MDD) diagnosis.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-9" orientation="portrait" xlink:href="HBM-44-2636-g007.jpg"/></fig></sec><sec id="hbm26235-sec-0013"><label>3.3</label><title>Replication of <styled-content style="fixed-case" toggle="no">MET</styled-content> effects on <styled-content style="fixed-case" toggle="no">RVI</styled-content> in subjects with <styled-content style="fixed-case" toggle="no">MDD</styled-content>
</title><p>The elevation in RVI was replicated in a cohort of MDD subjects who were not a part of the group used to derive RVI for MET. MDD subjects with MET showed significantly higher RVI&#8208;MET than MET&#8208;free MDD subjects (Cohen's <italic toggle="yes">d</italic>&#160;=&#160;0.35, <italic toggle="yes">p</italic>&#160;=&#160;1.13&#8201;&#215;&#8201;10<sup>&#8722;13</sup>). Among the tissue specific RVIs, the effects of MET were strongest in cortical GM (<italic toggle="yes">d</italic>&#160;=&#160;0.38, <italic toggle="yes">p</italic>&#160;=&#160;3.3&#8201;&#215;&#8201;10<sup>&#8722;15</sup>), followed by the WM (<italic toggle="yes">d</italic>&#160;=&#160;0.29, <italic toggle="yes">p</italic>&#160;=&#160;3.5&#8201;&#215;&#8201;10<sup>&#8722;9</sup>) and subcortical (<italic toggle="yes">d</italic>&#160;=&#160;0.12, <italic toggle="yes">p</italic>&#160;=&#160;.02) values. However, when examining MDD subjects between ages of 60&#8211;66&#8201;years, the effects were larger in all regions (GM: <italic toggle="yes">d</italic>&#160;=&#160;0.55, <italic toggle="yes">p</italic>&#160;=&#160;2.3&#8201;&#215;&#8201;10<sup>&#8722;8</sup>; WM: <italic toggle="yes">d</italic>&#160;=&#160;0.53, <italic toggle="yes">p</italic>&#160;=&#160;9.9&#8201;&#215;&#8201;10<sup>&#8722;8</sup>; SUB: <italic toggle="yes">d</italic>&#160;=&#160;0.20, <italic toggle="yes">p</italic>&#160;=&#160;.04) and in the whole&#8208;brain RVI&#8208;MET (<italic toggle="yes">d</italic>&#160;=&#160;0.58, <italic toggle="yes">p</italic>&#160;=&#160;5.2&#8201;&#215;&#8201;10<sup>&#8722;9</sup>). The effects of MET on RVI were not significantly different between non&#8208;psychiatric and MDD samples (Figure&#160;<xref rid="hbm26235-fig-0004" ref-type="fig">4b</xref>).</p></sec><sec id="hbm26235-sec-0014"><label>3.4</label><title>A four&#8208;group analysis of <styled-content style="fixed-case" toggle="no">RVI&#8208;MET</styled-content> values</title><p>A two&#8208;way ANOVA in the validation set demonstrated significant differences (<italic toggle="yes">F</italic>&#160;=&#160;52.4, <italic toggle="yes">p</italic>&#160;=&#160;3.8&#8201;&#215;&#8201;10<sup>&#8722;33</sup>) in the mean of the whole&#8208;brain RVI&#8208;MET scores across the non&#8208;psychiatric and MDD groups. The follow up test of Tukey's honest significant difference demonstrated significance in average RVI&#8208;MET values between participants with MET in both the non&#8208;psychiatric group (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;10<sup>&#8722;8</sup>) and the MDD patients (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;10<sup>&#8722;8</sup>). There was also significant elevation in the mean RVI&#8208;MET between non&#8208;psychiatric and MDD subjects within the corresponding MET status (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;10<sup>&#8722;4</sup>) (Figure&#160;<xref rid="hbm26235-fig-0005" ref-type="fig">5a</xref>). ANOVA was significant for all tissue specific RVI (WM: <italic toggle="yes">F</italic>&#160;=&#160;46.3, <italic toggle="yes">p</italic>&#160;=&#160;2&#8201;&#215;&#8201;10<sup>&#8722;29</sup>; GM: <italic toggle="yes">F</italic>&#160;=&#160;40.4, <italic toggle="yes">p</italic>&#160;=&#160;1&#8201;&#215;&#8201;10<sup>&#8722;25</sup>; SUB: <italic toggle="yes">F</italic>&#160;=&#160;9.2, <italic toggle="yes">p</italic>&#160;=&#160;4&#8201;&#215;&#8201;10<sup>&#8722;6</sup>). For white matter RVI, MET+ had significantly elevated RVI scores than MET&#8722; both in the MDD group (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;10<sup>&#8722;8</sup>) and control group (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;10<sup>&#8722;8</sup>), as well as between MDD patients and controls in the MET&#8722; group (<italic toggle="yes">p</italic>&#160;=&#160;1&#8201;&#215;&#8201;10<sup>&#8722;5</sup>) (Figure&#160;<xref rid="hbm26235-fig-0005" ref-type="fig">5b</xref>). Similarly, cortical RVIs were significantly higher between the MET+ and MET&#8722; in both the MDD (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;10<sup>&#8722;8</sup>) and control groups (<italic toggle="yes">p</italic>&#160;=&#160;2.0&#8201;&#215;&#8201;10<sup>&#8722;7</sup>) (Figure&#160;<xref rid="hbm26235-fig-0005" ref-type="fig">5c</xref>). The subcortical RVI also was only significantly elevated between the MDD patients and controls in a MET&#8722; group (.036) (Figure&#160;<xref rid="hbm26235-fig-0005" ref-type="fig">5d</xref>).</p><fig position="float" fig-type="FIGURE" id="hbm26235-fig-0005" orientation="portrait"><label>FIGURE 5</label><caption><p>Mean regional vulnerability index (RVI) scores in the major depressive disorder (MDD) and metabolic illnesses (MET) diagnosis and control groups for (a) whole&#8208;brain, (b) white matter fractional anisotropy (FA), (c) cortical thickness, and (d) subcortical volume.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-11" orientation="portrait" xlink:href="HBM-44-2636-g005.jpg"/></fig></sec><sec id="hbm26235-sec-0015"><label>3.5</label><title>Effects of <styled-content style="fixed-case" toggle="no">MET</styled-content> and <styled-content style="fixed-case" toggle="no">MDD</styled-content> diagnosis and substance abuse, <styled-content style="fixed-case" toggle="no">BMI</styled-content>, age, and sex on <styled-content style="fixed-case" toggle="no">RVI</styled-content>
</title><p>We evaluated the full model with RVI from the combined subclinical and validation sets to test the significance of diagnoses in the presence of covariates. This model was significant for the whole&#8208;brain (<italic toggle="yes">F</italic>&#160;=&#160;87.7, <italic toggle="yes">p</italic>&#160;=&#160;1.6&#8201;&#215;&#8201;10<sup>&#8722;160</sup>) and tissue&#8208;specific RVI (white matter: <italic toggle="yes">F</italic>&#160;=&#160;54.2, <italic toggle="yes">p</italic>&#160;=&#160;5.4&#8201;&#215;&#8201;10<sup>&#8722;98</sup>; cortical thickness: <italic toggle="yes">F</italic>&#160;=&#160;106.2, <italic toggle="yes">p</italic>&#160;=&#160;1.0&#8201;&#215;&#8201;10<sup>&#8722;194</sup>; subcortical volume: <italic toggle="yes">F</italic>&#160;=&#160;30.0, <italic toggle="yes">p</italic>&#160;=&#160;1.4&#8201;&#215;&#8201;10<sup>&#8722;52</sup>) (Table&#160;<xref rid="hbm26235-tbl-0005" ref-type="table">5</xref>).</p><table-wrap position="float" id="hbm26235-tbl-0005" content-type="TABLE" orientation="portrait"><label>TABLE 5</label><caption><p>Regression of MET regional vulnerability index with MET and MDD diagnosis and substance use.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">RVI</th><th align="left" valign="bottom" rowspan="1" colspan="1">MET diagnosis</th><th align="left" valign="bottom" rowspan="1" colspan="1">MDD diagnosis</th><th align="left" valign="bottom" rowspan="1" colspan="1">Smoke rank</th><th align="left" valign="bottom" rowspan="1" colspan="1">Alcohol rank</th><th align="left" valign="bottom" rowspan="1" colspan="1">BMI</th><th align="left" valign="bottom" rowspan="1" colspan="1">MET &#215; MDD</th><th align="left" valign="bottom" rowspan="1" colspan="1">Age</th><th align="left" valign="bottom" rowspan="1" colspan="1">Sex</th><th align="left" valign="bottom" rowspan="1" colspan="1">Age &#215; sex</th><th align="left" valign="bottom" rowspan="1" colspan="1">Full model</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Whole brain</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = 4.1, <bold>
<italic toggle="yes">p</italic> = 4.1 &#215;&#8201;10</bold>
<sup>
<bold>&#8722;5</bold>
</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = 2.3, <bold>
<italic toggle="yes">p</italic> = .02</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = 4.1, <bold>
<italic toggle="yes">p</italic> = 4.5 &#215;&#8201;10</bold>
<sup>
<bold>&#8722;5</bold>
</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = 3.5, <bold>
<italic toggle="yes">p</italic> = 4.3 &#215;&#8201;10</bold>
<sup>
<bold>&#8722;4</bold>
</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = 17.0, <bold>
<italic toggle="yes">p</italic> = 1.3 &#215;&#8201;10</bold>
<sup>
<bold>&#8722;64</bold>
</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = 0.9, <italic toggle="yes">p</italic> = .34</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = &#8722;12.7, <bold>
<italic toggle="yes">p</italic> = 6.3 &#215;&#8201;10</bold>
<sup>
<bold>&#8722;37</bold>
</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = &#8722;11.9, <bold>
<italic toggle="yes">p</italic> = 1.7 &#215;&#8201;10</bold>
<sup>
<bold>&#8722;32</bold>
</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = 11.2, <bold>
<italic toggle="yes">p</italic> = 6.9 &#215;&#8201;10</bold>
<sup>
<bold>&#8722;29</bold>
</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">F</italic> = 87.7, <bold>
<italic toggle="yes">p</italic> = 1.6 &#215;&#8201;10</bold>
<sup>
<bold>&#8722;160</bold>
</sup>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">White matter</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = 5.8, <bold>
<italic toggle="yes">p</italic> = 7.0 &#215;&#8201;10</bold>
<sup>
<bold>&#8722;9</bold>
</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = 3.4, <bold>
<italic toggle="yes">p</italic> = 7.1 &#215;&#8201;10</bold>
<sup>
<bold>&#8722;4</bold>
</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = 3.2, <italic toggle="yes">p</italic> = .001</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = 3.4, <bold>
<italic toggle="yes">p</italic> = 7.1 &#215;&#8201;10</bold>
<sup>
<bold>&#8722;4</bold>
</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = 12.7, <bold>
<italic toggle="yes">p</italic> = 9.6 &#215;&#8201;10</bold>
<sup>
<bold>&#8722;37</bold>
</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = &#8722;0.8, <italic toggle="yes">p</italic> = .4</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = &#8722;8.5, <bold>
<italic toggle="yes">p</italic> = 1.6 &#215;&#8201;10</bold>
<sup>
<bold>&#8722;17</bold>
</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = &#8722;5.6, <bold>
<italic toggle="yes">p</italic> = 1.7 &#215;&#8201;10</bold>
<sup>
<bold>&#8722;8</bold>
</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = 5.1, <bold>
<italic toggle="yes">p</italic> = 3.6 &#215;&#8201;10</bold>
<sup>
<bold>&#8722;7</bold>
</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">F</italic> = 54.2, <bold>
<italic toggle="yes">p</italic> = 5.4 &#215;&#8201;10</bold>
<sup>
<bold>&#8722;98</bold>
</sup>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cortical thickness</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = 2.0, <italic toggle="yes">p</italic> = .05</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = 0.2, <italic toggle="yes">p</italic> = .8</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = &#8722;0.3, <italic toggle="yes">p</italic> = .8</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = &#8722;2.2, <bold>
<italic toggle="yes">p</italic> = .03</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = 26.0, <bold>
<italic toggle="yes">p</italic> = 1.7 &#215;&#8201;10</bold>
<sup>
<bold>&#8722;146</bold>
</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = 1.4, <italic toggle="yes">p</italic> = .2</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = &#8722;3.9, <bold>
<italic toggle="yes">p</italic> = 7.4 &#215;&#8201;10</bold>
<sup>
<bold>&#8722;5</bold>
</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = &#8722;4.7, <bold>
<italic toggle="yes">p</italic> = 2.9 &#215;&#8201;10</bold>
<sup>
<bold>&#8722;6</bold>
</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = 4.3, <bold>
<italic toggle="yes">p</italic> = 2.1 &#215;&#8201;10</bold>
<sup>
<bold>&#8722;5</bold>
</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">F</italic> = 106.2, <bold>
<italic toggle="yes">p</italic> = 1.0 &#215;&#8201;10</bold>
<sup>
<bold>&#8722;194</bold>
</sup>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Subcortical volume</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = 1.3, <italic toggle="yes">p</italic> = .2</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = 1.2, <italic toggle="yes">p</italic> = .2</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = 4.2, <bold>
<italic toggle="yes">p</italic> = 2.2 &#215;&#8201;10</bold>
<sup>
<bold>&#8722;5</bold>
</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = 4.3, <bold>
<italic toggle="yes">p</italic> = 1.4 &#215;&#8201;10</bold>
<sup>
<bold>&#8722;5</bold>
</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = 3.0, <bold>
<italic toggle="yes">p</italic> = .003</bold>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = 1.1, <italic toggle="yes">p</italic> = .3</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = &#8722;11.5, <bold>
<italic toggle="yes">p</italic> = 2.7 &#215;&#8201;10</bold>
<sup>
<bold>&#8722;30</bold>
</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = &#8722;11.7, <bold>
<italic toggle="yes">p</italic> = 2.3 &#215;&#8201;10</bold>
<sup>
<bold>&#8722;31</bold>
</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">t</italic> = 11.2, <bold>
<italic toggle="yes">p</italic> = 6.5 &#215;&#8201;10</bold>
<sup>
<bold>&#8722;29</bold>
</sup>
</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic toggle="yes">F</italic> = 30.0, <bold>
<italic toggle="yes">p</italic> = 1.7 &#215;&#8201;10</bold>
<sup>
<bold>&#8722;52</bold>
</sup>
</td></tr></tbody></table><table-wrap-foot id="hbm26235-ntgp-0004"><fn id="hbm26235-note-0006"><p>
<italic toggle="yes">Note</italic>: Bolded <italic toggle="yes">p</italic>&#8208;values passed the FDR threshold at &lt;.05.</p></fn><fn id="hbm26235-note-0007"><p>Abbreviations: MDD, major depressive disorder; MET, metabolic illnesses; RVI, regional vulnerability index.</p></fn></table-wrap-foot></table-wrap><p>Whole&#8208;brain RVI was significantly and independently associated with MET and MDD diagnosis, but not with their interaction. Smoking, alcohol consumption, BMI, age, sex and the interaction of age and sex were likewise significant predictors of RVI (Figure&#160;<xref rid="hbm26235-fig-0006" ref-type="fig">6</xref>). White matter RVI showed a similar pattern of association (Table&#160;<xref rid="hbm26235-tbl-0005" ref-type="table">5</xref>). The cortical RVI was only significantly associated with alcohol consumption, BMI, age, sex, and the interaction between age and sex. The subcortical RVI&#8208;MET was only significantly associated with smoking and drinking habits as well as BMI, age, sex, and the interaction of age and sex.</p><fig position="float" fig-type="FIGURE" id="hbm26235-fig-0006" orientation="portrait"><label>FIGURE 6</label><caption><p>Regression coefficients of metabolic illnesses (MET) and major depressive disorder (MDD) diagnosis, smoking rank, alcohol consumption rank, and the interaction of MET and MDD diagnosis on the whole brain regional vulnerability index (RVI)&#8208;MET scores. Significance at FDR&#160;=&#160;0.05.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-13" orientation="portrait" xlink:href="HBM-44-2636-g004.jpg"/></fig></sec><sec id="hbm26235-sec-0016"><label>3.6</label><title>Repeat of the four&#8208;group analysis of <styled-content style="fixed-case" toggle="no">RVI</styled-content> values in the non&#8208;smoking, social drinking cohort</title><p>There were <italic toggle="yes">N</italic>&#160;=&#160;1307 total non&#8208;smoking, social drinkers included in the repeated ANOVA. Within the whole&#8208;brain ANOVA, there were still significant differences in the mean RVI&#8208;MET scores between MET+ diagnosis and MET&#8722; free in both the MDD (<italic toggle="yes">p</italic>&#160;=&#160;.001) and control groups (<italic toggle="yes">p</italic>&#160;=&#160;2.7&#8201;&#215;&#8201;10<sup>&#8722;4</sup>) after Tukey's test of honest significant difference. The white matter RVI&#8208;MET scores were also significantly different between MET+ diagnosis and MET&#8722; free individuals in the MDD (<italic toggle="yes">p</italic>&#160;=&#160;.01) and control (<italic toggle="yes">p</italic>&#160;=&#160;3.5&#8201;&#215;&#8201;10<sup>&#8722;5</sup>) groups. There was also a significant difference in the mean scores of the gray matter RVI&#8208;MET between MET+ and MET&#8722; free in both the MDD (<italic toggle="yes">p</italic>&#160;=&#160;.03) and control groups (<italic toggle="yes">p</italic>&#160;=&#160;4.9&#8201;&#215;&#8201;10<sup>&#8722;4</sup>). There were no significant differences in the subcortical RVI&#8208;MET (<italic toggle="yes">p</italic>&#8201;&gt;&#8201;.1).</p></sec><sec id="hbm26235-sec-0017"><label>3.7</label><title>
<styled-content style="fixed-case" toggle="no">RVI&#8208;MET</styled-content> and <styled-content style="fixed-case" toggle="no">WM</styled-content> hyperintensity volume</title><p>The FLAIR hyperintensive white matter volume is an index used to quantify negative effects of MET on brain integrity. In the validation set, FLAIR volume was significantly elevated in MET in non&#8208;psychiatric subjects (<italic toggle="yes">t</italic>&#160;=&#160;12.1, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;2.3&#160;&#215;&#8201;10<sup>&#8722;16</sup>). Within the MDD patients, total FLAIR volume was also significantly elevated in MET (<italic toggle="yes">t</italic>&#160;=&#160;13.5, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;2.3&#160;&#215;&#8201;10<sup>&#8722;16</sup>). The RVI&#8208;MET and FLAIR volume were significantly correlated (<italic toggle="yes">r</italic>&#160;=&#160;0.22, adj. <italic toggle="yes">p</italic>&#8201;&lt;&#8201;.0001). All tissue&#8208;specific RVI likewise showed significant correlation with FLAIR volume, suggesting that cortical and subcortical RVI were also sensitive to brain changes reflected by accumulation of FLAIR volume. The highest correlation with FLAIR volume was observed for RVI values for cerebral white matter (<italic toggle="yes">r</italic>&#160;=&#160;0.20, adj. <italic toggle="yes">p</italic>&#8201;&lt;&#8201;.0001), followed by cortical gray matter (<italic toggle="yes">r</italic>&#160;=&#160;0.17, adj. <italic toggle="yes">p</italic>&#8201;&lt;&#8201;.0001) and subcortical volumes (<italic toggle="yes">r</italic>&#160;=&#160;0.10, adj. <italic toggle="yes">p</italic>&#8201;&lt;&#8201;.0001).</p></sec><sec id="hbm26235-sec-0018"><label>3.8</label><title>Effects of antidepressants on <styled-content style="fixed-case" toggle="no">RVI&#8208;MET</styled-content>
</title><p>
<italic toggle="yes">N</italic>&#160;=&#160;2977 (77%) participants from the MDD sample in the validation and subclinical datasets were reported to take antidepressant medications. There were no significant differences in the whole&#8208;brain RVI&#8208;MET in MDD subjects who took antidepressant versus those who did not (<italic toggle="yes">t</italic>&#160;=&#160;0.15, <italic toggle="yes">p</italic>&#160;=&#160;.9).</p></sec><sec id="hbm26235-sec-0019"><label>3.9</label><title>Effects of antihypertensive, cholesterol&#8208;lowering, and diabetes medications on <styled-content style="fixed-case" toggle="no">RVI&#8208;MET</styled-content>
</title><p>The MET medication analyses were completed using the MDD controls from the validation dataset and subclinical MET datasets. The participants from the subclinical MDD or subclinical MDD and MET datasets had no overlap with the representative dataset. From these data, <italic toggle="yes">N</italic>&#160;=&#160;2378 (32%) participants reported taking medication for hypertension, hyperlipidemia, and/or diabetes. Subjects who took MET medication showed significantly higher whole&#8208;brain RVI (<italic toggle="yes">t</italic>&#160;=&#160;6.5, <italic toggle="yes">p</italic>&#160;=&#160;1.0&#8201;&#215;&#8201;10<sup>&#8722;10</sup>). They also showed significantly higher WM (<italic toggle="yes">t</italic>&#160;=&#160;6.0, <italic toggle="yes">p</italic>&#160;=&#160;71.7&#8201;&#215;&#8201;10<sup>&#8722;9</sup>), cortical (<italic toggle="yes">t</italic>&#160;=&#160;5.4, <italic toggle="yes">p</italic>&#160;=&#160;7.1&#8201;&#215;&#8201;10<sup>&#8722;8</sup>), and subcortical (<italic toggle="yes">t</italic>&#160;=&#160;3.0, <italic toggle="yes">p</italic>&#160;=&#160;.003) RVI. However, when these analyses were performed in the MET+ group, to correct for MET status, these differences became non&#8208;significant.</p></sec><sec id="hbm26235-sec-0020"><label>3.10</label><title>
<styled-content style="fixed-case" toggle="no">MET</styled-content> and depression symptom severity</title><p>In the MDD samples from the validation and subclinical datasets, MET diagnosis was associated with higher MDD symptom severity than subjects without MET (<italic toggle="yes">t</italic>&#160;=&#160;3.1, <italic toggle="yes">p</italic>&#160;=&#160;.002). The subjects in the non&#8208;psychiatric group did not show significant differences in depression symptoms between MET+ versus controls (<italic toggle="yes">t</italic>&#160;=&#160;&#8722;0.9, <italic toggle="yes">p</italic>&#160;=&#160;.34). The whole&#8208;brain RVI&#8208;MET was significantly correlated with depression scores in the MDD sample (<italic toggle="yes">r</italic>&#160;=&#160;0.06, adj. <italic toggle="yes">p</italic>&#8201;&lt;&#8201;.0001), as were the cortical (<italic toggle="yes">r</italic>&#160;=&#160;0.06, adj. <italic toggle="yes">p</italic>&#8201;&lt;&#8201;.0001), white matter (<italic toggle="yes">r</italic>&#160;=&#160;0.06, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;.0001), and subcortical (<italic toggle="yes">r</italic>&#160;=&#160;0.03, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;.0001) RVI&#8208;MET.</p></sec><sec id="hbm26235-sec-0021"><label>3.11</label><title>
<styled-content style="fixed-case" toggle="no">BMI</styled-content> and <styled-content style="fixed-case" toggle="no">MDD</styled-content>
</title><p>In the validation dataset, subjects with MDD showed significantly higher BMI than the non&#8208;psychiatric subjects (<italic toggle="yes">t</italic>&#160;=&#160;13.44, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;2.2&#8201;&#215;&#8201;10<sup>&#8722;16</sup>). The MET&#8208;free MDD subjects showed significantly higher BMI than MET&#8208;free non&#8208;psychiatric subjects (<italic toggle="yes">t</italic>&#160;=&#160;2.1, <italic toggle="yes">p</italic>&#160;=&#160;.03). Moreover, there was a significant correlation between depression scores and BMI (<italic toggle="yes">r</italic>&#160;=&#160;0.11, adj. <italic toggle="yes">p</italic>&#8201;&lt;&#8201;.0001) in MDD cohorts but not in the non&#8208;psychiatric subjects (<italic toggle="yes">r</italic>&#160;=&#160;&#8722;0.03, <italic toggle="yes">p</italic>&#160;=&#160;.7).</p></sec><sec id="hbm26235-sec-0022"><label>3.12</label><title>
<styled-content style="fixed-case" toggle="no">RVI&#8208;MET</styled-content> and <styled-content style="fixed-case" toggle="no">BMI</styled-content>
</title><p>The whole&#8208;brain (<italic toggle="yes">r</italic>&#160;=&#160;0.13, adj. <italic toggle="yes">p</italic>&#8201;&lt;&#8201;.0001), white matter (<italic toggle="yes">r</italic>&#160;=&#160;0.12, adj. <italic toggle="yes">p</italic>&#8201;&lt;&#8201;.0001), and cortical thickness (<italic toggle="yes">r</italic>&#160;=&#160;0.19, adj. <italic toggle="yes">p</italic>&#8201;&lt;&#8201;.0001) RVIs were significantly correlated with BMI in the non&#8208;psychiatric sample of the validation and subclinical datasets. The correlation between subcortical RVI and BMI was not significant (<italic toggle="yes">r</italic>&#160;=&#160;0.009, <italic toggle="yes">p</italic>&#160;=&#160;.4). After correction for MET status, only the correlation between gray matter thickness RVI and BMI remained significant (<italic toggle="yes">r</italic>&#160;=&#160;0.12, adj. <italic toggle="yes">p</italic>&#8201;&lt;&#8201;.0001). In the MDD subsample, we replicated the significant correlations for the whole brain (<italic toggle="yes">r</italic>&#160;=&#160;0.15, adj. <italic toggle="yes">p</italic>&#8201;&lt;&#8201;.0001), white matter (<italic toggle="yes">r</italic>&#160;=&#160;0.13, adj. <italic toggle="yes">p</italic>&#8201;&lt;&#8201;.0001), and cortical thickness (<italic toggle="yes">r</italic>&#160;=&#160;0.16, adj. <italic toggle="yes">p</italic>&#8201;&lt;&#8201;.0001) RVI and BMI. In contrast to non&#8208;psychiatric status, most correlations remained significant even after correction for MET status (whole&#8208;brain: <italic toggle="yes">r</italic>&#160;=&#160;0.20, adj. <italic toggle="yes">p</italic>&#8201;&lt;&#8201;.0001; white matter: <italic toggle="yes">r</italic>&#160;=&#160;0.14, adj. <italic toggle="yes">p</italic>&#160;=&#160;.0001; cortical thickness: <italic toggle="yes">r</italic>&#160;=&#160;0.25, adj. <italic toggle="yes">p</italic>&#8201;&lt;&#8201;.0001; subcortical: <italic toggle="yes">r</italic>&#160;=&#160;0.05, <italic toggle="yes">p</italic>&#160;=&#160;.4).</p></sec></sec><sec sec-type="discussion" id="hbm26235-sec-0023"><label>4</label><title>DISCUSSION</title><p>We evaluated the effects of MET on cerebral integrity in a large and representative sample provided by the UK Biobank. MET exerted deleterious effects that were tissue and region&#8208;specific. We used the anatomical profile of effect sizes of MET to develop a RVI as a measure of the similarity between individual and expected deficit patterns in MET (Schmaal et al.,&#160;<xref rid="hbm26235-bib-0075" ref-type="bibr">2016</xref>, <xref rid="hbm26235-bib-0074" ref-type="bibr">2017</xref>). Participants with MET had significant elevation in whole&#8208;brain RVI compared to subjects without MET. The effect sizes for the whole&#8208;brain and tissue specific RVI were higher for both whole&#8208;brain average and individual brain measures. We replicated this finding in an independent cohort of MDD subjects with and without MET. This suggested that the similarity to a regional pattern of MET was a phenotype that was more sensitive and specific than any regional brain measures. The individual RVI values were positively associated with the volume of the FLAIR T2&#8208;hyperintensive white matter regions and BMI in both non&#8208;psychiatric and MDD samples. The cortical, subcortical, and white matter regional pattern of these effect sizes overlapped closely with those reported by independent large&#8208;scale meta&#8208;analyses of MDD findings (Schmaal et al.,&#160;<xref rid="hbm26235-bib-0075" ref-type="bibr">2016</xref>, <xref rid="hbm26235-bib-0074" ref-type="bibr">2017</xref>; van Velzen et al.,&#160;<xref rid="hbm26235-bib-0088" ref-type="bibr">2020</xref>). MDD subjects had significantly higher RVI&#8208;MET values versus the corresponding non&#8208;psychiatric group. BMI, alcohol, and tobacco use contributed to elevated RVI values but not the antidepressant medications. In summary, we developed and replicated RVI for MET, which is a more sensitive index of effects of MET on the brain than individual brain measurements. The overlap between MET and MDD regional deficit patterns was partially explained by higher incidence of MET and substance use in subjects with MDD.</p><p>MET are common disorders that begin in early to mid&#8208;adulthood and act as significant risk factors for the integrity of cerebral tissues through hormonal, inflammatory, cerebrovascular, and cardio&#8208;metabolic pathways. The effects of the MET are especially severe for the cerebral white matter, which is considered the end&#8208;target organ for MET (Bateman,&#160;<xref rid="hbm26235-bib-0006" ref-type="bibr">2002</xref>; Henry Feugeas et al.,&#160;<xref rid="hbm26235-bib-0025" ref-type="bibr">2005</xref>; Marks et al.,&#160;<xref rid="hbm26235-bib-0055" ref-type="bibr">2011</xref>; Spieker et al.,&#160;<xref rid="hbm26235-bib-0079" ref-type="bibr">2015</xref>). Chronic MET is associated with damage to the long&#8208;penetrating cerebral blood vessels (Kochunov et al.,&#160;<xref rid="hbm26235-bib-0035" ref-type="bibr">2010</xref>) that leads to hypoperfusion, reduced white matter integrity and formation of hyperintense T2&#8208;FALIR lesions (Jagust et al.,&#160;<xref rid="hbm26235-bib-0026" ref-type="bibr">2005</xref>). The linkage between white matter damage in MET has been confirmed by genetic studies that showed shared genetic variance (Kochunov et al.,&#160;<xref rid="hbm26235-bib-0033" ref-type="bibr">2012</xref>) as well as the overlap in the associated genetic loci between two illnesses (Kochunov et al.,&#160;<xref rid="hbm26235-bib-0037" ref-type="bibr">2009</xref>, <xref rid="hbm26235-bib-0035" ref-type="bibr">2010</xref>, <xref rid="hbm26235-bib-0033" ref-type="bibr">2012</xref>). We replicated the significant negative effect sizes for MET on the average cerebral white matter FA values (<italic toggle="yes">d&#8201;=</italic>&#160;0.2), while subjects with MET did not show significant differences in average cortical thickness and subcortical measures. We further plotted the regional effect sizes for MET versus those found in common neuropsychiatric illnesses.</p><p>MET are common comorbidities in neuropsychiatric illnesses and are hypothesized to contribute to accelerated brain aging in patients (Lung et al.,&#160;<xref rid="hbm26235-bib-0047" ref-type="bibr">2007</xref>; Simon et al.,&#160;<xref rid="hbm26235-bib-0077" ref-type="bibr">2006</xref>; Wolkowitz et al.,&#160;<xref rid="hbm26235-bib-0089" ref-type="bibr">2011</xref>). We plotted the regional effect size for MET calculated in non&#8208;psychiatric sample against the patient&#8208;control SSD (Kelly et al.,&#160;<xref rid="hbm26235-bib-0029" ref-type="bibr">2018</xref>), MDD (van Velzen et al.,&#160;<xref rid="hbm26235-bib-0088" ref-type="bibr">2020</xref>), BD (Favre et al.,&#160;<xref rid="hbm26235-bib-0016" ref-type="bibr">2019</xref>), and AD (Kochunov, Ryan, et al.,&#160;<xref rid="hbm26235-bib-0041" ref-type="bibr">2021</xref>). This provided the first opportunity to evaluate how effects of MET may overlap with findings in neuropsychiatric disorders. The effect sizes of the neuropsychiatric illnesses were tabulated from the independent studies of the largest samples of the respective disorders that consisted of hundreds to thousands of patients and controls that were independent of the current sample. Among the three psychiatric and one neurological illness, regional effects of the MET were significantly correlated with the effects of the MDD with a remarkable overlap between effects of the two illnesses (<italic toggle="yes">r</italic>&#160;=&#160;0.70, adj. <italic toggle="yes">p</italic>&#8201;&lt;&#8201;.0001). This is consistent with findings that MET co&#8208;occur with MDD at nearly five times versus normal controls and double the rates versus other mental illnesses (Jantaratnotai et al.,&#160;<xref rid="hbm26235-bib-0027" ref-type="bibr">2017</xref>; Luo et al.,&#160;<xref rid="hbm26235-bib-0048" ref-type="bibr">2018</xref>; Malmir et al.,&#160;<xref rid="hbm26235-bib-0052" ref-type="bibr">2019</xref>; Milaneschi et al.,&#160;<xref rid="hbm26235-bib-0057" ref-type="bibr">2019</xref>). We calculated RVI for MET to measure individual similarity to expected MET patterns in both non&#8208;psychiatric and MDD cohorts to evaluate the potential causes of this overlap.</p><p>RVI is a linear measure of similarity between regionally derived metrics from an individual's brain MRI (e.g., regional volumes, thicknesses, microstructure measurements) and the expected pattern of those metrics with respect to the patient&#8208;control effect sizes. The RVI approach assumes that the effects of the disorder on the brain are regionally specific and that the regional pattern of the illness is more stable and replicable than effects of the illness on any individual structure (Kochunov, Thompson, et al.,&#160;<xref rid="hbm26235-bib-0042" ref-type="bibr">2019</xref>). The utility of this approach was demonstrated by showing that RVI for schizophrenia predicted treatment resistance in schizophrenia better than any individual imaging measure (Kochunov, Huang, et al.,&#160;<xref rid="hbm26235-bib-0039" ref-type="bibr">2019</xref>) and later findings suggested that RVI serves as an important index for cross&#8208;disorder research (Kochunov, Hong, et al.,&#160;<xref rid="hbm26235-bib-0038" ref-type="bibr">2020</xref>; Kochunov, Zavaliangos&#8208;Petropuli, et al.,&#160;<xref rid="hbm26235-bib-0043" ref-type="bibr">2021</xref>). Prior research using RVI has primarily focused on neuropsychiatric illness, but this study showed that the effects of the MET are likewise regionally specific, and the pattern of MET effect sizes is stable, replicable, and informative. The whole&#8208;brain RVI showed approximately twice the effect sizes for MET versus whole&#8208;brain average values. The RVI derived for cortical and subcortical difference demonstrate the significance effects of MET replicating previous findings (Alfaro et al.,&#160;<xref rid="hbm26235-bib-0002" ref-type="bibr">2016</xref>; Kochunov et al.,&#160;<xref rid="hbm26235-bib-0035" ref-type="bibr">2010</xref>, <xref rid="hbm26235-bib-0033" ref-type="bibr">2012</xref>; Kochunov, Glahn, Lancaster, et al.,&#160;<xref rid="hbm26235-bib-0034" ref-type="bibr">2011</xref>; Kochunov, Glahn, Nichols, et al.,&#160;<xref rid="hbm26235-bib-0036" ref-type="bibr">2011</xref>), even in the absence of significant effects of MET for the average cortical thickness or subcortical gray matter volume.</p><p>The whole brain and tissue&#8208;specific RVIs were significantly correlated with the volume of FLAIR T2&#8208;hyperintensive lesions and BMI of the non&#8208;psychiatric subjects, supporting the sensitivity of this approach. FLAIR T2&#8208;hyperintensities are regions of accumulation of extracellular water due to focal degradation of the myelin sheath and are considered as an end&#8208;organ damage of MET in the brain (Fazekas et al.,&#160;<xref rid="hbm26235-bib-0017" ref-type="bibr">1993</xref>; Kochunov et al.,&#160;<xref rid="hbm26235-bib-0037" ref-type="bibr">2009</xref>). The cortical and subcortical RVI were likewise significantly correlated with T2&#8208;FLAIR volume. This suggests that RVI is capturing the whole&#8208;brain nature of MET&#8208;related damage. Whole&#8208;brain and cortical RVI were also significantly correlated with BMI, thus capturing the well&#8208;known risks that obesity exerts on cerebral integrity (Marks et al.,&#160;<xref rid="hbm26235-bib-0055" ref-type="bibr">2011</xref>; Ryan et al.,&#160;<xref rid="hbm26235-bib-0073" ref-type="bibr">2017</xref>). The causative links between obesity and lower cerebral integrity are complex and occur through multiple pathways. Obesity is associated with hypertension and atherosclerosis, and both are direct cerebrovascular risk factors associated with lower cerebral integrity (Allen et al.,&#160;<xref rid="hbm26235-bib-0003" ref-type="bibr">2016</xref>; Despr&#233;s et al.,&#160;<xref rid="hbm26235-bib-0012" ref-type="bibr">1990</xref>; Lewington et al.,&#160;<xref rid="hbm26235-bib-0044" ref-type="bibr">2007</xref>; Spieker et al.,&#160;<xref rid="hbm26235-bib-0079" ref-type="bibr">2015</xref>). Obesity is also associated with elevated systemic inflammatory activity which in turn impairs cerebral healing abilities and leads to cognitive changes (Luo &amp; Lin,&#160;<xref rid="hbm26235-bib-0049" ref-type="bibr">2021</xref>; Miller &amp; Spencer,&#160;<xref rid="hbm26235-bib-0058" ref-type="bibr">2014</xref>). MET, including hypertension, diabetes, fatty liver disorder and others, is an outcome of chronic obesity and the relationship between obesity and cerebral integrity, as captured by RVI, was continuous and was readily replicable in an independent sample.</p><p>The elevation of whole&#8208;brain and regional RVI in subjects with MET was replicated in an independent group of MDD subjects. The absolute values of the effect sizes of the whole brain MET on RVI in subjects with and without MET were similar to those observed in the non&#8208;psychiatric subjects (<italic toggle="yes">d</italic>&#160;=&#160;0.36 vs. 0.39 for MDD and non&#8208;psychiatric groups, respectively). The tissue&#8208;specific RVI also showed significant elevations in subjects with MET in the MDD cohort. For MDD subjects, cortical RVI showed the biggest effect versus white matter RVI in controls, but this difference was not statistically significant (<italic toggle="yes">Z</italic>&#160;=&#160;0.7, <italic toggle="yes">p</italic>&#8201;&gt;&#8201;.6). We also replicated the positive correlation between all RVI and FLAIR volume. The direct comparison among the four groups demonstrated subjects with MDD had significantly higher RVI than the corresponding group from the non&#8208;psychiatric participants. MDD subjects with MET had significantly higher whole&#8208;brain RVI (<italic toggle="yes">p</italic>&#160;=&#160;.03) than non&#8208;psychiatric subjects with MET. Likewise, MET free subjects with MDD had significantly higher RVI versus MET free non&#8208;psychiatric controls (<italic toggle="yes">p</italic>&#160;=&#160;7.4&#8201;&#215;&#8201;10<sup>&#8722;5</sup>).</p><p>Daily use of alcohol and tobacco are the most common environmental risk factors associated with MET (Bertoglia et al.,&#160;<xref rid="hbm26235-bib-0007" ref-type="bibr">2017</xref>; Friedman et al.,&#160;<xref rid="hbm26235-bib-0019" ref-type="bibr">1982</xref>). Drinking and smoking frequencies are directly associated with insulin resistance, pancreatic health, and genetic pathways, which culminate in MET (Bertoglia et al.,&#160;<xref rid="hbm26235-bib-0007" ref-type="bibr">2017</xref>; Duell,&#160;<xref rid="hbm26235-bib-0015" ref-type="bibr">2012</xref>; Maisonneuve et al.,&#160;<xref rid="hbm26235-bib-0051" ref-type="bibr">2005</xref>). We thus asked if smoking and alcohol use and/or use of antidepressant medication in patients with MDD could account for the differences between subgroups using RVI as an intermediate phenotype to quantify effects of MET on brain integrity. The negative effects of daily use of alcohol and tobacco on cerebral health were readily captured by the elevation of RVI in both samples. The effects of these substances on RVI were consistent between the two samples but subjects with MDD had significantly higher rates of smoking and daily alcohol drinking vs. non&#8208;psychiatric samples. In contrast, the use of antidepressant medications was not associated with significant differences in the whole&#8208;brain or tissue specific RVI in the MDD cohort. The use of common medications to treat effects of MET was robustly associated with higher RVI but this difference became non&#8208;significant once the MET status was included in the model. Together these findings suggest that heavy alcohol and tobacco use&#8212;but not antidepressants&#8212;contribute to higher RVI for MET and potentially to group differences in RVI between MDD and non&#8208;psychiatric samples.</p><p>We modeled the effects of the MET and MDD diagnosis together with substance use on the RVI in the combined sample. The diagnosis of MET and MDD remained significant predictors for the whole&#8208;brain RVI even after correcting for other factors. The interaction between MET and MDD was not statistically significant. Among the tissue specific RVI, MET, and MDD diagnosis was significant for white matter and cortical thickness, while subcortical RVI showed significant association with smoking and alcohol use, only. Considering these findings together, we can conclude that RVI&#8208;MET is a sensitive and useful tool to evaluate the effect of MET on cerebral integrity as compared to regional brain structures. Higher RVI&#8208;MET values in MDD patients were to a large extent explained by differences in the tobacco and alcohol use rather than antidepressant medication, suggesting that population biases in MDD patients are skewed toward MET risks and contributed to regional patterns of MDD&#8208;control differences.</p><p>This study has some limitations. The representative, validation, and subclinical datasets consisted of non&#8208;overlapping subjects but were derived from the same UK biobank cohort which may limit the generalizability to other non&#8208;British cohorts. The neuropsychiatric RVIs have been accurate across diverse cohorts (Kochunov, Fan, et al.,&#160;<xref rid="hbm26235-bib-0032" ref-type="bibr">2020</xref>), but this analysis did not test the validity of RVI&#8208;MET outside of data provided by UK BioBank. Another limitation is in the population data: UKBB subjects have a limited age range, chiefly Caucasian British and were less likely to be the current smokers or have depression compared to the general population (Adams et al.,&#160;<xref rid="hbm26235-bib-0001" ref-type="bibr">2020</xref>). The hyperlipidemia, hypertension, and Type 2 diabetes&#8212;the main components of MET&#8212;often manifest in people in their 50s or later, while MDD often begins in adolescence. Because of this, and the relatively older mean age of the UKBB participants, we were unable to fully test the directions of causality between MET and MDD, which was beyond the focus of this study but is a potential direction for the future studies. Also, participants may have underdiagnosed MET or MDD and may not have reported medications. For example, there was a category for participants to disclose if they were taking insulin, blood pressure, or cholesterol medication, but they were not asked to disclose which specific medications at that point in the interview. Similarly, though we attempted to make the requirements for MET&#8208;controls as stringent as possible, there could be some contamination of at&#8208;risk for MET participants in representative set. We mitigated risk of contamination by checking each participant's bloodwork data and blood pressure measures, as well as checking the mental health survey answers. We checked survey questions about recreational drug or alcohol use as unprescribed medicine, survey questions about specific medication usage, and alcohol and smoking data.</p><p>In summary, the deleterious effects of the MET lead to a formation of a tissue and region&#8208;specific cerebral deficit pattern. We developed RVI&#8208;MET as a measure of similarity between individual and expected deficit patterns in MET. The whole&#8208;brain RVI values were significantly elevated in subjects with MET and the effect sizes for the whole&#8208;brain and tissue specific RVI were higher than for standard brain measures. The individual RVI values, including these for cortical thickness and subcortical volumes were positively associated with the volume of the FLAIR T2&#8208;hyperintensive white matter regions and BMI, suggesting whole&#8208;brain nature of the MET deficits. The cortical, subcortical, and white matter deficits patterns for MET overlapped closely with those reported by independent large&#8208;scale meta&#8208;analyses of MDD findings and MDD subjects had significantly higher RVI&#8208;MET values versus the corresponding non&#8208;psychiatric group. This overlap was partially explained by contributions of higher BMI, alcohol, and tobacco use in subjects with MDD.</p></sec><sec id="hbm26235-sec-0024"><title>FUNDING INFORMATION</title><p>This work was supported by the National Institutes of Health grants R01MH112180, R01MH116948, S10OD023696, R01EB015611, R01MH117601, R01AG095874, R01MH116147, and U01MH108148. These funding sources provided financial support to enable design and conduct of the study or collection, management, or analysis of the data. Lianne Schmaal is supported by a NHMRC Career Development Fellowship (1140764) and a University of Melbourne Dame Kate Campbell fellowship. None of the funding agencies had a role in the interpretation of the data. None had a role in the preparation, review, or approval of the manuscript. None had a role in the decision to submit the manuscript for publication.</p></sec><sec sec-type="COI-statement" id="hbm26235-sec-0025"><title>CONFLICT OF INTEREST STATEMENT</title><p>L. Elliot Hong has received or plans to receive research funding or consulting fees on research projects from Mitsubishi, Your Energy Systems LLC, Neuralstem, Taisho, Heptares, Pfizer, Luye Pharma, IGC Pharma, Sound Pharma, Takeda, and Regeneron. None was involved in the design, analysis, or outcomes of the study. Paul M. Thompson and Neda Jahanshad received grant support from Biogen, Inc. (Boston, MA, USA) for research unrelated to the topic of this manuscript. Aristeidis Sotiras has equity in TheraPanacea and received compensation for reviewing grants with BrightFocus Foundations (Clarksburg, MD, USA). All other authors declare no conflicts of interest.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="hbm26235-supitem-0001" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Table S1.</bold> Demographics of representative and validation datasets.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="HBM-44-2636-s008.docx" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="hbm26235-supitem-0002" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Table S2.</bold> UKBB ICD10 IDs for MET and MDD.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="HBM-44-2636-s001.docx" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="hbm26235-supitem-0003" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Table S3.</bold> UKBB IDs for subclinical MET and MDD criteria.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="HBM-44-2636-s004.docx" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="hbm26235-supitem-0004" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Table S4.</bold> UKBB imaging field IDs.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="HBM-44-2636-s002.docx" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="hbm26235-supitem-0005" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Table S5.</bold> UKBB field IDs for subclinical depression score.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="HBM-44-2636-s007.docx" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="hbm26235-supitem-0006" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Table S6.</bold> Number of participants taking medication for a metabolic illness.*</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="HBM-44-2636-s006.docx" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="hbm26235-supitem-0007" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Table S7.</bold> Number of participants taking medication for depression.*</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="HBM-44-2636-s003.docx" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="hbm26235-supitem-0008" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Table S8.</bold> UKBB IDs for alcohol and tobacco consumption data.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="HBM-44-2636-s005.docx" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><sec sec-type="data-availability" id="hbm26235-sec-0027"><title>DATA AVAILABILITY STATEMENT</title><p>The data that support the findings of this study are available from the UK BioBank. Restrictions apply to the availability of these data, which were used under license for this study. Data are available from the authors with the permission of the UK BioBank.</p></sec><ref-list id="hbm26235-bibl-0001" content-type="cited-references"><title>REFERENCES</title><ref id="hbm26235-bib-0001"><mixed-citation publication-type="journal" id="hbm26235-cit-0001"><string-name name-style="western"><surname>Adams</surname>, <given-names>M. J.</given-names></string-name>, <string-name name-style="western"><surname>Hill</surname>, <given-names>W. D.</given-names></string-name>, <string-name name-style="western"><surname>Howard</surname>, <given-names>D. M.</given-names></string-name>, <string-name name-style="western"><surname>Dashti</surname>, <given-names>H. S.</given-names></string-name>, <string-name name-style="western"><surname>Davis</surname>, <given-names>K. A. S.</given-names></string-name>, <string-name name-style="western"><surname>Campbell</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Clarke</surname>, <given-names>T. K.</given-names></string-name>, <string-name name-style="western"><surname>Deary</surname>, <given-names>I. J.</given-names></string-name>, <string-name name-style="western"><surname>Hayward</surname>, <given-names>C.</given-names></string-name>, <string-name name-style="western"><surname>Porteous</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western"><surname>Hotopf</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name name-style="western"><surname>McIntosh</surname>, <given-names>A. M.</given-names></string-name> (<year>2020</year>). <article-title>Factors associated with sharing e&#8208;mail information and mental health survey participation in large population cohorts</article-title>. <source>International Journal of Epidemiology</source>, <volume>49</volume>, <fpage>410</fpage>&#8211;<lpage>421</lpage>.<pub-id pub-id-type="pmid">31263887</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ije/dyz134</pub-id><pub-id pub-id-type="pmcid">PMC7266553</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0002"><mixed-citation publication-type="journal" id="hbm26235-cit-0002"><string-name name-style="western"><surname>Alfaro</surname>, <given-names>F. J.</given-names></string-name>, <string-name name-style="western"><surname>Lioutas</surname>, <given-names>V.&#8208;A.</given-names></string-name>, <string-name name-style="western"><surname>Pimentel</surname>, <given-names>D. A.</given-names></string-name>, <string-name name-style="western"><surname>Chung</surname>, <given-names>C. C.</given-names></string-name>, <string-name name-style="western"><surname>Bedoya</surname>, <given-names>F.</given-names></string-name>, <string-name name-style="western"><surname>Yoo</surname>, <given-names>W. K.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Novak</surname>, <given-names>V.</given-names></string-name> (<year>2016</year>). <article-title>Cognitive decline in metabolic syndrome is linked to microstructural white matter abnormalities</article-title>. <source>Journal of Neurology</source>, <volume>263</volume>, <fpage>2505</fpage>&#8211;<lpage>2514</lpage>.<pub-id pub-id-type="pmid">27730376</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00415-016-8292-z</pub-id><pub-id pub-id-type="pmcid">PMC5112142</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0003"><mixed-citation publication-type="journal" id="hbm26235-cit-0003"><string-name name-style="western"><surname>Allen</surname>, <given-names>B.</given-names></string-name>, <string-name name-style="western"><surname>Muldoon</surname>, <given-names>M. F.</given-names></string-name>, <string-name name-style="western"><surname>Gianaros</surname>, <given-names>P. J.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Jennings</surname>, <given-names>J. R.</given-names></string-name> (<year>2016</year>). <article-title>Higher blood pressure partially links greater adiposity to reduced brain white matter integrity</article-title>. <source>American Journal of Hypertension</source>, <volume>29</volume>, <fpage>1029</fpage>&#8211;<lpage>1037</lpage>.<pub-id pub-id-type="pmid">26970287</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ajh/hpw026</pub-id><pub-id pub-id-type="pmcid">PMC5661494</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0004"><mixed-citation publication-type="journal" id="hbm26235-cit-0004"><string-name name-style="western"><surname>Andersohn</surname>, <given-names>F.</given-names></string-name>, <string-name name-style="western"><surname>Schade</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western"><surname>Suissa</surname>, <given-names>S.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Garbe</surname>, <given-names>E.</given-names></string-name> (<year>2009</year>). <article-title>Long&#8208;term use of antidepressants for depressive disorders and the risk of diabetes mellitus</article-title>. <source>The American Journal of Psychiatry</source>, <volume>166</volume>, <fpage>591</fpage>&#8211;<lpage>598</lpage>.<pub-id pub-id-type="pmid">19339356</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1176/appi.ajp.2008.08071065</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0005"><mixed-citation publication-type="journal" id="hbm26235-cit-0005"><string-name name-style="western"><surname>Angoff</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western"><surname>Himali</surname>, <given-names>J. J.</given-names></string-name>, <string-name name-style="western"><surname>Maillard</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western"><surname>Aparicio</surname>, <given-names>H. J.</given-names></string-name>, <string-name name-style="western"><surname>Vasan</surname>, <given-names>R. S.</given-names></string-name>, <string-name name-style="western"><surname>Seshadri</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Beiser</surname>, <given-names>A. S.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Tsao</surname>, <given-names>C. W.</given-names></string-name> (<year>2022</year>). <article-title>Relations of metabolic health and obesity to brain aging in young to middle&#8208;aged adults</article-title>. <source>Journal of the American Heart Association</source>, <volume>11</volume>, <elocation-id>e022107</elocation-id>.<pub-id pub-id-type="pmid">35229662</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/JAHA.121.022107</pub-id><pub-id pub-id-type="pmcid">PMC9075324</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0006"><mixed-citation publication-type="journal" id="hbm26235-cit-0006"><string-name name-style="western"><surname>Bateman</surname>, <given-names>G. A.</given-names></string-name> (<year>2002</year>). <article-title>Pulse&#8208;wave encephalopathy: A comparative study of the hydrodynamics of leukoaraiosis and normal&#8208;pressure hydrocephalus</article-title>. <source>Neuroradiology</source>, <volume>44</volume>, <fpage>740</fpage>&#8211;<lpage>748</lpage>.<pub-id pub-id-type="pmid">12221445</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00234-002-0812-0</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0007"><mixed-citation publication-type="journal" id="hbm26235-cit-0007"><string-name name-style="western"><surname>Bertoglia</surname>, <given-names>M. P.</given-names></string-name>, <string-name name-style="western"><surname>Gormaz</surname>, <given-names>J. G.</given-names></string-name>, <string-name name-style="western"><surname>Libuy</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western"><surname>Sanhueza</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western"><surname>Gajardo</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Srur</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Wallbaum</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Erazo</surname>, <given-names>M.</given-names></string-name> (<year>2017</year>). <article-title>The population impact of obesity, sedentary lifestyle, and tobacco and alcohol consumption on the prevalence of type 2 diabetes: Analysis of a health population survey in Chile, 2010</article-title>. <source>PLoS One</source>, <volume>12</volume>, <elocation-id>e0178092</elocation-id>.<pub-id pub-id-type="pmid">28542472</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0178092</pub-id><pub-id pub-id-type="pmcid">PMC5444782</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0008"><mixed-citation publication-type="journal" id="hbm26235-cit-0008"><string-name name-style="western"><surname>Buterbaugh</surname>, <given-names>J. S.</given-names></string-name> (<year>2021</year>). <article-title>Pediatric dyslipidemia and screening recommendations</article-title>. <source>The Journal for Nurse Practitioners</source>, <volume>17</volume>, <fpage>1178</fpage>&#8211;<lpage>1182</lpage>.</mixed-citation></ref><ref id="hbm26235-bib-0009"><mixed-citation publication-type="journal" id="hbm26235-cit-0009"><string-name name-style="western"><surname>Clarke</surname>, <given-names>T. K.</given-names></string-name>, <string-name name-style="western"><surname>Obsteter</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Hall</surname>, <given-names>L. S.</given-names></string-name>, <string-name name-style="western"><surname>Hayward</surname>, <given-names>C.</given-names></string-name>, <string-name name-style="western"><surname>Thomson</surname>, <given-names>P. A.</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname>, <given-names>B. H.</given-names></string-name>, <string-name name-style="western"><surname>Padmanabhan</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Hocking</surname>, <given-names>L. J.</given-names></string-name>, <string-name name-style="western"><surname>Deary</surname>, <given-names>I. J.</given-names></string-name>, <string-name name-style="western"><surname>Porteous</surname>, <given-names>D. J.</given-names></string-name>, &amp; <string-name name-style="western"><surname>McIntosh</surname>, <given-names>A. M.</given-names></string-name> (<year>2017</year>). <article-title>Investigating shared aetiology between type 2 diabetes and major depressive disorder in a population based cohort</article-title>. <source>American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics</source>, <volume>174</volume>, <fpage>227</fpage>&#8211;<lpage>234</lpage>.<pub-id pub-id-type="pmid">27480393</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ajmg.b.32478</pub-id><pub-id pub-id-type="pmcid">PMC5363226</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0010"><mixed-citation publication-type="journal" id="hbm26235-cit-0010"><string-name name-style="western"><surname>Cohen</surname>, <given-names>J. I.</given-names></string-name>, <string-name name-style="western"><surname>Cazettes</surname>, <given-names>F.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Convit</surname>, <given-names>A.</given-names></string-name> (<year>2011</year>). <article-title>Abnormal cholesterol is associated with prefrontal White matter abnormalities among obese adults: A diffusion tensor imaging study</article-title>. <source>The Neuroradiology Journal</source>, <volume>24</volume>, <fpage>854</fpage>&#8211;<lpage>861</lpage>.<pub-id pub-id-type="pmid">24059886</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/197140091102400604</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0011"><mixed-citation publication-type="journal" id="hbm26235-cit-0011"><string-name name-style="western"><surname>Crookes</surname>, <given-names>D. M.</given-names></string-name>, <string-name name-style="western"><surname>Demmer</surname>, <given-names>R. T.</given-names></string-name>, <string-name name-style="western"><surname>Keyes</surname>, <given-names>K. M.</given-names></string-name>, <string-name name-style="western"><surname>Koenen</surname>, <given-names>K. C.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Suglia</surname>, <given-names>S. F.</given-names></string-name> (<year>2018</year>). <article-title>Depressive symptoms, antidepressant use, and hypertension in young adulthood</article-title>. <source>Epidemiology</source>, <volume>29</volume>, <fpage>547</fpage>&#8211;<lpage>555</lpage>.<pub-id pub-id-type="pmid">29629939</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/EDE.0000000000000840</pub-id><pub-id pub-id-type="pmcid">PMC5980764</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0012"><mixed-citation publication-type="journal" id="hbm26235-cit-0012"><string-name name-style="western"><surname>Despr&#233;s</surname>, <given-names>J. P.</given-names></string-name>, <string-name name-style="western"><surname>Moorjani</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Lupien</surname>, <given-names>P. J.</given-names></string-name>, <string-name name-style="western"><surname>Tremblay</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Nadeau</surname>, <given-names>A.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Bouchard</surname>, <given-names>C.</given-names></string-name> (<year>1990</year>). <article-title>Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease</article-title>. <source>Arteriosclerosis (Dallas, Texas)</source>, <volume>10</volume>, <fpage>497</fpage>&#8211;<lpage>511</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/01.atv.10.4.497</pub-id><pub-id pub-id-type="pmid">2196040</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0013"><mixed-citation publication-type="journal" id="hbm26235-cit-0013"><string-name name-style="western"><surname>Diminic&#8208;Lisica</surname>, <given-names>I.</given-names></string-name>, <string-name name-style="western"><surname>Popovic</surname>, <given-names>B.</given-names></string-name>, <string-name name-style="western"><surname>Rebic</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Klaric</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Franciskovic</surname>, <given-names>T.</given-names></string-name> (<year>2014</year>). <article-title>Outcome of treatment with antidepressants in patients with hypertension and undetected depression</article-title>. <source>International Journal of Psychiatry in Medicine</source>, <volume>47</volume>, <fpage>115</fpage>&#8211;<lpage>129</lpage>.<pub-id pub-id-type="pmid">25084798</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2190/PM.47.2.c</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0014"><mixed-citation publication-type="journal" id="hbm26235-cit-0014"><string-name name-style="western"><surname>Du</surname>, <given-names>X. L.</given-names></string-name>, <string-name name-style="western"><surname>Song</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western"><surname>Schulz</surname>, <given-names>P. E.</given-names></string-name>, <string-name name-style="western"><surname>Xu</surname>, <given-names>H.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Chan</surname>, <given-names>W.</given-names></string-name> (<year>2022</year>). <article-title>Risk of developing Alzheimer's disease and related dementias in association with cardiovascular disease, stroke, hypertension, and diabetes in a large cohort of women with breast cancer and with up to 26&#8201;years of follow&#8208;up</article-title>. <source>Journal of Alzheimer's Disease</source>, <volume>87</volume>, <fpage>415</fpage>&#8211;<lpage>432</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3233/JAD-215657</pub-id><pub-id pub-id-type="pmcid">PMC9117151</pub-id><pub-id pub-id-type="pmid">35311707</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0015"><mixed-citation publication-type="journal" id="hbm26235-cit-0015"><string-name name-style="western"><surname>Duell</surname>, <given-names>E. J.</given-names></string-name> (<year>2012</year>). <article-title>Epidemiology and potential mechanisms of tobacco smoking and heavy alcohol consumption in pancreatic cancer</article-title>. <source>Molecular Carcinogenesis</source>, <volume>51</volume>, <fpage>40</fpage>&#8211;<lpage>52</lpage>.<pub-id pub-id-type="pmid">22162230</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mc.20786</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0016"><mixed-citation publication-type="journal" id="hbm26235-cit-0016"><string-name name-style="western"><surname>Favre</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western"><surname>Pauling</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western"><surname>Stout</surname>, <given-names>J.</given-names></string-name>, et al. (<year>2019</year>). <article-title>Widespread white matter microstructural abnormalities in bipolar disorder: Evidence from mega&#8208; and meta&#8208;analyses across 3033 individuals</article-title>. <source>Neuropsychopharmacology</source>, <volume>44</volume>, <fpage>2285</fpage>&#8211;<lpage>2293</lpage>.<pub-id pub-id-type="pmid">31434102</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41386-019-0485-6</pub-id><pub-id pub-id-type="pmcid">PMC6898371</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0017"><mixed-citation publication-type="journal" id="hbm26235-cit-0017"><string-name name-style="western"><surname>Fazekas</surname>, <given-names>F.</given-names></string-name>, <string-name name-style="western"><surname>Kleinert</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western"><surname>Offenbacher</surname>, <given-names>H.</given-names></string-name>, <string-name name-style="western"><surname>Schmidt</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western"><surname>Kleinert</surname>, <given-names>G.</given-names></string-name>, <string-name name-style="western"><surname>Payer</surname>, <given-names>F.</given-names></string-name>, <string-name name-style="western"><surname>Radner</surname>, <given-names>H.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Lechner</surname>, <given-names>H.</given-names></string-name> (<year>1993</year>). <article-title>Pathologic correlates of incidental MRI white matter signal hyperintensities</article-title>. <source>Neurology</source>, <volume>43</volume>, <fpage>1683</fpage>&#8211;<lpage>1689</lpage>.<pub-id pub-id-type="pmid">8414012</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/wnl.43.9.1683</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0018"><mixed-citation publication-type="journal" id="hbm26235-cit-0018"><string-name name-style="western"><surname>Ferri</surname>, <given-names>F.</given-names></string-name>, <string-name name-style="western"><surname>Deschenes</surname>, <given-names>S. S.</given-names></string-name>, <string-name name-style="western"><surname>Power</surname>, <given-names>N.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Schmitz</surname>, <given-names>N.</given-names></string-name> (<year>2021</year>). <article-title>Association between depressive symptoms, metabolic risk factors, and cognitive function: Cross&#8208;sectional results from a community study in Quebec, Canada</article-title>. <source>Aging and Mental Health</source>, <volume>25</volume>, <fpage>2003</fpage>&#8211;<lpage>2010</lpage>.<pub-id pub-id-type="pmid">32662305</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/13607863.2020.1792412</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0019"><mixed-citation publication-type="journal" id="hbm26235-cit-0019"><string-name name-style="western"><surname>Friedman</surname>, <given-names>G. D.</given-names></string-name>, <string-name name-style="western"><surname>Klatsky</surname>, <given-names>A. L.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Siegelaub</surname>, <given-names>A. B.</given-names></string-name> (<year>1982</year>). <article-title>Alcohol, tobacco, and hypertension</article-title>. <source>Hypertension</source>, <volume>4</volume>, <fpage>III143</fpage>&#8211;<lpage>III150</lpage>.<pub-id pub-id-type="pmid">7049929</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/01.hyp.4.5_pt_2.iii143</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0020"><mixed-citation publication-type="journal" id="hbm26235-cit-0020"><string-name name-style="western"><surname>Fu</surname>, <given-names>W.</given-names></string-name>, <string-name name-style="western"><surname>Ma</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname>, <given-names>X.</given-names></string-name>, <string-name name-style="western"><surname>Li</surname>, <given-names>Y.</given-names></string-name>, <string-name name-style="western"><surname>Zhu</surname>, <given-names>H.</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname>, <given-names>W.</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname>, <given-names>C.</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Han</surname>, <given-names>R.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Liu</surname>, <given-names>H.</given-names></string-name> (<year>2015</year>). <article-title>Antidepressant medication can improve hypertension in elderly patients with depression</article-title>. <source>Journal of Clinical Neuroscience</source>, <volume>22</volume>, <fpage>1911</fpage>&#8211;<lpage>1915</lpage>.<pub-id pub-id-type="pmid">26256065</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jocn.2015.03.067</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0021"><mixed-citation publication-type="miscellaneous" id="hbm26235-cit-0021"><string-name name-style="western"><surname>Gao</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Kochunov</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western"><surname>Hatch</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western"><surname>Ma</surname>, <given-names>Y.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Talib</surname>, <given-names>F.</given-names></string-name> (<year>2021</year>). <article-title>
<italic toggle="yes">RVIpkg [computer program]</italic>. Version R package version 0.2.8</article-title>.</mixed-citation></ref><ref id="hbm26235-bib-0022"><mixed-citation publication-type="journal" id="hbm26235-cit-0022"><string-name name-style="western"><surname>Haight</surname>, <given-names>T.</given-names></string-name>, <string-name name-style="western"><surname>Nick Bryan</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western"><surname>Erus</surname>, <given-names>G.</given-names></string-name>, <string-name name-style="western"><surname>Hsieh</surname>, <given-names>M. K.</given-names></string-name>, <string-name name-style="western"><surname>Davatzikos</surname>, <given-names>C.</given-names></string-name>, <string-name name-style="western"><surname>Nasrallah</surname>, <given-names>I.</given-names></string-name>, <string-name name-style="western"><surname>D'Esposito</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western"><surname>Jacobs</surname>, <given-names>D. R.</given-names>, <suffix>Jr.</suffix></string-name>, <string-name name-style="western"><surname>Lewis</surname>, <given-names>C.</given-names></string-name>, <string-name name-style="western"><surname>Schreiner</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western"><surname>Sidney</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Meirelles</surname>, <given-names>O.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Launer</surname>, <given-names>L. J.</given-names></string-name> (<year>2018</year>). <article-title>White matter microstructure, white matter lesions, and hypertension: An examination of early surrogate markers of vascular&#8208;related brain change in midlife</article-title>. <source>Neuroimage. Clinical</source>, <volume>18</volume>, <fpage>753</fpage>&#8211;<lpage>761</lpage>.<pub-id pub-id-type="pmid">29785359</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.nicl.2018.02.032</pub-id><pub-id pub-id-type="pmcid">PMC5959740</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0023"><mixed-citation publication-type="journal" id="hbm26235-cit-0023"><string-name name-style="western"><surname>Hannesdottir</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western"><surname>Nitkunan</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Charlton</surname>, <given-names>R. A.</given-names></string-name>, <string-name name-style="western"><surname>Barrick</surname>, <given-names>T. R.</given-names></string-name>, <string-name name-style="western"><surname>MacGregor</surname>, <given-names>G. A.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Markus</surname>, <given-names>H. S.</given-names></string-name> (<year>2009</year>). <article-title>Cognitive impairment and white matter damage in hypertension: A pilot study</article-title>. <source>Acta Neurologica Scandinavica</source>, <volume>119</volume>, <fpage>261</fpage>&#8211;<lpage>268</lpage>.<pub-id pub-id-type="pmid">18798828</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1600-0404.2008.01098.x</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0024"><mixed-citation publication-type="journal" id="hbm26235-cit-0024"><string-name name-style="western"><surname>Hennekens</surname>, <given-names>C. H.</given-names></string-name>, <string-name name-style="western"><surname>Hennekens</surname>, <given-names>A. R.</given-names></string-name>, <string-name name-style="western"><surname>Hollar</surname>, <given-names>D.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Casey</surname>, <given-names>D. E.</given-names></string-name> (<year>2005</year>). <article-title>Schizophrenia and increased risks of cardiovascular disease</article-title>. <source>American Heart Journal</source>, <volume>150</volume>, <fpage>1115</fpage>&#8211;<lpage>1121</lpage>.<pub-id pub-id-type="pmid">16338246</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ahj.2005.02.007</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0025"><mixed-citation publication-type="journal" id="hbm26235-cit-0025"><string-name name-style="western"><surname>Henry Feugeas</surname>, <given-names>M. C.</given-names></string-name>, <string-name name-style="western"><surname>De Marco</surname>, <given-names>G.</given-names></string-name>, <string-name name-style="western"><surname>Peretti</surname>, <given-names>I. I.</given-names></string-name>, <string-name name-style="western"><surname>Godon&#8208;Hardy</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Fredy</surname>, <given-names>D.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Claeys</surname>, <given-names>E. S.</given-names></string-name> (<year>2005</year>). <article-title>Age&#8208;related cerebral white matter changes and pulse&#8208;wave encephalopathy: Observations with three&#8208;dimensional MRI</article-title>. <source>Magnetic Resonance Imaging</source>, <volume>23</volume>, <fpage>929</fpage>&#8211;<lpage>937</lpage>.<pub-id pub-id-type="pmid">16310108</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.mri.2005.09.002</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0026"><mixed-citation publication-type="journal" id="hbm26235-cit-0026"><string-name name-style="western"><surname>Jagust</surname>, <given-names>W. H. D.</given-names></string-name>, <string-name name-style="western"><surname>Mungas</surname>, <given-names>D.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Haan</surname>, <given-names>M.</given-names></string-name> (<year>2005</year>). <article-title>Central obesity and the aging brain</article-title>. <source>Archives of Neurology</source>, <volume>62</volume>, <fpage>1545</fpage>&#8211;<lpage>1548</lpage>.<pub-id pub-id-type="pmid">16216937</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/archneur.62.10.1545</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0027"><mixed-citation publication-type="journal" id="hbm26235-cit-0027"><string-name name-style="western"><surname>Jantaratnotai</surname>, <given-names>N.</given-names></string-name>, <string-name name-style="western"><surname>Mosikanon</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname>, <given-names>Y.</given-names></string-name>, &amp; <string-name name-style="western"><surname>McIntyre</surname>, <given-names>R. S.</given-names></string-name> (<year>2017</year>). <article-title>The interface of depression and obesity</article-title>. <source>Obesity Research &amp; Clinical Practice</source>, <volume>11</volume>, <fpage>1</fpage>&#8211;<lpage>10</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.orcp.2016.07.003</pub-id><pub-id pub-id-type="pmid">27498907</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0028"><mixed-citation publication-type="journal" id="hbm26235-cit-0028"><string-name name-style="western"><surname>Jongen</surname>, <given-names>C.</given-names></string-name>, <string-name name-style="western"><surname>van der Grond</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Kappelle</surname>, <given-names>L. J.</given-names></string-name>, <string-name name-style="western"><surname>Biessels</surname>, <given-names>G. J.</given-names></string-name>, <string-name name-style="western"><surname>Viergever</surname>, <given-names>M. A.</given-names></string-name>, <string-name name-style="western"><surname>Pluim</surname>, <given-names>J. P. W.</given-names></string-name>, &amp; <collab collab-type="authors">Utrecht Diabetic Encephalopathy Study Group</collab>
. (<year>2007</year>). <article-title>Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus</article-title>. <source>Diabetologia</source>, <volume>50</volume>, <fpage>1509</fpage>&#8211;<lpage>1516</lpage>.<pub-id pub-id-type="pmid">17492428</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00125-007-0688-y</pub-id><pub-id pub-id-type="pmcid">PMC1914300</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0029"><mixed-citation publication-type="journal" id="hbm26235-cit-0029"><string-name name-style="western"><surname>Kelly</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Jahanshad</surname>, <given-names>N.</given-names></string-name>, <string-name name-style="western"><surname>Zalesky</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Kochunov</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western"><surname>Agartz</surname>, <given-names>I.</given-names></string-name>, <string-name name-style="western"><surname>Alloza</surname>, <given-names>C.</given-names></string-name>, <string-name name-style="western"><surname>Andreassen</surname>, <given-names>O. A.</given-names></string-name>, <string-name name-style="western"><surname>Arango</surname>, <given-names>C.</given-names></string-name>, <string-name name-style="western"><surname>Banaj</surname>, <given-names>N.</given-names></string-name>, <string-name name-style="western"><surname>Bouix</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Bousman</surname>, <given-names>C. A.</given-names></string-name>, <string-name name-style="western"><surname>Brouwer</surname>, <given-names>R. M.</given-names></string-name>, <string-name name-style="western"><surname>Bruggemann</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Bustillo</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Cahn</surname>, <given-names>W.</given-names></string-name>, <string-name name-style="western"><surname>Calhoun</surname>, <given-names>V.</given-names></string-name>, <string-name name-style="western"><surname>Cannon</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western"><surname>Carr</surname>, <given-names>V.</given-names></string-name>, <string-name name-style="western"><surname>Catts</surname>, <given-names>S.</given-names></string-name>, &#8230; <string-name name-style="western"><surname>Donohoe</surname>, <given-names>G.</given-names></string-name> (<year>2018</year>). <article-title>Widespread white matter microstructural differences in schizophrenia across 4322 individuals: Results from the ENIGMA schizophrenia DTI working group</article-title>. <source>Molecular Psychiatry</source>, <volume>23</volume>, <fpage>1261</fpage>&#8211;<lpage>1269</lpage>.<pub-id pub-id-type="pmid">29038599</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/mp.2017.170</pub-id><pub-id pub-id-type="pmcid">PMC5984078</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0030"><mixed-citation publication-type="journal" id="hbm26235-cit-0030"><string-name name-style="western"><surname>Khandker</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western"><surname>Chekani</surname>, <given-names>F.</given-names></string-name>, <string-name name-style="western"><surname>Limone</surname>, <given-names>B.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Thiel</surname>, <given-names>E.</given-names></string-name> (<year>2022</year>). <article-title>Cardiometabolic outcomes among schizophrenia patients using antipsychotics: The impact of high weight gain risk vs low weight gain risk treatment</article-title>. <source>BMC Psychiatry</source>, <volume>22</volume>, <fpage>133</fpage>.<pub-id pub-id-type="pmid">35183142</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12888-022-03746-0</pub-id><pub-id pub-id-type="pmcid">PMC8857781</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0031"><mixed-citation publication-type="journal" id="hbm26235-cit-0031"><string-name name-style="western"><surname>Kirkpatrick</surname>, <given-names>B.</given-names></string-name>, <string-name name-style="western"><surname>Messias</surname>, <given-names>E.</given-names></string-name>, <string-name name-style="western"><surname>Harvey</surname>, <given-names>P. D.</given-names></string-name>, <string-name name-style="western"><surname>Fernandez&#8208;Egea</surname>, <given-names>E.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Bowie</surname>, <given-names>C. R.</given-names></string-name> (<year>2008</year>). <article-title>Is schizophrenia a syndrome of accelerated aging?</article-title><source>Schizophrenia Bulletin</source>, <volume>34</volume>, <fpage>1024</fpage>&#8211;<lpage>1032</lpage>.<pub-id pub-id-type="pmid">18156637</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/schbul/sbm140</pub-id><pub-id pub-id-type="pmcid">PMC2632500</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0032"><mixed-citation publication-type="journal" id="hbm26235-cit-0032"><string-name name-style="western"><surname>Kochunov</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western"><surname>Fan</surname>, <given-names>F.</given-names></string-name>, <string-name name-style="western"><surname>Ryan</surname>, <given-names>M. C.</given-names></string-name>, <string-name name-style="western"><surname>Hatch</surname>, <given-names>K. S.</given-names></string-name>, <string-name name-style="western"><surname>Tan</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Jahanshad</surname>, <given-names>N.</given-names></string-name>, <string-name name-style="western"><surname>Thompson</surname>, <given-names>P. M.</given-names></string-name>, <string-name name-style="western"><surname>van Erp</surname>, <given-names>T. G. M.</given-names></string-name>, <string-name name-style="western"><surname>Turner</surname>, <given-names>J. A.</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Du</surname>, <given-names>X.</given-names></string-name>, <string-name name-style="western"><surname>Adhikari</surname>, <given-names>B.</given-names></string-name>, <string-name name-style="western"><surname>Bruce</surname>, <given-names>H.</given-names></string-name>, <string-name name-style="western"><surname>Hare</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Goldwaser</surname>, <given-names>E.</given-names></string-name>, <string-name name-style="western"><surname>Kvarta</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Tong</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Cui</surname>, <given-names>Y.</given-names></string-name>, &#8230; <string-name name-style="western"><surname>Hong</surname>, <given-names>L. E.</given-names></string-name> (<year>2020</year>). <article-title>Translating ENIGMA schizophrenia findings using the regional vulnerability index: Association with cognition, symptoms, and disease trajectory</article-title>. <source>Human Brain Mapping</source>, <volume>43</volume>(<issue>1</issue>), <fpage>566</fpage>&#8211;<lpage>575</lpage>.<pub-id pub-id-type="pmid">32463560</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/hbm.25045</pub-id><pub-id pub-id-type="pmcid">PMC8675428</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0033"><mixed-citation publication-type="journal" id="hbm26235-cit-0033"><string-name name-style="western"><surname>Kochunov</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western"><surname>Glahn</surname>, <given-names>D. C.</given-names></string-name>, <string-name name-style="western"><surname>Hong</surname>, <given-names>L. E.</given-names></string-name>, <string-name name-style="western"><surname>Lancaster</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Curran</surname>, <given-names>J. E.</given-names></string-name>, <string-name name-style="western"><surname>Johnson</surname>, <given-names>M. P.</given-names></string-name>, <string-name name-style="western"><surname>Winkler</surname>, <given-names>A. M.</given-names></string-name>, <string-name name-style="western"><surname>Holcomb</surname>, <given-names>H. H.</given-names></string-name>, <string-name name-style="western"><surname>Kent</surname>, <given-names>J. W.</given-names></string-name>, <string-name name-style="western"><surname>Mitchell</surname>, <given-names>B.</given-names></string-name>, <string-name name-style="western"><surname>Kochunov</surname>, <given-names>V.</given-names></string-name>, <string-name name-style="western"><surname>Olvera</surname>, <given-names>R. L.</given-names></string-name>, <string-name name-style="western"><surname>Cole</surname>, <given-names>S. A.</given-names></string-name>, <string-name name-style="western"><surname>Dyer</surname>, <given-names>T. D.</given-names></string-name>, <string-name name-style="western"><surname>Moses</surname>, <given-names>E. K.</given-names></string-name>, <string-name name-style="western"><surname>Goring</surname>, <given-names>H.</given-names></string-name>, <string-name name-style="western"><surname>Almasy</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western"><surname>Duggirala</surname>, <given-names>R.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Blangero</surname>, <given-names>J.</given-names></string-name> (<year>2012</year>). <article-title>P&#8208;selectin expression tracks cerebral atrophy in Mexican&#8208;Americans</article-title>. <source>Frontiers in Genetics</source>, <volume>3</volume>, <fpage>65</fpage>.<pub-id pub-id-type="pmid">22558002</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fgene.2012.00065</pub-id><pub-id pub-id-type="pmcid">PMC3340599</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0034"><mixed-citation publication-type="journal" id="hbm26235-cit-0034"><string-name name-style="western"><surname>Kochunov</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western"><surname>Glahn</surname>, <given-names>D. C.</given-names></string-name>, <string-name name-style="western"><surname>Lancaster</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Winkler</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Karlsgodt</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western"><surname>Olvera</surname>, <given-names>R. L.</given-names></string-name>, <string-name name-style="western"><surname>Curran</surname>, <given-names>J. E.</given-names></string-name>, <string-name name-style="western"><surname>Carless</surname>, <given-names>M. A.</given-names></string-name>, <string-name name-style="western"><surname>Dyer</surname>, <given-names>T. D.</given-names></string-name>, <string-name name-style="western"><surname>Almasy</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western"><surname>Duggirala</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western"><surname>Fox</surname>, <given-names>P. T.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Blangero</surname>, <given-names>J.</given-names></string-name> (<year>2011</year>). <article-title>Blood pressure and cerebral white matter share common genetic factors in Mexican Americans</article-title>. <source>Hypertension</source>, <volume>57</volume>, <fpage>330</fpage>&#8211;<lpage>335</lpage>.<pub-id pub-id-type="pmid">21135356</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/HYPERTENSIONAHA.110.162206</pub-id><pub-id pub-id-type="pmcid">PMC3024472</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0035"><mixed-citation publication-type="journal" id="hbm26235-cit-0035"><string-name name-style="western"><surname>Kochunov</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western"><surname>Glahn</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western"><surname>Lancaster</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Winkler</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Kent</surname>, <given-names>J. W.</given-names>, <suffix>Jr.</suffix></string-name>, <string-name name-style="western"><surname>Olvera</surname>, <given-names>R. L.</given-names></string-name>, <string-name name-style="western"><surname>Cole</surname>, <given-names>S. A.</given-names></string-name>, <string-name name-style="western"><surname>Dyer</surname>, <given-names>T. D.</given-names></string-name>, <string-name name-style="western"><surname>Almasy</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western"><surname>Duggirala</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western"><surname>Fox</surname>, <given-names>P. T.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Blangero</surname>, <given-names>J.</given-names></string-name> (<year>2010</year>). <article-title>Whole brain and regional hyperintense white matter volume and blood pressure: Overlap of genetic loci produced by bivariate, whole&#8208;genome linkage analyses</article-title>. <source>Stroke</source>, <volume>41</volume>, <fpage>2137</fpage>&#8211;<lpage>2142</lpage>.<pub-id pub-id-type="pmid">20724716</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/STROKEAHA.110.590943</pub-id><pub-id pub-id-type="pmcid">PMC3084627</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0036"><mixed-citation publication-type="journal" id="hbm26235-cit-0036"><string-name name-style="western"><surname>Kochunov</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western"><surname>Glahn</surname>, <given-names>D. C.</given-names></string-name>, <string-name name-style="western"><surname>Nichols</surname>, <given-names>T. E.</given-names></string-name>, <string-name name-style="western"><surname>Winkler</surname>, <given-names>A. M.</given-names></string-name>, <string-name name-style="western"><surname>Hong</surname>, <given-names>E. L.</given-names></string-name>, <string-name name-style="western"><surname>Holcomb</surname>, <given-names>H. H.</given-names></string-name>, <string-name name-style="western"><surname>Stein</surname>, <given-names>J. L.</given-names></string-name>, <string-name name-style="western"><surname>Thompson</surname>, <given-names>P. M.</given-names></string-name>, <string-name name-style="western"><surname>Curran</surname>, <given-names>J. E.</given-names></string-name>, <string-name name-style="western"><surname>Carless</surname>, <given-names>M. A.</given-names></string-name>, <string-name name-style="western"><surname>Olvera</surname>, <given-names>R. L.</given-names></string-name>, <string-name name-style="western"><surname>Johnson</surname>, <given-names>M. P.</given-names></string-name>, <string-name name-style="western"><surname>Cole</surname>, <given-names>S. A.</given-names></string-name>, <string-name name-style="western"><surname>Kochunov</surname>, <given-names>V.</given-names></string-name>, <string-name name-style="western"><surname>Kent</surname>, <given-names>J.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Blangero</surname>, <given-names>J.</given-names></string-name> (<year>2011</year>). <article-title>Genetic analysis of cortical thickness and fractional anisotropy of water diffusion in the brain</article-title>. <source>Frontiers in Neuroscience</source>, <volume>5</volume>, <fpage>120</fpage>.<pub-id pub-id-type="pmid">22028680</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fnins.2011.00120</pub-id><pub-id pub-id-type="pmcid">PMC3199541</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0037"><mixed-citation publication-type="journal" id="hbm26235-cit-0037"><string-name name-style="western"><surname>Kochunov</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western"><surname>Glahn</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western"><surname>Winkler</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Duggirala</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western"><surname>Olvera</surname>, <given-names>R. L.</given-names></string-name>, <string-name name-style="western"><surname>Cole</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Dyer</surname>, <given-names>T. D.</given-names></string-name>, <string-name name-style="western"><surname>Almasy</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western"><surname>Fox</surname>, <given-names>P. T.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Blangero</surname>, <given-names>J.</given-names></string-name> (<year>2009</year>). <article-title>Analysis of genetic variability and whole genome linkage of whole&#8208;brain, subcortical, and ependymal hyperintense white matter volume</article-title>. <source>Stroke</source>, <volume>40</volume>, <fpage>3685</fpage>&#8211;<lpage>3690</lpage>.<pub-id pub-id-type="pmid">19834011</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/STROKEAHA.109.565390</pub-id><pub-id pub-id-type="pmcid">PMC2787844</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0038"><mixed-citation publication-type="journal" id="hbm26235-cit-0038"><string-name name-style="western"><surname>Kochunov</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western"><surname>Hong</surname>, <given-names>L. E.</given-names></string-name>, <string-name name-style="western"><surname>Dennis</surname>, <given-names>E. L.</given-names></string-name>, <string-name name-style="western"><surname>Morey</surname>, <given-names>R. A.</given-names></string-name>, <string-name name-style="western"><surname>Tate</surname>, <given-names>D. F.</given-names></string-name>, <string-name name-style="western"><surname>Wilde</surname>, <given-names>E. A.</given-names></string-name>, <string-name name-style="western"><surname>Logue</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western"><surname>Kelly</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Donohoe</surname>, <given-names>G.</given-names></string-name>, <string-name name-style="western"><surname>Favre</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western"><surname>Houenou</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Ching</surname>, <given-names>C. R. K.</given-names></string-name>, <string-name name-style="western"><surname>Holleran</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western"><surname>Andreassen</surname>, <given-names>O. A.</given-names></string-name>, <string-name name-style="western"><surname>van Velzen</surname>, <given-names>L. S.</given-names></string-name>, <string-name name-style="western"><surname>Schmaal</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western"><surname>Villal&#243;n&#8208;Reina</surname>, <given-names>J. E.</given-names></string-name>, <string-name name-style="western"><surname>Bearden</surname>, <given-names>C. E.</given-names></string-name>, <string-name name-style="western"><surname>Piras</surname>, <given-names>F.</given-names></string-name>, &#8230; <string-name name-style="western"><surname>Jahanshad</surname>, <given-names>N.</given-names></string-name> (<year>2020</year>). <article-title>ENIGMA&#8208;DTI: Translating reproducible white matter deficits into personalized vulnerability metrics in cross&#8208;diagnostic psychiatric research</article-title>. <source>Human Brain Mapping</source>, <volume>43</volume>(<issue>1</issue>), <fpage>194</fpage>&#8211;<lpage>206</lpage>.<pub-id pub-id-type="pmid">32301246</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/hbm.24998</pub-id><pub-id pub-id-type="pmcid">PMC8675425</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0039"><mixed-citation publication-type="journal" id="hbm26235-cit-0039"><string-name name-style="western"><surname>Kochunov</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Li</surname>, <given-names>Y.</given-names></string-name>, <string-name name-style="western"><surname>Tan</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Fan</surname>, <given-names>F.</given-names></string-name>, <string-name name-style="western"><surname>Feng</surname>, <given-names>W.</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname>, <given-names>Y.</given-names></string-name>, <string-name name-style="western"><surname>Rowland</surname>, <given-names>L. M.</given-names></string-name>, <string-name name-style="western"><surname>Savransky</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Du</surname>, <given-names>X.</given-names></string-name>, <string-name name-style="western"><surname>Chiappelli</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Jahanshad</surname>, <given-names>N.</given-names></string-name>, <string-name name-style="western"><surname>Thompson</surname>, <given-names>P. M.</given-names></string-name>, <string-name name-style="western"><surname>Ryan</surname>, <given-names>M. C.</given-names></string-name>, <string-name name-style="western"><surname>Adhikari</surname>, <given-names>B.</given-names></string-name>, <string-name name-style="western"><surname>Sampath</surname>, <given-names>H.</given-names></string-name>, <string-name name-style="western"><surname>Cui</surname>, <given-names>Y.</given-names></string-name>, &#8230; <string-name name-style="western"><surname>Hong</surname>, <given-names>L. E.</given-names></string-name> (<year>2019</year>). <article-title>White matter in schizophrenia treatment resistance</article-title>. <source>The American Journal of Psychiatry</source>, <volume>176</volume>, <fpage>829</fpage>&#8211;<lpage>838</lpage>.<pub-id pub-id-type="pmid">31352812</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1176/appi.ajp.2019.18101212</pub-id><pub-id pub-id-type="pmcid">PMC6773514</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0040"><mixed-citation publication-type="journal" id="hbm26235-cit-0040"><string-name name-style="western"><surname>Kochunov</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western"><surname>Ma</surname>, <given-names>Y.</given-names></string-name>, <string-name name-style="western"><surname>Hatch</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western"><surname>Gao</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Jahanshad</surname>, <given-names>N.</given-names></string-name>, <string-name name-style="western"><surname>Thompson</surname>, <given-names>P. M.</given-names></string-name>, <string-name name-style="western"><surname>Adhikari</surname>, <given-names>B. M.</given-names></string-name>, <string-name name-style="western"><surname>Bruce</surname>, <given-names>H.</given-names></string-name>, <string-name name-style="western"><surname>Van der Vaart</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Goldwaser</surname>, <given-names>E. L.</given-names></string-name>, <string-name name-style="western"><surname>Sotiras</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Kvarta</surname>, <given-names>M. D.</given-names></string-name>, <string-name name-style="western"><surname>Ma</surname>, <given-names>T.</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Nichols</surname>, <given-names>T. E.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Hong</surname>, <given-names>L. E.</given-names></string-name> (<year>2022</year>). <article-title>Brain&#8208;wide versus genome&#8208;wide vulnerability biomarkers for severe mental illnesses</article-title>. <source>Human Brain Mapping</source>, <volume>43</volume>(<issue>16</issue>), <fpage>4970</fpage>&#8211;<lpage>4983</lpage>.<pub-id pub-id-type="pmid">36040723</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/hbm.26056</pub-id><pub-id pub-id-type="pmcid">PMC9582367</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0041"><mixed-citation publication-type="journal" id="hbm26235-cit-0041"><string-name name-style="western"><surname>Kochunov</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western"><surname>Ryan</surname>, <given-names>M. C.</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname>, <given-names>Q.</given-names></string-name>, <string-name name-style="western"><surname>Hatch</surname>, <given-names>K. S.</given-names></string-name>, <string-name name-style="western"><surname>Zhu</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Thomopoulos</surname>, <given-names>S. I.</given-names></string-name>, <string-name name-style="western"><surname>Jahanshad</surname>, <given-names>N.</given-names></string-name>, <string-name name-style="western"><surname>Schmaal</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western"><surname>Thompson</surname>, <given-names>P. M.</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>du</surname>, <given-names>X.</given-names></string-name>, <string-name name-style="western"><surname>Adhikari</surname>, <given-names>B. M.</given-names></string-name>, <string-name name-style="western"><surname>Bruce</surname>, <given-names>H.</given-names></string-name>, <string-name name-style="western"><surname>Hare</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Goldwaser</surname>, <given-names>E. L.</given-names></string-name>, <string-name name-style="western"><surname>Kvarta</surname>, <given-names>M. D.</given-names></string-name>, <string-name name-style="western"><surname>Nichols</surname>, <given-names>T. E.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Hong</surname>, <given-names>L. E.</given-names></string-name> (<year>2021</year>). <article-title>Comparison of regional brain deficit patterns in common psychiatric and neurological disorders as revealed by big data</article-title>. <source>NeuroImage Clinical</source>, <volume>29</volume>, <elocation-id>102574</elocation-id>.<pub-id pub-id-type="pmid">33530016</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.nicl.2021.102574</pub-id><pub-id pub-id-type="pmcid">PMC7851406</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0042"><mixed-citation publication-type="journal" id="hbm26235-cit-0042"><string-name name-style="western"><surname>Kochunov</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western"><surname>Thompson</surname>, <given-names>P. M.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Hong</surname>, <given-names>L. E.</given-names></string-name> (<year>2019</year>). <article-title>Toward high reproducibility and accountable heterogeneity in schizophrenia research</article-title>. <source>JAMA Psychiatry</source>, <volume>76</volume>, <fpage>680</fpage>&#8211;<lpage>681</lpage>.<pub-id pub-id-type="pmid">30969327</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamapsychiatry.2019.0208</pub-id><pub-id pub-id-type="pmcid">PMC6757339</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0043"><mixed-citation publication-type="journal" id="hbm26235-cit-0043"><string-name name-style="western"><surname>Kochunov</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western"><surname>Zavaliangos&#8208;Petropuli</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Jahandshad</surname>, <given-names>N.</given-names></string-name>, <string-name name-style="western"><surname>Thompson</surname>, <given-names>P. M.</given-names></string-name>, <string-name name-style="western"><surname>Ryan</surname>, <given-names>M. C.</given-names></string-name>, <string-name name-style="western"><surname>Chiappelli</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Du</surname>, <given-names>X.</given-names></string-name>, <string-name name-style="western"><surname>Hatch</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western"><surname>Adhikari</surname>, <given-names>B.</given-names></string-name>, <string-name name-style="western"><surname>Sampath</surname>, <given-names>H.</given-names></string-name>, <string-name name-style="western"><surname>Hare</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Kvarta</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western"><surname>Goldwaser</surname>, <given-names>E.</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname>, <given-names>F.</given-names></string-name>, <string-name name-style="western"><surname>Olvera</surname>, <given-names>R. L.</given-names></string-name>, <string-name name-style="western"><surname>Fox</surname>, <given-names>P. T.</given-names></string-name>, <string-name name-style="western"><surname>Curran</surname>, <given-names>J. E.</given-names></string-name>, <string-name name-style="western"><surname>Blangero</surname>, <given-names>J.</given-names></string-name>, &#8230; <string-name name-style="western"><surname>Hong</surname>, <given-names>L. E.</given-names></string-name> (<year>2021</year>). <article-title>A white matter connection of schizophrenia and Alzheimer's disease</article-title>. <source>Schizophrenia Bulletin</source>, <volume>47</volume>(<issue>1</issue>), <fpage>197</fpage>&#8211;<lpage>206</lpage>.<pub-id pub-id-type="pmid">32681179</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/schbul/sbaa078</pub-id><pub-id pub-id-type="pmcid">PMC7825012</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0044"><mixed-citation publication-type="journal" id="hbm26235-cit-0044"><string-name name-style="western"><surname>Lewington</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Whitlock</surname>, <given-names>G.</given-names></string-name>, <string-name name-style="western"><surname>Clarke</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western"><surname>Sherliker</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western"><surname>Emberson</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Halsey</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Qizilbash</surname>, <given-names>N.</given-names></string-name>, <string-name name-style="western"><surname>Peto</surname>, <given-names>R.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Collins</surname>, <given-names>R.</given-names></string-name> (<year>2007</year>). <article-title>Blood cholesterol and vascular mortality by age, sex, and blood pressure: A meta&#8208;analysis of individual data from 61 prospective studies with 55,000 vascular deaths</article-title>. <source>Lancet</source>, <volume>370</volume>, <fpage>1829</fpage>&#8211;<lpage>1839</lpage>.<pub-id pub-id-type="pmid">18061058</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(07)61778-4</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0045"><mixed-citation publication-type="journal" id="hbm26235-cit-0045"><string-name name-style="western"><surname>Liang</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western"><surname>Cai</surname>, <given-names>X.</given-names></string-name>, <string-name name-style="western"><surname>Tang</surname>, <given-names>Y.</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname>, <given-names>X. L.</given-names></string-name>, <string-name name-style="western"><surname>Fang</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Li</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname>, <given-names>S. H.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Zhou</surname>, <given-names>Q.</given-names></string-name> (<year>2019</year>). <article-title>Diffusion tensor imaging of white matter in patients with prediabetes by trace&#8208;based spatial statistics</article-title>. <source>Journal of Magnetic Resonance Imaging</source>, <volume>49</volume>, <fpage>1105</fpage>&#8211;<lpage>1112</lpage>.<pub-id pub-id-type="pmid">30302864</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jmri.26290</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0046"><mixed-citation publication-type="journal" id="hbm26235-cit-0046"><string-name name-style="western"><surname>Liang</surname>, <given-names>C.</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Feng</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname>, <given-names>N.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Guo</surname>, <given-names>L.</given-names></string-name> (<year>2022</year>). <article-title>White matter changes, duration of hypertension, and age are associated with cerebral microbleeds in patients with different stages of hypertension</article-title>. <source>Quantitative Imaging in Medicine and Surgery</source>, <volume>12</volume>, <fpage>119</fpage>&#8211;<lpage>130</lpage>.<pub-id pub-id-type="pmid">34993065</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.21037/qims-21-28</pub-id><pub-id pub-id-type="pmcid">PMC8666759</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0047"><mixed-citation publication-type="journal" id="hbm26235-cit-0047"><string-name name-style="western"><surname>Lung</surname>, <given-names>F. W.</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname>, <given-names>N. C.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Shu</surname>, <given-names>B. C.</given-names></string-name> (<year>2007</year>). <article-title>Genetic pathway of major depressive disorder in shortening telomeric length</article-title>. <source>Psychiatric Genetics</source>, <volume>17</volume>, <fpage>195</fpage>&#8211;<lpage>199</lpage>.<pub-id pub-id-type="pmid">17417064</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/YPG.0b013e32808374f6</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0048"><mixed-citation publication-type="journal" id="hbm26235-cit-0048"><string-name name-style="western"><surname>Luo</surname>, <given-names>H.</given-names></string-name>, <string-name name-style="western"><surname>Li</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname>, <given-names>Q.</given-names></string-name>, <string-name name-style="western"><surname>Cao</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western"><surname>Ren</surname>, <given-names>X.</given-names></string-name>, <string-name name-style="western"><surname>Fang</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Liao</surname>, <given-names>H.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Liu</surname>, <given-names>L.</given-names></string-name> (<year>2018</year>). <article-title>Obesity and the onset of depressive symptoms among middle&#8208;aged and older adults in China: Evidence from the CHARLS</article-title>. <source>BMC Public Health</source>, <volume>18</volume>, <fpage>909</fpage>.<pub-id pub-id-type="pmid">30041632</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12889-018-5834-6</pub-id><pub-id pub-id-type="pmcid">PMC6057008</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0049"><mixed-citation publication-type="journal" id="hbm26235-cit-0049"><string-name name-style="western"><surname>Luo</surname>, <given-names>Y.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Lin</surname>, <given-names>H.</given-names></string-name> (<year>2021</year>). <article-title>Inflammation initiates a vicious cycle between obesity and nonalcoholic fatty liver disease</article-title>. <source>Immunity, Inflammation and Disease</source>, <volume>9</volume>, <fpage>59</fpage>&#8211;<lpage>73</lpage>.<pub-id pub-id-type="pmid">33332766</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/iid3.391</pub-id><pub-id pub-id-type="pmcid">PMC7860600</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0050"><mixed-citation publication-type="journal" id="hbm26235-cit-0050"><string-name name-style="western"><surname>Maaroganye</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western"><surname>Mohapi</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western"><surname>Kruger</surname>, <given-names>C.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Rheeder</surname>, <given-names>P.</given-names></string-name> (<year>2013</year>). <article-title>The prevalence of metabolic syndrome and its associated factors in long&#8208;term patients in a specialist psychiatric hospital in South Africa</article-title>. <source>African Journal of Psychiatry (Johannesbg)</source>, <volume>16</volume>,&#160;<fpage>1</fpage>&#8211;<lpage>10</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.4314/ajpsy.v16i6.53</pub-id><pub-id pub-id-type="pmid">24173635</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0051"><mixed-citation publication-type="journal" id="hbm26235-cit-0051"><string-name name-style="western"><surname>Maisonneuve</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western"><surname>Lowenfels</surname>, <given-names>A. B.</given-names></string-name>, <string-name name-style="western"><surname>Mullhaupt</surname>, <given-names>B.</given-names></string-name>, <string-name name-style="western"><surname>Cavallini</surname>, <given-names>G.</given-names></string-name>, <string-name name-style="western"><surname>Lankisch</surname>, <given-names>P. G.</given-names></string-name>, <string-name name-style="western"><surname>Andersen</surname>, <given-names>J. R.</given-names></string-name>, <string-name name-style="western"><surname>Dimagno</surname>, <given-names>E. P.</given-names></string-name>, <string-name name-style="western"><surname>Andr&#233;n&#8208;Sandberg</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Domell&#246;f</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western"><surname>Frulloni</surname>, <given-names>L.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Ammann</surname>, <given-names>R. W.</given-names></string-name> (<year>2005</year>). <article-title>Cigarette smoking accelerates progression of alcoholic chronic pancreatitis</article-title>. <source>Gut</source>, <volume>54</volume>, <fpage>510</fpage>&#8211;<lpage>514</lpage>.<pub-id pub-id-type="pmid">15753536</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/gut.2004.039263</pub-id><pub-id pub-id-type="pmcid">PMC1774435</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0052"><mixed-citation publication-type="journal" id="hbm26235-cit-0052"><string-name name-style="western"><surname>Malmir</surname>, <given-names>H.</given-names></string-name>, <string-name name-style="western"><surname>Mirzababaei</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Moradi</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Rezaei</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Mirzaei</surname>, <given-names>K.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Dadfarma</surname>, <given-names>A.</given-names></string-name> (<year>2019</year>). <article-title>Metabolically healthy status and BMI in relation to depression: A systematic review of observational studies</article-title>. <source>Diabetes &amp; Metabolic Syndrome</source>, <volume>13</volume>, <fpage>1099</fpage>&#8211;<lpage>1103</lpage>.<pub-id pub-id-type="pmid">31336451</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.dsx.2019.01.027</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0053"><mixed-citation publication-type="journal" id="hbm26235-cit-0053"><string-name name-style="western"><surname>Man</surname>, <given-names>K. K. C.</given-names></string-name>, <string-name name-style="western"><surname>Shao</surname>, <given-names>S. C.</given-names></string-name>, <string-name name-style="western"><surname>Chaiyakunapruk</surname>, <given-names>N.</given-names></string-name>, <string-name name-style="western"><surname>Dilokthornsakul</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western"><surname>Kubota</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western"><surname>Li</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Ooba</surname>, <given-names>N.</given-names></string-name>, <string-name name-style="western"><surname>Pratt</surname>, <given-names>N.</given-names></string-name>, <string-name name-style="western"><surname>Potteg&#229;rd</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Rasmussen</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western"><surname>Roughead</surname>, <given-names>E. E.</given-names></string-name>, <string-name name-style="western"><surname>Shin</surname>, <given-names>J. Y.</given-names></string-name>, <string-name name-style="western"><surname>Su</surname>, <given-names>C. C.</given-names></string-name>, <string-name name-style="western"><surname>Wong</surname>, <given-names>I. C. K.</given-names></string-name>, <string-name name-style="western"><surname>Kao Yang</surname>, <given-names>Y. H.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Lai</surname>, <given-names>E. C. C.</given-names></string-name> (<year>2022</year>). <article-title>Metabolic events associated with the use of antipsychotics in children, adolescents and young adults: A multinational sequence symmetry study</article-title>. <source>European Child &amp; Adolescent Psychiatry</source>, <volume>31</volume>, <fpage>99</fpage>&#8211;<lpage>120</lpage>.<pub-id pub-id-type="pmid">33185773</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00787-020-01674-6</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0054"><mixed-citation publication-type="journal" id="hbm26235-cit-0054"><string-name name-style="western"><surname>Manschot</surname>, <given-names>S. M.</given-names></string-name>, <string-name name-style="western"><surname>Brands</surname>, <given-names>A. M.</given-names></string-name>, <string-name name-style="western"><surname>van der Grond</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Kessels</surname>, <given-names>R. P. C.</given-names></string-name>, <string-name name-style="western"><surname>Algra</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Kappelle</surname>, <given-names>L. J.</given-names></string-name>, <string-name name-style="western"><surname>Biessels</surname>, <given-names>G. J.</given-names></string-name>, &amp; <collab collab-type="authors">Utrecht Diabetic Encephalopathy Study Group</collab>
. (<year>2006</year>). <article-title>Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes</article-title>. <source>Diabetes</source>, <volume>55</volume>, <fpage>1106</fpage>&#8211;<lpage>1113</lpage>.<pub-id pub-id-type="pmid">16567535</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2337/diabetes.55.04.06.db05-1323</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0055"><mixed-citation publication-type="journal" id="hbm26235-cit-0055"><string-name name-style="western"><surname>Marks</surname>, <given-names>B.</given-names></string-name>, <string-name name-style="western"><surname>Katz</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western"><surname>Styner</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Smith</surname>, <given-names>J.</given-names></string-name> (<year>2011</year>). <article-title>Aerobic fitness and obesity: Relationship to cerebral white matter integrity in the brain of active and sedentary older adults</article-title>. <source>British Journal of Sports Medicine</source>, <volume>45</volume>(<issue>15</issue>), <fpage>1208</fpage>&#8211;<lpage>1215</lpage>.<pub-id pub-id-type="pmid">20558529</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bjsm.2009.068114</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0056"><mixed-citation publication-type="journal" id="hbm26235-cit-0056"><string-name name-style="western"><surname>Marseglia</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Darin&#8208;Mattsson</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Skoog</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Ryd&#233;n</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western"><surname>Hadarsson&#8208;Bodin</surname>, <given-names>T.</given-names></string-name>, <string-name name-style="western"><surname>Kern</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Rydberg Sterner</surname>, <given-names>T.</given-names></string-name>, <string-name name-style="western"><surname>Shang</surname>, <given-names>Y.</given-names></string-name>, <string-name name-style="western"><surname>Zettergren</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Westman</surname>, <given-names>E.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Skoog</surname>, <given-names>I.</given-names></string-name> (<year>2021</year>). <article-title>Metabolic syndrome is associated with poor cognition: A population&#8208;based study of 70&#8208;year&#8208;old adults without dementia</article-title>. <source>The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences</source>, <volume>76</volume>, <fpage>2275</fpage>&#8211;<lpage>2283</lpage>.<pub-id pub-id-type="pmid">34228116</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/gerona/glab195</pub-id><pub-id pub-id-type="pmcid">PMC8599084</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0057"><mixed-citation publication-type="journal" id="hbm26235-cit-0057"><string-name name-style="western"><surname>Milaneschi</surname>, <given-names>Y.</given-names></string-name>, <string-name name-style="western"><surname>Simmons</surname>, <given-names>W. K.</given-names></string-name>, <string-name name-style="western"><surname>van Rossum</surname>, <given-names>E. F. C.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Penninx</surname>, <given-names>B. W.</given-names></string-name> (<year>2019</year>). <article-title>Depression and obesity: Evidence of shared biological mechanisms</article-title>. <source>Molecular Psychiatry</source>, <volume>24</volume>, <fpage>18</fpage>&#8211;<lpage>33</lpage>.<pub-id pub-id-type="pmid">29453413</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41380-018-0017-5</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0058"><mixed-citation publication-type="journal" id="hbm26235-cit-0058"><string-name name-style="western"><surname>Miller</surname>, <given-names>A. A.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Spencer</surname>, <given-names>S. J.</given-names></string-name> (<year>2014</year>). <article-title>Obesity and neuroinflammation: A pathway to cognitive impairment</article-title>. <source>Brain, Behavior, and Immunity</source>, <volume>42</volume>, <fpage>10</fpage>&#8211;<lpage>21</lpage>.<pub-id pub-id-type="pmid">24727365</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bbi.2014.04.001</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0059"><mixed-citation publication-type="journal" id="hbm26235-cit-0059"><string-name name-style="western"><surname>Mitchell</surname>, <given-names>A. J.</given-names></string-name>, <string-name name-style="western"><surname>Vancampfort</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western"><surname>Sweers</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western"><surname>van Winkel</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname>, <given-names>W.</given-names></string-name>, &amp; <string-name name-style="western"><surname>De Hert</surname>, <given-names>M.</given-names></string-name> (<year>2013</year>). <article-title>Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders&#8212;A systematic review and meta&#8208;analysis</article-title>. <source>Schizophrenia Bulletin</source>, <volume>39</volume>, <fpage>306</fpage>&#8211;<lpage>318</lpage>.<pub-id pub-id-type="pmid">22207632</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/schbul/sbr148</pub-id><pub-id pub-id-type="pmcid">PMC3576174</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0060"><mixed-citation publication-type="journal" id="hbm26235-cit-0060"><string-name name-style="western"><surname>Nishtala</surname>, <given-names>P. S.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Chyou</surname>, <given-names>T. Y.</given-names></string-name> (<year>2017</year>). <article-title>Real&#8208;world risk of diabetes with antipsychotic use in older New Zealanders: A case&#8208;crossover study</article-title>. <source>European Journal of Clinical Pharmacology</source>, <volume>73</volume>, <fpage>233</fpage>&#8211;<lpage>239</lpage>.<pub-id pub-id-type="pmid">27885398</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00228-016-2158-2</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0061"><mixed-citation publication-type="journal" id="hbm26235-cit-0061"><string-name name-style="western"><surname>Noordam</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western"><surname>Aarts</surname>, <given-names>N.</given-names></string-name>, <string-name name-style="western"><surname>de Keyser</surname>, <given-names>C. E.</given-names></string-name>, <string-name name-style="western"><surname>Hofman</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Stricker</surname>, <given-names>B. H.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Visser</surname>, <given-names>L. E.</given-names></string-name> (<year>2015</year>). <article-title>Antidepressants with a high serotonin reuptake transporter affinity and serum lipid levels in a population&#8208;based study in older adults</article-title>. <source>Journal of Psychopharmacology</source>, <volume>29</volume>, <fpage>1112</fpage>&#8211;<lpage>1118</lpage>.<pub-id pub-id-type="pmid">26152323</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0269881115592340</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0062"><mixed-citation publication-type="journal" id="hbm26235-cit-0062"><string-name name-style="western"><surname>Olguner Eker</surname>, <given-names>O.</given-names></string-name>, <string-name name-style="western"><surname>Ozsoy</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Eker</surname>, <given-names>B.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Dogan</surname>, <given-names>H.</given-names></string-name> (<year>2017</year>). <article-title>Metabolic effects of antidepressant treatment</article-title>. <source>Noro Psikiyatri Arsivi</source>, <volume>54</volume>, <fpage>49</fpage>&#8211;<lpage>56</lpage>.<pub-id pub-id-type="pmid">28566959</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5152/npa.2016.12373</pub-id><pub-id pub-id-type="pmcid">PMC5439472</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0063"><mixed-citation publication-type="journal" id="hbm26235-cit-0063"><string-name name-style="western"><surname>Osama</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Khalil</surname>, <given-names>T. H.</given-names></string-name>, <string-name name-style="western"><surname>Negm</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western"><surname>AbdEl&#8208;Razek</surname>, <given-names>R.</given-names></string-name>, &amp; <string-name name-style="western"><surname>AbouElhamd</surname>, <given-names>H.</given-names></string-name> (<year>2020</year>). <article-title>Association between microstructural white matter abnormalities and cognitive functioning in patients with type 2 diabetes mellitus: A diffusion tensor imaging study</article-title>. <source>The Egyptian Journal of Neurology, Psychiatry and Neurosurgery</source>, <fpage>56</fpage>.</mixed-citation></ref><ref id="hbm26235-bib-0064"><mixed-citation publication-type="journal" id="hbm26235-cit-0064"><string-name name-style="western"><surname>Ouyang</surname>, <given-names>F.</given-names></string-name>, <string-name name-style="western"><surname>He</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Cheng</surname>, <given-names>X.</given-names></string-name>, <string-name name-style="western"><surname>Zhou</surname>, <given-names>W.</given-names></string-name>, <string-name name-style="western"><surname>Xiao</surname>, <given-names>S.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Fang</surname>, <given-names>J.</given-names></string-name> (<year>2022</year>). <article-title>Antipsychotic&#8208;related risks of type 2 diabetes mellitus in enrollees with schizophrenia in the National Basic Public Health Service Program in Hunan Province, China</article-title>. <source>Frontier Psychiatry</source>, <volume>13</volume>, <elocation-id>754775</elocation-id>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fpsyt.2022.754775</pub-id><pub-id pub-id-type="pmcid">PMC8909132</pub-id><pub-id pub-id-type="pmid">35280179</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0065"><mixed-citation publication-type="journal" id="hbm26235-cit-0065"><string-name name-style="western"><surname>Pannacciulli</surname>, <given-names>N.</given-names></string-name>, <string-name name-style="western"><surname>Del Parigi</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western"><surname>Le</surname>, <given-names>D. S.</given-names></string-name>, <string-name name-style="western"><surname>Reiman</surname>, <given-names>E. M.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Tataranni</surname>, <given-names>P. A.</given-names></string-name> (<year>2006</year>). <article-title>Brain abnormalities in human obesity: A voxel&#8208;based morphometric study</article-title>. <source>NeuroImage</source>, <volume>31</volume>, <fpage>1419</fpage>&#8211;<lpage>1425</lpage>.<pub-id pub-id-type="pmid">16545583</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neuroimage.2006.01.047</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0066"><mixed-citation publication-type="journal" id="hbm26235-cit-0066"><string-name name-style="western"><surname>Papakostas</surname>, <given-names>G. I.</given-names></string-name>, <string-name name-style="western"><surname>Petersen</surname>, <given-names>T.</given-names></string-name>, <string-name name-style="western"><surname>Iosifescu</surname>, <given-names>D. V.</given-names></string-name>, <string-name name-style="western"><surname>Burns</surname>, <given-names>A. M.</given-names></string-name>, <string-name name-style="western"><surname>Nierenberg</surname>, <given-names>A. A.</given-names></string-name>, <string-name name-style="western"><surname>Alpert</surname>, <given-names>J. E.</given-names></string-name>, <string-name name-style="western"><surname>Rosenbaum</surname>, <given-names>J. F.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Fava</surname>, <given-names>M.</given-names></string-name> (<year>2005</year>). <article-title>Obesity among outpatients with major depressive disorder</article-title>. <source>The International Journal of Neuropsychopharmacology</source>, <volume>8</volume>, <fpage>59</fpage>&#8211;<lpage>63</lpage>.<pub-id pub-id-type="pmid">15361263</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1017/S1461145704004602</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0067"><mixed-citation publication-type="journal" id="hbm26235-cit-0067"><string-name name-style="western"><surname>Patriarca</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western"><surname>Magerowski</surname>, <given-names>G.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Alonso&#8208;Alonso</surname>, <given-names>M.</given-names></string-name> (<year>2017</year>). <article-title>Functional neuroimaging in obesity</article-title>. <source>Current Opinion in Endocrinology, Diabetes, and Obesity</source>, <volume>24</volume>, <fpage>260</fpage>&#8211;<lpage>265</lpage>.<pub-id pub-id-type="pmid">28277342</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MED.0000000000000340</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0068"><mixed-citation publication-type="journal" id="hbm26235-cit-0068"><string-name name-style="western"><surname>Reiman</surname>, <given-names>E. M.</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western"><surname>Langbaum</surname>, <given-names>J. B.</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname>, <given-names>W.</given-names></string-name>, <string-name name-style="western"><surname>Reschke</surname>, <given-names>C.</given-names></string-name>, <string-name name-style="western"><surname>Bandy</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western"><surname>Alexander</surname>, <given-names>G. E.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Caselli</surname>, <given-names>R. J.</given-names></string-name> (<year>2010</year>). <article-title>Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging</article-title>. <source>NeuroImage</source>, <volume>49</volume>, <fpage>169</fpage>&#8211;<lpage>176</lpage>.<pub-id pub-id-type="pmid">19631758</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neuroimage.2009.07.025</pub-id><pub-id pub-id-type="pmcid">PMC2888804</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0069"><mixed-citation publication-type="journal" id="hbm26235-cit-0069"><string-name name-style="western"><surname>Renteria</surname>, <given-names>M. E.</given-names></string-name>, <string-name name-style="western"><surname>Schmaal</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western"><surname>Hibar</surname>, <given-names>D. P.</given-names></string-name>, <string-name name-style="western"><surname>Couvy&#8208;Duchesne</surname>, <given-names>B.</given-names></string-name>, <string-name name-style="western"><surname>Strike</surname>, <given-names>L. T.</given-names></string-name>, <string-name name-style="western"><surname>Mills</surname>, <given-names>N. T.</given-names></string-name>, <string-name name-style="western"><surname>de Zubicaray</surname>, <given-names>G. I.</given-names></string-name>, <string-name name-style="western"><surname>McMahon</surname>, <given-names>K. L.</given-names></string-name>, <string-name name-style="western"><surname>Medland</surname>, <given-names>S. E.</given-names></string-name>, <string-name name-style="western"><surname>Gillespie</surname>, <given-names>N. A.</given-names></string-name>, <string-name name-style="western"><surname>Hatton</surname>, <given-names>S. N.</given-names></string-name>, <string-name name-style="western"><surname>Lagopoulos</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Veltman</surname>, <given-names>D. J.</given-names></string-name>, <string-name name-style="western"><surname>van der Wee</surname>, <given-names>N.</given-names></string-name>, <string-name name-style="western"><surname>van Erp</surname>, <given-names>T. G. M.</given-names></string-name>, <string-name name-style="western"><surname>Wittfeld</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western"><surname>Grabe</surname>, <given-names>H. J.</given-names></string-name>, <string-name name-style="western"><surname>Block</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Hegenscheid</surname>, <given-names>K.</given-names></string-name>, &#8230; <string-name name-style="western"><surname>Hickie</surname>, <given-names>I. B.</given-names></string-name> (<year>2017</year>). <article-title>Subcortical brain structure and suicidal behaviour in major depressive disorder: A meta&#8208;analysis from the ENIGMA&#8208;MDD working group</article-title>. <source>Translational Psychiatry</source>, <volume>7</volume>, <elocation-id>e1116</elocation-id>.<pub-id pub-id-type="pmid">28463239</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/tp.2017.84</pub-id><pub-id pub-id-type="pmcid">PMC5534952</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0070"><mixed-citation publication-type="book" id="hbm26235-cit-0070"><string-name name-style="western"><surname>Revelle</surname>, <given-names>W.</given-names></string-name> (<year>2021</year>). <source>Psych: Procedures for psychological, psychometric, and personality research [computer program]. Version R package version 2.1.9</source>. <publisher-name>Northwestern University</publisher-name>.</mixed-citation></ref><ref id="hbm26235-bib-0071"><mixed-citation publication-type="book" id="hbm26235-cit-0071"><collab collab-type="authors">RStudioTeam</collab>
. <source>RStudio: Integrated development for R</source>. <year>2020</year>.</mixed-citation></ref><ref id="hbm26235-bib-0072"><mixed-citation publication-type="journal" id="hbm26235-cit-0072"><string-name name-style="western"><surname>Ryan</surname>, <given-names>M. C.</given-names></string-name>, <string-name name-style="western"><surname>Hong</surname>, <given-names>L. E.</given-names></string-name>, <string-name name-style="western"><surname>Hatch</surname>, <given-names>K. S.</given-names></string-name>, <string-name name-style="western"><surname>Gao</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Haerian</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Goldwaser</surname>, <given-names>E. L.</given-names></string-name>, <string-name name-style="western"><surname>du</surname>, <given-names>X.</given-names></string-name>, <string-name name-style="western"><surname>Adhikari</surname>, <given-names>B. M.</given-names></string-name>, <string-name name-style="western"><surname>Bruce</surname>, <given-names>H.</given-names></string-name>, <string-name name-style="western"><surname>Hare</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Kvarta</surname>, <given-names>M. D.</given-names></string-name>, <string-name name-style="western"><surname>Jahanshad</surname>, <given-names>N.</given-names></string-name>, <string-name name-style="western"><surname>Nichols</surname>, <given-names>T. E.</given-names></string-name>, <string-name name-style="western"><surname>Thompson</surname>, <given-names>P. M.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Kochunov</surname>, <given-names>P.</given-names></string-name> (<year>2022</year>). <article-title>The additive impact of cardio&#8208;metabolic disorders and psychiatric illnesses on accelerated brain aging</article-title>. <source>Human Brain Mapping</source>, <volume>43</volume>, <fpage>1997</fpage>&#8211;<lpage>2010</lpage>.<pub-id pub-id-type="pmid">35112422</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/hbm.25769</pub-id><pub-id pub-id-type="pmcid">PMC8933252</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0073"><mixed-citation publication-type="journal" id="hbm26235-cit-0073"><string-name name-style="western"><surname>Ryan</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western"><surname>Kochunov</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western"><surname>Rowland</surname>, <given-names>L. M.</given-names></string-name>, <string-name name-style="western"><surname>Mitchell</surname>, <given-names>B. D.</given-names></string-name>, <string-name name-style="western"><surname>Wijtenburg</surname>, <given-names>S. A.</given-names></string-name>, <string-name name-style="western"><surname>Fieremans</surname>, <given-names>E.</given-names></string-name>, <string-name name-style="western"><surname>Veraart</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Novikov</surname>, <given-names>D. S.</given-names></string-name>, <string-name name-style="western"><surname>du</surname>, <given-names>X.</given-names></string-name>, <string-name name-style="western"><surname>Adhikari</surname>, <given-names>B.</given-names></string-name>, <string-name name-style="western"><surname>Fisseha</surname>, <given-names>F.</given-names></string-name>, <string-name name-style="western"><surname>Bruce</surname>, <given-names>H.</given-names></string-name>, <string-name name-style="western"><surname>Chiappelli</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Sampath</surname>, <given-names>H.</given-names></string-name>, <string-name name-style="western"><surname>Ament</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>O'Connell</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Shuldiner</surname>, <given-names>A. R.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Hong</surname>, <given-names>L. E.</given-names></string-name> (<year>2017</year>). <article-title>Lipid metabolism, abdominal adiposity, and cerebral health in the Amish</article-title>. <source>Obesity (Silver Spring)</source>, <volume>25</volume>, <fpage>1876</fpage>&#8211;<lpage>1880</lpage>.<pub-id pub-id-type="pmid">28834322</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/oby.21946</pub-id><pub-id pub-id-type="pmcid">PMC5667552</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0074"><mixed-citation publication-type="journal" id="hbm26235-cit-0074"><string-name name-style="western"><surname>Schmaal</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western"><surname>Hibar</surname>, <given-names>D. P.</given-names></string-name>, <string-name name-style="western"><surname>Samann</surname>, <given-names>P. G.</given-names></string-name>, <string-name name-style="western"><surname>Hall</surname>, <given-names>G. B.</given-names></string-name>, <string-name name-style="western"><surname>Baune</surname>, <given-names>B. T.</given-names></string-name>, <string-name name-style="western"><surname>Jahanshad</surname>, <given-names>N.</given-names></string-name>, <string-name name-style="western"><surname>Cheung</surname>, <given-names>J. W.</given-names></string-name>, <string-name name-style="western"><surname>van Erp</surname>, <given-names>T. G. M.</given-names></string-name>, <string-name name-style="western"><surname>Bos</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western"><surname>Ikram</surname>, <given-names>M. A.</given-names></string-name>, <string-name name-style="western"><surname>Vernooij</surname>, <given-names>M. W.</given-names></string-name>, <string-name name-style="western"><surname>Niessen</surname>, <given-names>W. J.</given-names></string-name>, <string-name name-style="western"><surname>Tiemeier</surname>, <given-names>H.</given-names></string-name>, <string-name name-style="western"><surname>Hofman</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Wittfeld</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western"><surname>Grabe</surname>, <given-names>H. J.</given-names></string-name>, <string-name name-style="western"><surname>Janowitz</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western"><surname>B&#252;low</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western"><surname>Selonke</surname>, <given-names>M.</given-names></string-name>, &#8230; <string-name name-style="western"><surname>Veltman</surname>, <given-names>D. J.</given-names></string-name> (<year>2017</year>). <article-title>Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA Major Depressive Disorder Working Group</article-title>. <source>Molecular Psychiatry</source>, <volume>22</volume>, <fpage>900</fpage>&#8211;<lpage>909</lpage>.<pub-id pub-id-type="pmid">27137745</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/mp.2016.60</pub-id><pub-id pub-id-type="pmcid">PMC5444023</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0075"><mixed-citation publication-type="journal" id="hbm26235-cit-0075"><string-name name-style="western"><surname>Schmaal</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western"><surname>Veltman</surname>, <given-names>D. J.</given-names></string-name>, <string-name name-style="western"><surname>van Erp</surname>, <given-names>T. G.</given-names></string-name>, <string-name name-style="western"><surname>S&#228;mann</surname>, <given-names>P. G.</given-names></string-name>, <string-name name-style="western"><surname>Frodl</surname>, <given-names>T.</given-names></string-name>, <string-name name-style="western"><surname>Jahanshad</surname>, <given-names>N.</given-names></string-name>, <string-name name-style="western"><surname>Loehrer</surname>, <given-names>E.</given-names></string-name>, <string-name name-style="western"><surname>Tiemeier</surname>, <given-names>H.</given-names></string-name>, <string-name name-style="western"><surname>Hofman</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Niessen</surname>, <given-names>W. J.</given-names></string-name>, <string-name name-style="western"><surname>Vernooij</surname>, <given-names>M. W.</given-names></string-name>, <string-name name-style="western"><surname>Ikram</surname>, <given-names>M. A.</given-names></string-name>, <string-name name-style="western"><surname>Wittfeld</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western"><surname>Grabe</surname>, <given-names>H. J.</given-names></string-name>, <string-name name-style="western"><surname>Block</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Hegenscheid</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western"><surname>V&#246;lzke</surname>, <given-names>H.</given-names></string-name>, <string-name name-style="western"><surname>Hoehn</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western"><surname>Czisch</surname>, <given-names>M.</given-names></string-name>, &#8230; <string-name name-style="western"><surname>Hibar</surname>, <given-names>D. P.</given-names></string-name> (<year>2016</year>). <article-title>Subcortical brain alterations in major depressive disorder: Findings from the ENIGMA Major Depressive Disorder Working Group</article-title>. <source>Molecular Psychiatry</source>, <volume>21</volume>, <fpage>806</fpage>&#8211;<lpage>812</lpage>.<pub-id pub-id-type="pmid">26122586</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/mp.2015.69</pub-id><pub-id pub-id-type="pmcid">PMC4879183</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0076"><mixed-citation publication-type="journal" id="hbm26235-cit-0076"><string-name name-style="western"><surname>Scott</surname>, <given-names>J. A.</given-names></string-name>, <string-name name-style="western"><surname>Braskie</surname>, <given-names>M. N.</given-names></string-name>, <string-name name-style="western"><surname>Tosun</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western"><surname>Thompson</surname>, <given-names>P. M.</given-names></string-name>, <string-name name-style="western"><surname>Weiner</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western"><surname>DeCarli</surname>, <given-names>C.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Carmichael</surname>, <given-names>O. T.</given-names></string-name> (<year>2015</year>). <article-title>Cerebral amyloid and hypertension are independently associated with White matter lesions in elderly</article-title>. <source>Frontiers in Aging Neuroscience</source>, <volume>7</volume>, <fpage>221</fpage>.<pub-id pub-id-type="pmid">26648866</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fnagi.2015.00221</pub-id><pub-id pub-id-type="pmcid">PMC4664630</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0077"><mixed-citation publication-type="journal" id="hbm26235-cit-0077"><string-name name-style="western"><surname>Simon</surname>, <given-names>N. M.</given-names></string-name>, <string-name name-style="western"><surname>Smoller</surname>, <given-names>J. W.</given-names></string-name>, <string-name name-style="western"><surname>McNamara</surname>, <given-names>K. L.</given-names></string-name>, <string-name name-style="western"><surname>Maser</surname>, <given-names>R. S.</given-names></string-name>, <string-name name-style="western"><surname>Zalta</surname>, <given-names>A. K.</given-names></string-name>, <string-name name-style="western"><surname>Pollack</surname>, <given-names>M. H.</given-names></string-name>, <string-name name-style="western"><surname>Nierenberg</surname>, <given-names>A. A.</given-names></string-name>, <string-name name-style="western"><surname>Fava</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Wong</surname>, <given-names>K.&#8208;K.</given-names></string-name> (<year>2006</year>). <article-title>Telomere shortening and mood disorders: Preliminary support for a chronic stress model of accelerated aging</article-title>. <source>Biological Psychiatry</source>, <volume>60</volume>, <fpage>432</fpage>&#8211;<lpage>435</lpage>.<pub-id pub-id-type="pmid">16581033</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biopsych.2006.02.004</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0078"><mixed-citation publication-type="journal" id="hbm26235-cit-0078"><string-name name-style="western"><surname>Smucny</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Cornier</surname>, <given-names>M. A.</given-names></string-name>, <string-name name-style="western"><surname>Eichman</surname>, <given-names>L. C.</given-names></string-name>, <string-name name-style="western"><surname>Thomas</surname>, <given-names>E. A.</given-names></string-name>, <string-name name-style="western"><surname>Bechtell</surname>, <given-names>J. L.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Tregellas</surname>, <given-names>J. R.</given-names></string-name> (<year>2012</year>). <article-title>Brain structure predicts risk for obesity</article-title>. <source>Appetite</source>, <volume>59</volume>, <fpage>859</fpage>&#8211;<lpage>865</lpage>.<pub-id pub-id-type="pmid">22963736</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.appet.2012.08.027</pub-id><pub-id pub-id-type="pmcid">PMC4111642</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0079"><mixed-citation publication-type="journal" id="hbm26235-cit-0079"><string-name name-style="western"><surname>Spieker</surname>, <given-names>E. A.</given-names></string-name>, <string-name name-style="western"><surname>Kochunov</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western"><surname>Rowland</surname>, <given-names>L. M.</given-names></string-name>, <string-name name-style="western"><surname>Sprooten</surname>, <given-names>E.</given-names></string-name>, <string-name name-style="western"><surname>Winkler</surname>, <given-names>A. M.</given-names></string-name>, <string-name name-style="western"><surname>Olvera</surname>, <given-names>R. L.</given-names></string-name>, <string-name name-style="western"><surname>Almasy</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western"><surname>Duggirala</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western"><surname>Fox</surname>, <given-names>P. T.</given-names></string-name>, <string-name name-style="western"><surname>Blangero</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Glahn</surname>, <given-names>D. C.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Curran</surname>, <given-names>J. E.</given-names></string-name> (<year>2015</year>). <article-title>Shared genetic variance between obesity and white matter integrity in Mexican Americans</article-title>. <source>Frontiers in Genetics</source>, <volume>6</volume>, <fpage>26</fpage>.<pub-id pub-id-type="pmid">25763009</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fgene.2015.00026</pub-id><pub-id pub-id-type="pmcid">PMC4327744</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0080"><mixed-citation publication-type="journal" id="hbm26235-cit-0080"><string-name name-style="western"><surname>Suvila</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western"><surname>Lima</surname>, <given-names>J. A. C.</given-names></string-name>, <string-name name-style="western"><surname>Cheng</surname>, <given-names>S.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Niiranen</surname>, <given-names>T. J.</given-names></string-name> (<year>2021</year>). <article-title>Clinical correlates of early&#8208;onset hypertension</article-title>. <source>American Journal of Hypertension</source>, <volume>34</volume>, <fpage>915</fpage>&#8211;<lpage>918</lpage>.<pub-id pub-id-type="pmid">33904901</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ajh/hpab066</pub-id><pub-id pub-id-type="pmcid">PMC8457426</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0081"><mixed-citation publication-type="journal" id="hbm26235-cit-0081"><string-name name-style="western"><surname>Toalson</surname>, <given-names>P.</given-names></string-name>, <string-name name-style="western"><surname>Ahmed</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Hardy</surname>, <given-names>T.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Kabinoff</surname>, <given-names>G.</given-names></string-name> (<year>2004</year>). <article-title>The metabolic syndrome in patients with severe mental illnesses</article-title>. <source>Primary Care Companion to the Journal of Clinical Psychiatry</source>, <volume>6</volume>, <fpage>152</fpage>&#8211;<lpage>158</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.4088/pcc.v06n0402</pub-id><pub-id pub-id-type="pmcid">PMC514841</pub-id><pub-id pub-id-type="pmid">15361918</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0082"><mixed-citation publication-type="miscellaneous" id="hbm26235-cit-0082"><string-name name-style="western"><surname>Torchiano</surname>, <given-names>M.</given-names></string-name> (<year>2020</year>). <article-title>
<italic toggle="yes">effsize: Efficient effect size computation</italic> [computer program]. Version R package version 0.8.1</article-title>.</mixed-citation></ref><ref id="hbm26235-bib-0083"><mixed-citation publication-type="journal" id="hbm26235-cit-0083"><string-name name-style="western"><surname>van Bussel</surname>, <given-names>F. C.</given-names></string-name>, <string-name name-style="western"><surname>Backes</surname>, <given-names>W. H.</given-names></string-name>, <string-name name-style="western"><surname>Hofman</surname>, <given-names>P. A.</given-names></string-name>, <string-name name-style="western"><surname>van Boxtel</surname>, <given-names>M. P. J.</given-names></string-name>, <string-name name-style="western"><surname>Schram</surname>, <given-names>M. T.</given-names></string-name>, <string-name name-style="western"><surname>Stehouwer</surname>, <given-names>C. D. A.</given-names></string-name>, <string-name name-style="western"><surname>Wildberger</surname>, <given-names>J. E.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Jansen</surname>, <given-names>J. F. A.</given-names></string-name> (<year>2016</year>). <article-title>Altered hippocampal White matter connectivity in type 2 diabetes mellitus and memory decrements</article-title>. <source>Journal of Neuroendocrinology</source>, <volume>28</volume>, <elocation-id>12366</elocation-id>.<pub-id pub-id-type="pmid">26791354</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/jne.12366</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0084"><mixed-citation publication-type="journal" id="hbm26235-cit-0084"><string-name name-style="western"><surname>van Erp</surname>, <given-names>T. G. M.</given-names></string-name>, <string-name name-style="western"><surname>Hibar</surname>, <given-names>D. P.</given-names></string-name>, <string-name name-style="western"><surname>Rasmussen</surname>, <given-names>J. M.</given-names></string-name>, <string-name name-style="western"><surname>Glahn</surname>, <given-names>D. C.</given-names></string-name>, <string-name name-style="western"><surname>Pearlson</surname>, <given-names>G. D.</given-names></string-name>, <string-name name-style="western"><surname>Andreassen</surname>, <given-names>O. A.</given-names></string-name>, <string-name name-style="western"><surname>Agartz</surname>, <given-names>I.</given-names></string-name>, <string-name name-style="western"><surname>Westlye</surname>, <given-names>L. T.</given-names></string-name>, <string-name name-style="western"><surname>Haukvik</surname>, <given-names>U. K.</given-names></string-name>, <string-name name-style="western"><surname>Dale</surname>, <given-names>A. M.</given-names></string-name>, <string-name name-style="western"><surname>Melle</surname>, <given-names>I.</given-names></string-name>, <string-name name-style="western"><surname>Hartberg</surname>, <given-names>C. B.</given-names></string-name>, <string-name name-style="western"><surname>Gruber</surname>, <given-names>O.</given-names></string-name>, <string-name name-style="western"><surname>Kraemer</surname>, <given-names>B.</given-names></string-name>, <string-name name-style="western"><surname>Zilles</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western"><surname>Donohoe</surname>, <given-names>G.</given-names></string-name>, <string-name name-style="western"><surname>Kelly</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>McDonald</surname>, <given-names>C.</given-names></string-name>, <string-name name-style="western"><surname>Morris</surname>, <given-names>D. W.</given-names></string-name>, &#8230; <collab collab-type="authors">for the ENIGMA Schizophrenia Working Group</collab>
. (<year>2016</year>). <article-title>Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium</article-title>. <source>Molecular Psychiatry</source>, <volume>21</volume>, <fpage>585</fpage>.<pub-id pub-id-type="pmid">26283641</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/mp.2015.118</pub-id><pub-id pub-id-type="pmcid">PMC5751698</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0085"><mixed-citation publication-type="journal" id="hbm26235-cit-0085"><string-name name-style="western"><surname>van Erp</surname>, <given-names>T. G. M.</given-names></string-name>, <string-name name-style="western"><surname>Walton</surname>, <given-names>E.</given-names></string-name>, <string-name name-style="western"><surname>Hibar</surname>, <given-names>D. P.</given-names></string-name>, <string-name name-style="western"><surname>Schmaal</surname>, <given-names>L.</given-names></string-name>, <string-name name-style="western"><surname>Jiang</surname>, <given-names>W.</given-names></string-name>, <string-name name-style="western"><surname>Glahn</surname>, <given-names>D. C.</given-names></string-name>, <string-name name-style="western"><surname>Pearlson</surname>, <given-names>G. D.</given-names></string-name>, <string-name name-style="western"><surname>Yao</surname>, <given-names>N.</given-names></string-name>, <string-name name-style="western"><surname>Fukunaga</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western"><surname>Hashimoto</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western"><surname>Okada</surname>, <given-names>N.</given-names></string-name>, <string-name name-style="western"><surname>Yamamori</surname>, <given-names>H.</given-names></string-name>, <string-name name-style="western"><surname>Bustillo</surname>, <given-names>J. R.</given-names></string-name>, <string-name name-style="western"><surname>Clark</surname>, <given-names>V. P.</given-names></string-name>, <string-name name-style="western"><surname>Agartz</surname>, <given-names>I.</given-names></string-name>, <string-name name-style="western"><surname>Mueller</surname>, <given-names>B. A.</given-names></string-name>, <string-name name-style="western"><surname>Cahn</surname>, <given-names>W.</given-names></string-name>, <string-name name-style="western"><surname>de Zwarte</surname>, <given-names>S. M. C.</given-names></string-name>, <string-name name-style="western"><surname>Hulshoff Pol</surname>, <given-names>H. E.</given-names></string-name>, &#8230; <string-name name-style="western"><surname>Orhan</surname>, <given-names>F.</given-names></string-name> (<year>2018</year>). <article-title>Cortical brain abnormalities in 4474 individuals with schizophrenia and 5098 control subjects via the enhancing neuro imaging genetics through meta analysis (ENIGMA) consortium</article-title>. <source>Biological Psychiatry</source>, <volume>84</volume>, <fpage>644</fpage>&#8211;<lpage>654</lpage>.<pub-id pub-id-type="pmid">29960671</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biopsych.2018.04.023</pub-id><pub-id pub-id-type="pmcid">PMC6177304</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0086"><mixed-citation publication-type="journal" id="hbm26235-cit-0086"><string-name name-style="western"><surname>van Harten</surname>, <given-names>B.</given-names></string-name>, <string-name name-style="western"><surname>Oosterman</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Muslimovic</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western"><surname>van Loon</surname>, <given-names>B. J.</given-names></string-name>, <string-name name-style="western"><surname>Scheltens</surname>, <given-names>P.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Weinstein</surname>, <given-names>H. C.</given-names></string-name> (<year>2007</year>). <article-title>Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitus</article-title>. <source>Age and Ageing</source>, <volume>36</volume>, <fpage>164</fpage>&#8211;<lpage>170</lpage>.<pub-id pub-id-type="pmid">17350976</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ageing/afl180</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0088"><mixed-citation publication-type="journal" id="hbm26235-cit-0088"><string-name name-style="western"><surname>van Velzen</surname>, <given-names>L. S.</given-names></string-name>, <string-name name-style="western"><surname>Kelly</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western"><surname>Isaev</surname>, <given-names>D.</given-names></string-name>, <string-name name-style="western"><surname>Aleman</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Aftanas</surname>, <given-names>L. I.</given-names></string-name>, <string-name name-style="western"><surname>Bauer</surname>, <given-names>J.</given-names></string-name>, <string-name name-style="western"><surname>Baune</surname>, <given-names>B. T.</given-names></string-name>, <string-name name-style="western"><surname>Brak</surname>, <given-names>I. V.</given-names></string-name>, <string-name name-style="western"><surname>Carballedo</surname>, <given-names>A.</given-names></string-name>, <string-name name-style="western"><surname>Connolly</surname>, <given-names>C. G.</given-names></string-name>, <string-name name-style="western"><surname>Couvy&#8208;Duchesne</surname>, <given-names>B.</given-names></string-name>, <string-name name-style="western"><surname>Cullen</surname>, <given-names>K. R.</given-names></string-name>, <string-name name-style="western"><surname>Danilenko</surname>, <given-names>K. V.</given-names></string-name>, <string-name name-style="western"><surname>Dannlowski</surname>, <given-names>U.</given-names></string-name>, <string-name name-style="western"><surname>Enneking</surname>, <given-names>V.</given-names></string-name>, <string-name name-style="western"><surname>Filimonova</surname>, <given-names>E.</given-names></string-name>, <string-name name-style="western"><surname>F&#246;rster</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western"><surname>Frodl</surname>, <given-names>T.</given-names></string-name>, <string-name name-style="western"><surname>Gotlib</surname>, <given-names>I. H.</given-names></string-name>, &#8230; <string-name name-style="western"><surname>Schmaal</surname>, <given-names>L.</given-names></string-name> (<year>2020</year>). <article-title>White matter disturbances in major depressive disorder: A coordinated analysis across 20 international cohorts in the ENIGMA MDD Working Group</article-title>. <source>Molecular Psychiatry</source>, <volume>25</volume>, <fpage>1511</fpage>&#8211;<lpage>1525</lpage>.<pub-id pub-id-type="pmid">31471575</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41380-019-0477-2</pub-id><pub-id pub-id-type="pmcid">PMC7055351</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0089"><mixed-citation publication-type="journal" id="hbm26235-cit-0089"><string-name name-style="western"><surname>Wolkowitz</surname>, <given-names>O. M.</given-names></string-name>, <string-name name-style="western"><surname>Reus</surname>, <given-names>V. I.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Mellon</surname>, <given-names>S. H.</given-names></string-name> (<year>2011</year>). <article-title>Of sound mind and body: Depression, disease, and accelerated aging</article-title>. <source>Dialogues in Clinical Neuroscience</source>, <volume>13</volume>, <fpage>25</fpage>&#8211;<lpage>39</lpage>.<pub-id pub-id-type="pmid">21485744</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.31887/DCNS.2011.13.1/owolkowitz</pub-id><pub-id pub-id-type="pmcid">PMC3181963</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0090"><mixed-citation publication-type="journal" id="hbm26235-cit-0090"><string-name name-style="western"><surname>Wu</surname>, <given-names>E. L.</given-names></string-name>, <string-name name-style="western"><surname>Chien</surname>, <given-names>I. C.</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname>, <given-names>C. H.</given-names></string-name>, <string-name name-style="western"><surname>Chou</surname>, <given-names>Y. J.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Chou</surname>, <given-names>P.</given-names></string-name> (<year>2012</year>). <article-title>Increased risk of hypertension in patients with major depressive disorder: A population&#8208;based study</article-title>. <source>Journal of Psychosomatic Research</source>, <volume>73</volume>, <fpage>169</fpage>&#8211;<lpage>174</lpage>.<pub-id pub-id-type="pmid">22850255</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpsychores.2012.07.002</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0091"><mixed-citation publication-type="journal" id="hbm26235-cit-0091"><string-name name-style="western"><surname>Xu</surname>, <given-names>W. L.</given-names></string-name>, <string-name name-style="western"><surname>Atti</surname>, <given-names>A. R.</given-names></string-name>, <string-name name-style="western"><surname>Gatz</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western"><surname>Pedersen</surname>, <given-names>N. L.</given-names></string-name>, <string-name name-style="western"><surname>Johansson</surname>, <given-names>B.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Fratiglioni</surname>, <given-names>L.</given-names></string-name> (<year>2011</year>). <article-title>Midlife overweight and obesity increase late&#8208;life dementia risk: A population&#8208;based twin study</article-title>. <source>Neurology</source>, <volume>76</volume>, <fpage>1568</fpage>&#8211;<lpage>1574</lpage>.<pub-id pub-id-type="pmid">21536637</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0b013e3182190d09</pub-id><pub-id pub-id-type="pmcid">PMC3100125</pub-id></mixed-citation></ref><ref id="hbm26235-bib-0092"><mixed-citation publication-type="journal" id="hbm26235-cit-0092"><string-name name-style="western"><surname>Zheng</surname>, <given-names>W.</given-names></string-name>, <string-name name-style="western"><surname>Jiang</surname>, <given-names>W. L.</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname>, <given-names>X.</given-names></string-name>, <string-name name-style="western"><surname>Cai</surname>, <given-names>D. B.</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname>, <given-names>J. W.</given-names></string-name>, <string-name name-style="western"><surname>Yin</surname>, <given-names>F.</given-names></string-name>, <string-name name-style="western"><surname>Ren</surname>, <given-names>P. C.</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname>, <given-names>H. W.</given-names></string-name>, <string-name name-style="western"><surname>Xiang</surname>, <given-names>Y. Q.</given-names></string-name>, <string-name name-style="western"><surname>Liang</surname>, <given-names>W. N.</given-names></string-name>, &amp; <string-name name-style="western"><surname>Zheng</surname>, <given-names>W.</given-names></string-name> (<year>2022</year>). <article-title>Use of the RBANS to evaluate cognition in patients with schizophrenia and metabolic syndrome: A meta&#8208;analysis of case&#8208;control studies</article-title>. <source>The Psychiatric Quarterly</source>, <volume>93</volume>, <fpage>137</fpage>&#8211;<lpage>149</lpage>.<pub-id pub-id-type="pmid">33751356</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11126-021-09889-9</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>